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General introduction
Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy in 
childhood. Boys with DMD suffer from progressive loss of muscle strength and loss of 
functional abilities from a very young age. They lose the ability to ambulate in their early 
teenage years and the ability to lift their arms soon after the onset of wheelchair 
dependency. Because there is no cure for DMD, patient management is symptomatic 
directed at relieving complaints, supporting bodily functions and activities, and optimizing 
social participation and quality of life. Recommendations on physical training in boys with 
DMD are focused on avoiding disuse atrophy and other secondary complications of 
physical inactivity. However, these recommendations are based on limited evidence. This 
thesis describes the development and results of the No Use is Disuse (NUD) study, an 
assisted physical training program for boys with DMD that aimed to delay the loss of 
functional abilities secondary to disuse. Furthermore, this thesis describes the validation of 
three specific outcome measures (i.e., quantitative skeletal muscle ultrasound (QMUS) to 
assess the muscle histology, the Assisted 6-Minute Cycling Test (A6MCT) to assess physical 
endurance, and the Kidscreen-52 to assess Health Related Quality of Life (HRQoL)) for 
monitoring disease progression and the effects of interventions.   
Duchenne muscular dystrophy 
Pathophysiology 
DMD affects approximately 1 in 5000 newborn boys.1 Girls who inherit a DMD mutation 
usually do not develop the disease, because the pattern of inheritance is X-linked recessive. 
DMD is caused by mutations in the DMD gene, resulting in an absence, or near-absence 
(<3%), of the functional protein dystrophin.2 Dystrophin forms a mechanical link between 
the actin filaments inside the muscle cells and the extracellular matrix, and it provides 
mechanical stability during muscle contractions (Figure 1). Absence of dystrophin results 
in fragile muscle fibers that are prone to contraction-induced injury, leading to ongoing 
cycles of degeneration and regeneration. These ongoing degenerative cycles cause 
chronic inflammation, impaired muscle tissue repair, and eventually a replacement of 
muscle fibers by fat and connective tissue.3
Clinical progression 
The course of DMD distinguishes a presymptomatic stage, an early and late ambulatory 
stage, and an early and late non-ambulatory stage.4 First, boys are in a presymptomatic 
stage in which they can still improve their functional abilities and do not show any balance 
or gait impairments.5 Subsequently, they develop early symptoms including a waddling 
gait, an inability to run and jump properly, difficulty with climbing stairs and frequent 
falls.4 Other early signs are pelvic girdle weakness indicated by the need for a Gowers’ 
maneuver (i.e., taking support and pushing off with the hands on the thighs to be able to 
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extend the knees, hips and trunk when rising from the floor), and by pseudo hypertrophy 
of the calves.6 The presence of these early signs often leads to a diagnosis around the 
age of 5 years.7 After a plateau stage (early ambulatory stage), in which the functional 
abilities neither improve nor decline, walking becomes increasingly difficult in the late 
ambulatory stage and boys lose the ability to climb stairs and to rise from the floor.5 
Eventually, boys completely lose their walking ability and become, if untreated, wheelchair 
dependent at an average age of 9 to 10 years.8-10 After the onset of wheelchair dependency, 
patients soon lose the ability to lift their arms against gravity (with only the distal muscles 
being able to overcome gravity) which results in severe limitations in motor capacities and 
in activities of daily living (ADL).9,11,12 Without treatment, Duchenne adolescents or young 
adults die prematurely in their twenties or early thirties due to heart and/or respiratory 
failure.13-15 
Figure 1   The location of dystrophin in skeletal muscle.
The dystrophin protein is located at the inside of the muscle cell membranes. It forms a mechanical 
link between the actin filaments of the cytoskeleton and, via its connexion to a group of other 
proteins in the cell membrane (i.e. the dystrophin-glycoprotein complex), the extracellular matrix. 
(Reprinted with permission from M. van Putten (2013). The influence of low dystropin levels on 
disease pathology in mouse models for Duchenne Muscular Dystrophy. Department of Human 
Genetics of the Leiden University Medical Center. Leiden, The Netherlands.)
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Treatment
Although promising therapies that aim to repair the disrupted dystrophin reading frame 
are now being developed16, there is no cure for DMD yet and boys still have to rely on 
symptomatic treatment. Symptomatic treatment in DMD includes rehabilitative interventions 
such as the use of corticosteroids, the management of respiratory, cardiac and orthopedic 
complications, the psychosocial management of stress associated with the progressive 
character of the disease, the management of gastrointestinal, speech/swallowing and 
nutritional problems and physiotherapy directed at the maintenance of joint mobility.4 
Corticosteroids are the only proven treatment to slow down the loss of muscle strength 
and prolong the ability to walk.8,17 Because there is no other cure, physiotherapy is 
important in the management of skeletal muscle complications such as contractures.18 
Physiotherapy
The primary aim of physiotherapy in the management of DMD is to minimize the 
development of joint contractures and maintain muscle length and strength in order to 
maximize functional capacities at all stages of the disease.19 The main techniques by which 
this aim is pursued are muscle stretching, joint splinting and physical training, but no clear 
guidelines on any of these methods exist. As a consequence, the applied techniques vary 
greatly. Currently, physical training often receives little attention in the management of 
DMD, since many physiotherapists focus on passive stretching.20 The reason for this is that 
they do not want to overburden the boys with too much training as exhaustion can be 
detrimental to the muscles, which can negatively affect training compliance. However, 
physiotherapists should be able to develop a safe training program for Duchenne patients 
that is relevant to their ADL and compatible with their actual disease status.18-20 Most 
importantly, physiotherapists need to be able to help these boys to remain as active as 
possible within their individual possibilities to prevent further physical deterioration due 
to disuse. But what exactly does the term ‘disuse’ stand for in the literature?
Disuse
Physical inactivity should be avoided in boys with DMD, because unloading the muscles 
results in a secondary physical deterioration.20,21 To illustrate the negative effects of 
physical inactivity, both bed rest for a simple fever and immobility after a lower limb 
fracture can lead to permanent loss of walking ability.22-25 Nevertheless, boys with DMD 
are particularly at risk of a sedentary lifestyle.26 This is not only because of the ongoing 
muscle weakness, but also because of the progressively limited physical and social 
activities that they are able to engage in.26 For example, the increasing amount of energy 
needed to ambulate and the increasing frequency of falls (without being able to stand up 
independently) will make boys move less and ‘force’ them to rely on a wheelchair. 
A wheelchair in its turn forces the boys to function within its confines, which accelerates 
the loss of reaching and lifting power of the arms. Thus, it is likely that the physical 
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deterioration in DMD is partly caused by ‘disuse’, which is defined here as a discrepancy 
between individual (latent) capacity and actual performance in daily life, as a result of a 
sedentary life style.21 From this perspective, the well-known saying “use it or lose it” seems 
to be highly applicable to boys with DMD. Physical training might therefore be beneficial 
to these patients if it prevents disuse and the related deterioration of the musculoskeletal 
and cardiovascular system. 
Physical training for Duchenne muscular dystrophy
Available scientific evidence
No clear training prescriptions exist for physical training in boys with DMD and only little 
research in this area has been conducted. Animal studies with mice who suffer from 
X-linked muscular dystrophy (mdx mice, the most commonly used mouse model in DMD 
research) showed that dynamic voluntary exercises (such as wheel running) had significant 
positive effects on muscle strength and fatigue resistance27,28, but they also showed that 
eccentric exercises accelerated muscle fiber injuries.29 Applying the results from animal 
studies to boys with DMD is, however, difficult. The research on training in DMD in man is 
limited to three studies investigating the effect of resistance exercises in ambulant 
boys.30-32 These studies concluded that submaximal resistance exercises did not cause any 
harm, but had only limited positive effects on muscle strength and timed functional tests 
(such as the time it took to walk 23 feet). A limitation of these studies was that they were 
conducted in uncontrolled settings, i.e. all boys received the training without comparison 
with a control group or control condition. No randomized controlled trial (RCT) concerning 
training has as yet been performed in boys with DMD. In general, the number of RCTs on 
physical training in muscle diseases is limited to five trials that included adults. These trials 
showed that moderate-intensity strength training and/or aerobic exercise training had 
limited value in patients with myotonic dystrophy type I, facioscapulohumeral muscular 
dystrophy, dermatomyositis and poliomyositis, but did not cause any harm either. A 
combination of strength training and aerobic exercises has been shown to increase 
submaximal endurance capacity in patients with mitochondrial myopathy. However, 
based on these trials no training advice can be deduced for boys with DMD.33   
Further intervention studies on physical training
The lack of RCTs on physical training in boys with DMD underscores the need for well 
controlled intervention studies in this area. Based on the current knowledge from animal 
studies and on pathophysiology, some recommendations can be made for such interventions. 
Boys with DMD are recommended to regularly participate in mildly intensive functional 
activities, including swimming and recreation-based exercises in the community, to avoid 
disuse.20 It is advised that eccentric (lengthening) exercises and exhausting high-load resistance 
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exercises are avoided.20,34-36 During eccentric exercises, actin and myosin filaments are 
pulled apart and cause damage to the stretched sarcomeres. This results in a loss of 
force-generating capacity and, with an inability to quickly repair this damage, subsequent 
fiber degeneration. In particular muscles with a lack of dystrophin, such as in DMD, are 
vulnerable to loss of force-generating capacity and fiber generation, probably because of 
the role that dystrophin plays in transmitting forces from the intracellular cytoskeleton to 
the extracellular matrix.35 Assisted physical training in which dynamic support is provided 
by a mechanic or electric device may be a feasible and a safe alternative for resistance training. 
Assistance would allow boys with severe muscle weakness to train their extremities 
without becoming exhausted, e.g. mechanical assistance by means of a powered or 
unpowered device reduces the muscle strength needed to train while subjects still 
contract their muscles. Yet, controlled research is needed to increase insight into what 
type of physical training boys with DMD can safely and effectively participate in throughout 
the course of their disease. This should lead to the development of more precise and 
evidence-based physical training recommendations reducing the uncertainty in boys with 
DMD and their families. In addition, appropriate outcome measures are needed to assess 
the effects of such physical training programs. 
Outcome measures for intervention studies in  
Duchenne muscular dystrophy
Prerequisites
Valid and reliable outcome measures are needed to evaluate the effect of training 
programs in DMD. Such measures should be sufficiently responsive to measure changes 
over time and should be related to clinical milestones such as the loss of the ability to 
walk.37 Furthermore, outcome measures should assess the varying levels of functional 
abilities and activities that are observed at the different ages.38 This means that they 
should be feasible for ambulant as well as wheelchair-dependent boys with DMD. 
Current set of clinical outcome measures
An overview of the most frequently used outcome measures in clinical trials in DMD is 
shown in Table 1. The most commonly used primary outcome measure in clinical trials is the 
Six-Minute Walk Test (6MWT), a submaximal physical endurance test.39 Although physical 
endurance tests are indeed clinically relevant since they are related to motor functioning 
in daily life39,40, a disadvantage of the 6MWT is that this test is not feasible for  wheelchair- 
dependent boys. A cycling test could be an alternative for more severely impaired boys, but 
the load of regular bicycle ergometers is often too high for these boys.41,42 
 Other proposed clinical outcome measures for boys with DMD include assessments 
of muscle strength, joint range of motion, activities of daily living, timed (functional) tests, 
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Table 1   Overview of frequently used outcome measures in DMD
Construct Instrument Advantages Disadvantages
Muscle 
histology
Biopsy Accurate Invasive
Sedation needed
MRI All muscles can be visualized Expensive
Sedation may be needed
QMUS Fast and child-friendly Normal values for each device 
required 
Muscle 
strength
HHD Continuous data 
Distinguishes between MRC 4 
and 5 
Not sensitive for muscles with 
strength MRC <3
MRC scale Fast
No HHD device needed
Not sensitive for muscles with 
strength MRC ≥4
Joint range 
of motion
Goniometry Fast and practical Test-retest reliability limited
3D motion 
analysis
Accurate and extensive Expensive
Time consuming 
Often not available
Physical 
endurance  
6MWT No specific equipment needed
Clear instructions 
Meaningful to patients
Not appropriate for wheelchair-
dependent boys
Fall risk 
Motor 
function 
Timed tests Fast
No specific equipment needed 
Difficult to analyze if a patient 
loses the ability to perform a test
HFMS/M-
HFMS
Minimal equipment needed Not appropriate for wheelchair-
dependent boys
Ceiling effect 
EK Meaningful to the patients Not appropriate for ambulant 
boys
Sensitiveness is limited
MFM Can be used in both ambulant 
and wheelchair-dependent boys
Generic
Limited number of items on 
proximal arm functions
NSAA Responsive to changes in motor 
functions over time
No items on arm function 
Not appropriate for wheelchair-
dependent boys
Jebsen Test Continuous data Assesses primarily hand-function
Test kit needed
HRQoL PedsQL DMD NMD module available No questions on psychological 
well-being 
MRI, Magnetic Resonance Imaging; QMUS, Quantitative Muscle Ultrasound; HHD, Hand-Held Dynamometry; 
MRC, Medical Research Council; 3D three dimensional; 6MWT, Six-Minute Walk Test; HFMS, Hammersmith 
Functional Motor Scale; M-HFMS, Modifief-Hammersmith Functional Motor Scale; EK, Egen Klassification; MFM, 
Motor Function Measure; NSAA, North Star Ambulatory Assessment; Jebsen Test, Jebsen-Taylor Hand Function 
Test; PedsQL DMD, Pediatric Quality of Life Inventory Duchenne Muscular Dystrophy Module 
(Table based on Mercuri et al. (2008), and adjusted.)
115
General introduction
and scales of general motor functioning.4,37,43,44 Especially the latter type of scale provides 
a composite score of various motor functions that allows to monitor disease progression 
and possible responsiveness to treatment. The Motor Function Measure (MFM) is the only 
scale of this type that assesses the functional abilities of both the lower and upper limbs. 
As such, it can be applied to ambulant and non-ambulant patients with a neuromuscular 
disorder (NMD).45 
Quantitative muscle imaging 
Quantitative muscle imaging is a relevant child-friendly supplement to the current set of 
clinical outcome measures in boys with DMD. It quantifies structural muscle changes 
underlying the functional deterioration.46,47 It is a non-invasive technique that is not 
influenced by fatigue, motivation or the ability to cooperate. To achieve motivation and 
cooperation is a challenge inherent in testing children, but especially in boys with DMD 
since cognitive deficits are present in approximately one-third of the patients.48,49 In 
particular the autism spectrum disorder and attention-deficit hyperactivity disorder 
(ADHD), affecting 3.1% and 11.7% of the boys with DMD respectively, can cause difficulty 
with following directions needed to perform clinical tests.50 Magnetic resonance imaging 
(MRI) is a highly reliable quantitative muscle imaging technique that assesses muscle 
histology in boys with DMD46,51, but it is expensive and not always available, while sedation 
is often needed in children. In contrast to MRI, quantitative muscle ultrasound (QMUS) is 
cheap, fast, child-friendly and does not require sedation. QMUS quantifies fatty infiltration 
and intramuscular fibrosis and distinguishes children with and without DMD with a 
positive predictive value of 86% and a negative predictive value of 95%.52,53,47 Yet, it is 
unknown whether QMUS is also sensitive to measure progressive changes in muscle 
structure over time and how these changes might relate to clinical disease progression 
and loss of functional abilities. 
Health related quality of life 
Finally, there is a need to determine how boys with DMD cope with situations in everyday 
life26 and how they perceive their own health status. Therefore, authorities such as the 
international Food and Drug Administration (FDA) have recognized that the inclusion of 
patient-reported outcome measures (PROM), such as Health Related Quality of Life 
(HRQoL) questionnaires, are useful in clinical trials.54 HRQoL refers to an individual’s 
perception of health and of one’s position in life. Although it is well-known that boys with 
DMD report lower physical well-being compared to healthy boys, little is known about 
the relationship between their HRQoL and disease severity as assessed with existing 
outcome measures.43 
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Aim of this thesis 
The main aim of the research presented in this thesis was to increase insight into the 
feasibility, safety and effectiveness of assisted physical training in boys with DMD who are 
ambulatory or wheelchair-dependent. In order to evaluate the effectiveness of the assisted 
physical training, three specific outcome measures were developed and/or validated. 
These aims led to the following main research questions that are addressed in this thesis: 
1)  Are QMUS, the Assisted Six-Minute Cycling Test (A6MCT) and HRQoL valid and/or 
responsive outcome measures to evaluate the effects of a physical training intervention 
in boys with DMD?
2)  Is assisted physical training feasible, safe and effective to delay the functional 
deterioration in ambulatory and wheelchair-dependent children with DMD? 
It was hypothesized that assisted physical training would delay the secondary functional 
deterioration due to disuse in DMD and that this delay could be assessed with QMUS, the 
A6MCT and HRQoL. 
Outline of this thesis
This thesis is divided into two parts addressing the previously specified main research 
questions. Part one encompasses the studies on outcome measures, whereas part two 
addresses the effectiveness of two assisted physical training programs.
Part 1 Outcome measures 
Chapter 2 starts with the investigation of the validity and responsiveness of QMUS by 
means of a longitudinal follow-up of 18 boys with DMD. In chapter 3, the development of 
the assisted 6-minute cycling test (A6MCT) meant to assess physical endurance is 
described. Its validity was examined in both healthy boys and boys with DMD. Chapter 4 
describes the HRQoL of boys with DMD who are either ambulant or wheelchair-depen-
dent as well as the HRQoL perception of the boys’ parents as assessed with the 
KIDSCREEN-52 questionnaire. 
Part 2 Physical training 
Chapter 5 describes the protocol of the No Use is Disuse (NUD) study. The NUD study is 
the first study in boys with DMD that examines whether assisted physical training is safe 
and beneficial to preserve muscle endurance and functional abilities. The study consists 
of two assisted physical training programs: study 1 “Dynamic leg and arm training for 
ambulant and recently wheelchair-dependent boys with DMD” (an RCT), and study 2 
“Functional training with arm-support for boys with DMD who have been confined to a 
wheelchair for several years” (a feasibility study). The results of these two physical training 
programs are described in chapter 6 and chapter 7, respectively. 
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In chapter 8, the methods and results of the studies in this thesis are summarized and 
subsequently discussed. Furthermore, recommendations for further research are provided. 
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Abstract
Responsive outcome measures are needed to follow the disease status of Duchenne 
muscular dystrophy (DMD) patients, as new therapeutic approaches become available for 
affected boys. Quantitative muscle ultrasound (QMUS) is potentially an attractive follow 
up tool for DMD because it reflects the severity of the dystrophic process without the 
need for invasive procedures, by quantifying echo intensity (i.e. mean grey level of muscle 
images) and muscle thickness. We performed a longitudinal follow-up of lower and upper 
extremity QMUS in 18 DMD patients and compared this with physical functioning in 11 of 
these patients. QMUS could be performed in every patient, and no patient was subjected 
to more than a total of 20 min of ultrasound scanning time for this study. As expected we 
found a significant increase of echo intensity with age, reflecting increasing dystrophic 
muscle changes. This increase was related to ambulatory status, functional grading, 
muscle strength and motor ability. Our study establishes QMUS as a practical and 
child-friendly tool for the longitudinal follow up of DMD patients.
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Introduction 
Duchenne muscular dystrophy (DMD) is the most common debilitating neuromuscular 
disorder affecting young boys and their families. In the past decade new and promising 
therapeutic approaches have become available that need validation in practice. For this, 
responsive outcome measures are needed to quantify the disease status of boys with 
DMD. Such outcome measures also need to be practical, feasible in young children and 
patient friendly, and should therefore preferably be noninvasive.
The frequently used battery of clinical outcomes for DMD consists of quantitative muscle 
strength tests, the Six-Minute Walk Test1, functional scales and timed function tests.2 
Although these outcome measures are clinically meaningful and have an immediate 
value to the boys and their parents, they also have their limitations. For example, sensitivity 
is often limited and ceiling effects exist for functional scales such as the Hammersmith 
Scale for Assessment of Motor Ability.2,3 Likewise, muscle strength tests have limited 
correlation with functionality because a small reduction in strength is often accompanied 
by a large reduction in functional ability when a paresis is already present.4 Specific testing 
can be difficult in the younger children for whom new therapies will preferably be 
intended. Taken together with the increased risk for cognitive5 and neurobehavioral 
problems6 in DMD, measuring these boys’ physical and functional capacities can be 
challenging.
Quantitative muscle ultrasound (QMUS) is a child-friendly imaging technique that is fast, 
painless and does not require sedation or anaesthesia.7,8 It provides an accurate and 
reliable tool to distinguish children with and without a neuromuscular disorder with high 
predictive values and can visualize the intramuscular fibrosis and fatty infiltration in DMD 
as a homogeneous increase of muscle echo intensity (i.e. the muscle becomes more 
echogenic, so that its image appears more uniformly filled with grey speckles).7,9-12
 Quantitative muscle imaging could be a relevant supplement to the current battery 
of clinical outcome measures, as it objectifies structural muscle changes without being 
influenced by fatigue, verbal understanding or cooperation, and can thus potentially 
quantify the pathology underlying deterioration of physical functioning without the need 
for muscle biopsy or sedated MR imaging. A recent cross-sectional study among 39 DMD 
patients has shown that the quantitatively determined muscle echo intensity of the elbow 
flexors linearly increased with age and correlated with physical functioning and disease 
severity.13 Using grayscale analysis, the echo intensity in healthy children does not change 
with age until they reach adulthood8,12, although the use of another quantifying technique 
showed a possible increase in calibrated muscle backscatter in a plot of the elbow flexors 
over time.13 Muscle echo intensity does increase significantly with age in healthy adults, 
probably as a result of age-related muscle replacement by fat and fibrous tissue.13-16
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It is suspected but not yet investigated that echo intensity and muscle thickness of lower 
extremity muscles correlate with age and disease severity in DMD boys. It is also still 
unknown whether quantitatively assessed echo intensity and muscle thickness are 
sensitive enough to measure progressive changes in muscle structure over time or how 
strongly these changes are associated with clinical disease progression and loss of 
function. The aim of our study was therefore to perform a longitudinal follow up of the 
changes and relation of lower and upper extremity QMUS with age, disease severity and 
physical functioning in a cohort of DMD boys. The objective was to assess whether QMUS 
can be used as a responsive follow up tool in upcoming treatment trials for DMD.
Methods
Design and patients
The longitudinal observational cohort study was conducted at the Radboud University 
Nijmegen Medical Centre. Nineteen boys with a DNA-confirmed diagnosis of DMD who 
regularly visited the out-patient clinic of the Radboud University Nijmegen Medical Centre 
were included. Data were obtained in a period without changes in the boys’ glucocorti-
coids regimen. Follow-up data were obtained from November 2006 to April 2010. Time 
intervals between measurements were allowed to vary. As the clinical and ultrasound 
assessments were part of our routine multidisciplinary care for DMD, no specific informed 
consent was obtained, but our institutional review board approved non-invasive skeletal 
muscle ultrasound data collection for this group of patients. Data were handled according 
to the guidelines for Good Clinical Practice.
Clinical assessments
Clinical assessments included grading of the ambulatory status (ambulant versus wheel-
chair-dependent), functional grading scales for the lower and upper extremity (Vignos 
and Brooke scales; see below), quantitative muscle testing of elbow flexors and knee 
extensors using dynamometry, and assessments of disease severity using the Childhood 
Myositis Assessment Scale and the Hammersmith Motor Ability Scale (see below). 
Unfortunately, our routine care did not yet include the Six-Minute Walk Test for endurance. 
Measurements were performed by three experienced pediatric physiotherapists. All 
clinical assessments were performed within 3 months of the QMUS measurements.
Functional grading
The Vignos functional grade, as described by Brooke in 198117, grades the severity of the 
involvement of the hips and legs on a scale from 1 (“Walks and climbs without assistance”) 
to 10 (“Is confined to bed”). The Brooke functional grade grades the severity of the 
involvement of the arms and shoulders on a scale from 1 (“Starting with the arms at the 
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sides, the patient can abduct the arms in a full circle until they touch above the head”) to 
7 (“Cannot raise hands to mouth and has no useful function of hands”).17 Both functional 
grades have been shown to have good inter- and intra-rater reliability17,18 and to correlate 
moderately with muscle strength19 in boys with DMD.
Quantitative muscle strength testing
Muscle strength of the elbow flexors (left side) and knee extensors (right side) was 
assessed with a hand-held dynamometer (MicroFet II, Biometrics, Almere, The Netherlands). 
Patient and therapist position, stabilization, myometer position and instructions were 
standardized20. Measurements were performed using the “break technique”.20 Both muscle 
groups were tested three times at 30 s intervals and the highest value of these contractions 
was recorded. Measurement results were recorded in Newton. Z-scores were calculated 
from normal values (obtained by subtracting the normal value from the measured value 
and then dividing the difference by the SD of the normal value) established by Beenakker 
et al. (2001).20 All results are presented as z-scores. Previous studies have shown good 
inter-rater reliability21 and moderate correlations of dynamometry with functional timed 
tests4 in boys with DMD.
Childhood Myositis Assessment Scale
As the Childhood Myositis Assessment Scale (CMAS) is used routinely as a follow-up tool 
for children with neuromuscular disorders at our centre, we assessed the severity of 
muscle involvement with this quantitative, observational, performance-based outcome 
measure which was originally developed for children with juvenile idiopathic inflammatory 
myopathies (IIM).22 The CMAS consists of 14 physical tests which mainly assess proximal 
and axial muscle groups. The maximum score is 52 points with a higher score indicating a 
greater muscle function, strength and endurance. Previous studies have shown good 
inter- and intra-rater reliability, construct validity and responsiveness in children with 
juvenile IIM.22,23 No studies have yet been conducted to assess the feasibility of the CMAS 
in boys with DMD.
Hammersmith Motor Ability Scale 
Motor ability was assessed using the Hammersmith Motor Ability Scale (HMAS). The HMAS 
consists of 20 assessments of axial and lower extremity abilities. Each item is scored on a 
3-point scale (2 = succeeds, 1 = succeeds with minimal assistance, 0 = unable to perform) 
and the scale has a maximum score of 40. A previous study has shown a high inter-rater 
reliability and a strong correlation with a total muscle strength score in boys with DMD.3
Quantitative muscle ultrasound measurements
Assessments were conducted with a real-time ultrasound scanner (IU22, Philips Healthcare, 
Eindhoven, The Netherlands) and a 17-5 MHz broadband linear transducer. Machine 
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settings were determined experimentally to achieve muscle ultrasound images in which 
healthy muscle and subcutaneous tissue appeared relatively black with strong reflections 
of fascia and bone. System settings were kept constant throughout the study, using a gain 
of 70, compression of 55, the time gain compensation switches in neutral position and the 
image focal zone at a depth of 1.0-2.5 cm. Power output was set so that the Tissue Index 
was 0.1 and the Mechanical Index was 0.8. We chose Gray Map #2 as this was the most 
linear look-up table, and we set 2D image optimization to “Gen” and persistency to “Low”. 
Additional image enhancement settings (e.g. Sono-CT and Xres) were not applied. 
 Boys were examined supine with their arms and legs extended (as much as possible 
in case of contractures) and their muscles relaxed. Quantitative ultrasound measurements 
were performed according to a standard protocol as previously described.8 A generous 
amount of contact gel was used to minimize the required pressure of the transducer on 
the skin. All scans were made in the transverse plane with a standard transducer location 
corresponding to the muscle belly, at the following anatomical sites: the biceps brachii 
muscle (BB) at two-thirds of the distance from the acromion to the antecubital crease; the 
forearm flexors (FF) at two-fifths of the distance from the antecubital crease to the distal 
end of the radius; the rectus femoris muscle (RF) halfway along the line from the anterior 
superior iliac spine to the superior aspect of the patella; and the tibialis anterior muscle 
(TA) at one-quarter of the distance from the inferior aspect of the patella to the lateral 
malleolus.
 For each muscle three consecutive measurements were made to minimize variation 
in echo intensity during analysis and the screen images of these measurements were 
stored offline in DICOM format. We did not use zoom or change the depth settings during 
the study as this would potentially alter echo intensity. As oblique scanning angles can 
lead to incorrect muscle thickness and echo intensity measurements, this was avoided by 
adjusting the angle of the probe until the best bone echo was obtained in every image.
 The captured images were analyzed offline for echo intensity by means of comput-
er-assisted grayscale histogram analysis, using custom software (Qumia) developed at our 
center. In each of the stored muscle images, a region of interest (ROI) was manually 
selected. The ROI was defined as the region that included as much muscle mass as 
possible without bone and fascia. Next, the software automatically selected the upper 
one-third of each ROI from the depth of the entire cross sectional area measured from the 
most superficial pixel to the deepest pixel within the ROI (Figure 1). This was done because 
of attenuation of the ultrasound beam in more severely affected dystrophic muscles 
(Figure 2), which would falsely lower the mean muscle echo intensity.12 From the selected 
region the mean muscle echo intensity was calculated based on a histogram analysis.
 As this study was performed with a different ultrasound device than that used to 
establish our database of normal values8, we converted all echo intensity values using a 
meat phantom and the conversion equation previously established and described.24 This 
conversion resulted in reliable results.24
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 Muscle thickness was measured online with electronic calipers at standardized 
positions.8 The biceps brachii muscle was measured between the bone echo of the 
humerus and the superficial fascia of the biceps (which includes the brachialis muscle); 
the forearm flexors between the interosseous membrane (next to the radius) and the 
ventral fascia of the most ventral flexors; the quadriceps muscle between the bone echo 
of the femur and the superficial fascia of the rectus femoris (which includes the rectus 
femoris and vastus intermedius); the tibialis anterior muscle between the interosseous 
membrane (next to the tibia) and the ventral fascia of the tibialis anterior muscle.
Figure 1  Quantitative ultrasound measurements were performed for the biceps brachii 
muscle (A), forearmflexors (B), rectus femoris muscle (C) and tibialis anterior muscle (D). 
A region of interest was selected for each muscle and included as much muscle mass as possible 
without bone and fascia (white lasso). The upper one-third of each ROI was automatically selected 
(dotted lines) from which the mean echo intensity was calculated. 
Bi, biceps brachii muscle; Br, brachialis muscle; H, humerus; Ff, forearmflexors; R, radius; U, ulna;, Rf, 
rectus femoris muscle; Vi, vastus intermedius muscle; Ta, tibialis anterior muscle; Ti, Tibia.
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Data analysis
Statistical analyses were performed using SPSS v. 16.0 for Windows (SPSS Inc., Chicago, IL, 
USA). A p-value of <0.05 was considered to be significant.
 Muscle thickness was first corrected for weight as described in a previous study by 
Scholten et al. (2003).8 Echo intensity did not need to be corrected for age, weight or sex, 
as it was found to be independent of these variables until the age of 18 years.8 QMUS 
results (echo intensity and muscle thickness) were compared to muscle specific reference 
values and expressed as z-scores. Z-scores represent the number of standard deviations 
from the mean. They were calculated by subtracting the reference value from the 
measured value and then dividing the difference by the standard deviation of the 
reference value for that patient.25 Analyses were done for the composite sum scores (sum 
z-scores biceps brachii muscle, forearm flexors, rectus femoris muscle and tibialis anterior 
muscle) as well as for the individual muscles (z-scores) separately. A Kolmogorov Smirnoff 
test confirmed that all ultrasound parameters showed a normal distribution (p = 0.20).
Analysis of age related changes
First it was investigated whether the ultrasound parameters changed significantly with 
age. This was performed using a linear Generalized Estimating Equation analysis (GEE).26,27 
GEE uses all available data for each subject and corrects for observations made at different 
Figure 2  Echo intensities for a healthy boy and boys with DMD. Transverse scan of the 
rectus femoris muscle of a healthy boy (A), an ambulant young boy with DMD (B), and a 
wheelchair-dependent teenage boy with DMD (C).  
The healthy 5-year old boy showed a normal echo intensity (z-score 0.1), whereas the 4.6 years old 
young boy with DMD showed already a mildly increased echo intensity (z-score 3.0). The teenage 
boy with DMD (10.6 years old) showed a strongly increased echo intensity (z-score 7.6) with an 
absent of the bone echo. RF, rectus femoris muscle; VI, vastus intermedius muscle; F, femur. Dotted 
line represents the border of the rectus femoris muscle, which was the region of interest for the 
calculation of the mean echo intensity.
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time intervals. Additionally, GEE corrects for the dependency of the observations from a 
single participant. A regression coefficient (β) was calculated, which expresses the 
relationship between the longitudinal development of the outcome variable (the 
ultrasound parameters) and the corresponding predictor variable (age per year). Therefore, 
β reflects the amount of change per year. In an additional GEE analysis, an age squared 
term (age²) was added to the GEE analysis in order to investigate whether a ceiling effect 
with age exists.27 Such a ceiling was expected to exist, as completely dystrophic muscles 
cannot further degenerate.
 Second, of the parameters that showed a significant increase with age in the GEE 
analysis, we analysed whether a significant change could be found over a 1 year time 
period, to evaluate if that parameter could be used in a treatment trial that would run for 
1 year. This was performed using a Standardized Response Mean analysis (SRM), which 
evaluates the changes in QMUS at a 1 year interval by dividing the mean score by the 
standard deviation of the change scores. SRM values of 0.2, 0.5 and 0.8 represent small, 
moderate and large values of responsiveness, respectively.28,29 Of each participant the 
first two assessments with one year interval that included both QMUS and clinical 
measurements were selected.
Relation between QMUS and other clinical parameters
Longitudinal relations between QMUS and disease severity and physical functioning were 
also examined using GEE, in which β reflects the relationship between the development 
of the ultrasound parameters and the corresponding clinical parameters. SRM analysis 
was performed to see if a significant change over a year could be observed for any of the 
clinical parameters.
Cross sectional data analysis
To make our results comparable with a previous study13 we also derived cross-sectional 
data from the first assessment of each participant that included both clinical measurements 
and muscle ultrasound during the study period. An independent t-test was used to 
compare the echo intensities of ambulant and wheelchair-dependent boys. Correlations 
between QMUS and age, disease severity and physical functioning were calculated using 
Pearson correlation coefficients (r) for continuous data and Spearman correlation 
coefficients (ρ) for ordinal data. 
Results
Study population characteristics 
Longitudinal follow-up data were available for 18 DMD boys; 15 ambulatory and 3 wheel-
chair-dependent, between the age of 3.7 and 15.1 years (median 8) (Table 1). All (but one) 
boy used corticosteroids (Prednisone) in a 10 days on 10 days off schedule of 0.75 mg/kg 
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during the study period. A total of 63 ultrasound measurements were performed with a 
median of 3.5 measurements per boy (range 2-5). Every ultrasound exam, including the 
positioning of the patient and transducer, and the performance of three scans of each 
muscle, could be performed in less than 20 min. An additional 10 min were needed for the 
manual selection of the ROI’s of each patient, the calculation of the mean echo intensity 
and muscle thickness and report generation. Median follow-up was 27.5 months 
(interquartile range (IQR) 22.5-32) with a median interval between two consecutive 
measurements of 11 months (IQR 8-12).
Table 1   Characteristics of the participants
n First assessment n Final assessment 
Demographics
Age (mean±SD (range))
Clinical assessements
Functional status (%)
- Ambulant
- Wheelchair-dependent
19
19
8.36±3.00 (3.72 – 15.10)
15 (79)
4 (21)
18
18
10.21±2.49 (6.26 – 15.20)
12 (67)
6 (33)
Median Vignos (range) 8 5 (2 -10) 13 2 (1 – 10) 
Median Brooke (range) 8 2 (1 - 5) 13 1 (1 – 5)
Mean muscle strength  
(mean z-scores) (SD)
- Elbow flexor (left side)
- Knee extensor (right side) 
7
6
-4.40 (2.28) 
-3.86 (0.71) 
11
11
-4.20 (1.84)
-3.18 (1.25)
Median CMAS (range) 7 27 (1 – 40) 13 25 (0 – 39) 
Median HMAS (range) 7 28 (0 – 35) 13 26 (0 – 30)
Quantitative skeletal muscle 
ultrasound measures
Mean echo intensity  
(mean z-scores) (SD)
- Composite sum score
- Biceps brachii muscle
- Tibialis anterior muscle
- Rectus femoris muscle
- Forearm flexors 
19
19
19
19
19
14.28 (8.64) 
3.06 (2.16) 
3.13 (1.95) 
5.29 (2.45) 
2.80 (2.69) 
18 
18
18 
18
17
18.60 (8.28)
3.92 (2.57)
4.52 (2.02)
6.30 (1.98)
3.66 (2.36)
Mean muscle thickness  
(mean z-scores) (SD)
- Composite sum score
- Biceps brachii muscle
- Tibialis anterior muscle
- Rectus femoris muscle
- Forearm flexors
16
19
19
16
18
1.61 (6.49)
0.11 (2.27)
1.19 (1.88) 
-0.56 (2.71) 
0.73 (1.47) 
12
16
16
13
17
1.98 (3.82)
-0.31 (1.49)
0.39 (1.69)
-0.28 (2.25)
1.7 (1.12)
CMAS, Childhood Myositis Assessment Scale; HMAS, Hammersmith Motor Ability Scale
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Echo intensity and ambulatory status were assessed during all 63 measurements. 
Combined muscle thickness of the rectus femoris and vastus intermedius in the quadriceps 
muscle could not be assessed in 25% of the ultrasound measurements because the 
severity of the dystrophic changes and accompanying attenuation made it impossible to 
visualize the bone echo even when a 8-5 MHz transducer was used instead of a 17-5 MHz 
transducer. Clinical assessments within 3 months of the ultrasound measurements were 
available for 59 to 70% of the measurements (Vignos in 70%; Brooke in 68%; elbow flexor 
dynamometry in 67%; knee extensor dynamometry in 59%; HMAS in 68%; CMAS in 70%).
Quantitative muscle ultrasound changes with age
Muscle echo intensities of all individual muscles as well as the composite sum score 
significantly increased with age (Table 2). The sum score increased with 2.2 SD per year 
(p < 0.01) (Figure 3). For individual muscle groups, the echo intensity of the rectus femoris 
muscle was already abnormal (above + 2 SD) in 50% of the boys aged 4-6 years (mean 
z-score = 2.7 SD ± 1.34), whereas the forearm flexors were still normal in all of these boys 
(mean z-score 0.10 SD ± 1.56). Above the age of 10 years, the echo intensity of the forearm 
flexors still increased (mean z-score in boys aged 8-10 years: 2.8 SD ± 1.8, and in boys aged 
>10 years: 6.6 SD ± 1.2 ) (Table 3). This is also reflected by the GEE analysis of the individual 
muscles: the strongest increase was found for the most distal muscles (forearm flexors 
(β = 0.64, p < 0.001) and tibialis anterior (β = 0.60, p < 0.01) muscles), as these muscle were 
near normal at young age. Conversely, we found a lesser increase with age for the proximal 
Table 2   The longitudinal relationship between QMUS and age
Echo 
intensity
Muscle 
thickness
Assessments 
included
β (95%CI) Assessments
included
β (95%CI)
Composite sum score 64 2.24 (1.52 ; 2,97)* 46 -.48 (-1.04 ; .07)
Biceps brachii muscle 64 .49 (.31 ; .67)* 60 -.24 (-.34 ; -.14)*
Forearm flexors 64 .64 (.42 ; .86)* 61 -.05 (-.19 ; .08)
Rectus femoris muscle 64 .50 (.25 ; .75)* 48 -.16 (-.41 ; .09)
Tibialis anterior muscle 64 .60 (.38 ; .82)* 57 .08 (-.09 ; .24)
Regression coefficients (β) and 95% confidence intervals (95% CI) regarding the longitudinal relationship 
between quantitative skeletal muscle ultrasound (z-scores) and age as derived from the GEE analyses. 
*p < .05
QMUS, Quantitative muscle ultrasound
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muscles (biceps brachii (β = 0.49, p < 0.01) and rectus femoris (β = 0.50, p < 0.01) muscles) 
(Table 2), as these muscles had already higher echo intensity at young age.
 Although it appeared from the data plots (Figure 3) that a ceiling effect might be 
present in the echo intensity after the age of twelve, this ceiling effect (age²) was not 
significant (p = 0.76) in our cohort.
 Muscle thickness of the biceps brachii decreased significantly with age (β = -0.24, 
p < 0.01). The other muscles did not show a significant decrease. (Table 2)
 The SRM analysis showed good responsiveness over a one year follow up period for 
the echo intensity sum score (SRM = 0.77), echo intensity of the rectus femoris (SRM = 
0.89) and tibialis anterior muscle (SRM = 0.79). This was comparable to the responsiveness 
of the clinical assessments (Table 4). Low to moderate responsiveness was found for the 
Figure 3   The longitudinal relationship between echo intensity and age.  
Developmental echo intensity sum score curves are presented for each participant (first to fifth 
assessments are visualized as following: o, x, +, +x, ) together with the predicted curve (dotted line). 
Regression coefficient (β) and 95% confidence interval are derived from the GEE analyses. Although 
there are some differences between the participants, the echo intensity sum score increased with 
age in our group of DMD participants.
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echo intensity of the upper extremity muscles (BB: SRM = 0.35; FF: SRM = 0.36) and the 
Vignos (SRM = 0.33) and Brooke (SRM = 0.30) functional grading scores. As shown in 
table 5, the echo intensity of the lower extremity has good responsiveness in boys aged 
4-8 years old, whereas the echo intensity of the upper extremity shows moderate 
responsiveness in boys older than 8 years.
Table 3   Echo intensities per age group
Echo intensity 
(mean±SD[range])
Age 4-6y 
(n=4)
Age 6-8y
(n=4)
Age 8-10y
(n=6)
Age >10y
(n=3)
Composite sum score 3.88±5.41 
(-2.30-9.80)
11.05±6.38
(7.50-20.60)
15.73±5.75
(6.80-21.80)
25.73±2.94 
(23.70-29.10)
Biceps brachii muscle 0.53±1.13
(-1.00-1.60)
2.50±1.85 
(0.70-5.10)
3.32±1.71 
(0.60-4.90)
5.53±1.08
(4.30-6.30)
Tibialis anterior muscle 0.60±1.63
(-0.90-2.50)
2.58±0.64
(2.00-3.50)
3.55±1.10
(2.00-4.60)
5.23±1.74
(3.90-7.20)
Rectus femoris muscle 2.65±1.34
(1.50-4.40)
4.53±2.8
(2.80-8.50)
6.08±1.67
(3.60-8.10)
8.33±1.01
(7.60-9.60)
Forearm flexors 0.10±1.56
(-1.90-1.80)
1.45±1.44
(0.20-3.50)
2.78±1.83
(-0.40-4.60)
6.63±1.15
(5.50-7.80)
Echo intensities are presented in z-scores.
Table 4   Responsiveness statistics of QMUS and the clinical assessments
n Mean change after 1 year 
follow-up (SD)
SRM
Clinical assessments
Vignos
Brooke
Muscle strength (z-scores)
- Elbow flexor
- Knee extensor
CMAS
HMAS
11
11
11
10
11
10
0.45 (1.37)
0.09 (0.30)
-1.30 (1.23)
-0.61 (0.87)
-3.82 (4.94)
-2.80 (3.39)
0.33
0.30
1.06
0.70
0.77
0.83
Echo intensity (z-scores)
- Composite sum score
- Biceps brachii muscle
- Tibialis anterior muscle
- Rectus femoris muscle
- Forearm flexors
15
15
15
15
15
2.54 (3.29)
0.41 (1.16)
0.81 (1.03)
0.79 (1.01)
0.52 (1.43)
0.77
0.35
0.79
0.89
0.36
QMUS, Quantitative muscle ultrasound ; SRM, Standardized Response Mean; CMAS, Childhood Myositis Assessment 
Scale, HMAS, Hammersmith Motor Ability Scale
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Quantitative muscle ultrasound in relation to clinical assessments
Increased echo intensities of the biceps brachii and rectus femoris muscles co-occurred 
with a decrease in strength of the elbow flexors and knee extensors, a decrease in 
functional status (Vignos and Brooke scales) and lower motor ability (CMAS and HMAS 
scores); see table 6 and figure 4. With respect to the functional status scales, echo 
intensities varied per Vignos and Brooke grade and increases in echo intensity were often 
not matched directly by higher functional grades (Figure 4).
Figure 4   Echo intensity versus the clinical assessments.  
Developmental echo intensity curves versus the Vignos (A) and Brooke (B) functional grades, muscle 
strength of the elbow flexors (C) and knee extensors (D), CMAS (E) and HMAS (F) are presented for 
each participant (first to fifth assessments are visualized as following: o, x, +, +x, ) together with the 
predicted curves (dotted lines). Regression coefficients (β) and 95% confidence intervals are derived 
from the GEE analyses. An increased echo intensity of the biceps brachii and rectus femoris muscles 
was related to a decreased muscle strength of the elbow flexors and knee extensors, respectively. 
Furthermore, an increased echo intensity sum score was related to a lower score on the CMAS and 
HMAS, indicating a lower motor ability.
A
C
E
B
D
F
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Additional cross-sectional data
Additional cross-sectional data were available for 19 boys, of whom 18 used corticoste-
roids. Cross-sectional correlations between QMUS and age and the clinical assessment 
were comparable to the results from our longitudinal study. Echo intensities of both the 
composite sum score (r = 0.69, p < 0.001) and the individual muscles (BB: r = 0.62, p = 0.05; 
FF: r = 0.76, p < 0.001; RF: r = 0.50, p = 0.03; TA: r = 0.64, p = 0.003) were positively correlated 
with age, which means that older boys showed higher echo intensities than younger 
boys. Muscle thickness was not correlated with age after the standard correction for the 
bodyweight related increase in muscle thickness during childhood8 (Table 7).
In relation to the clinical assessments, we found that wheelchair-dependent boys had a 
significant higher echo intensity (mean sum score = 24.1 SD ± 3.1) than ambulant boys 
(mean sum score = 12.9 SD ± 6.6) (p = 0.01). Furthermore, the sum score of the echo 
intensity correlated with all clinical assessments: positive correlations with the Vignos (ρ = 
0.85, p < 0.001) and Brooke (ρ = 0.71, p = 0.01) functional grades, and negative correlations 
with muscle strength (elbow flexors: r = -0.74, p < 0.01; knee extensors: r = -0.73, p = 0.01), 
the CMAS (ρ = -0.69, p = 0.02) and the HMAS (ρ = -0.66, p = 0.04) scores were found. As 
shown in figure4, all wheelchair-dependent boys (Vignos grade 10) had composite sum 
z-scores of > 20 SD. For ultrasound of individual muscle groups we found significant 
positive correlations between the echo intensity of the rectus femoris (ρ = 0.68, p = 0.02) 
and tibialis anterior (ρ = 0.74, p < 0.01) muscles and the Vignos functional grade, and 
between the echo intensity of the biceps brachii muscle (ρ = 0.65, p = 0.02), forearm flexors 
(ρ = 0.66, p = 0.02) and the Brooke functional grade. Negative correlations were found 
between the echo intensity of the biceps brachii muscle and the muscle strength of the 
elbow flexors (r = -0.77, p < 0.01), and also between the echo intensity of the quadriceps 
Table 5   Responsiveness statistics of the echo intensity per age group
Boys <8 years 
old
Boys ≥8years old
n Mean change 
after 1 year 
follow-up (SD)
SRM n Mean change 
after 1 year 
follow-up (SD)
SRM
Echo intensity (z-scores)
- Composite sum score
- Biceps brachii muscle
- Tibialis anterior muscle
- Rectus femoris muscle
- Forearm flexors
6
6
6
6
6
2.18 (3.16)
-0.15 (0.88)
0.95 (0.40)
1.00 (1.05)
0.38 (1.43)
0.69
0.17
0.95
0.95
0.27
9
9
9
9
9
2.78 (3.53)
0.79 (1.21)
0.72 (1.32)
0.66 (1.03)
0.61 (1.51)
0.79
0.65
0.55
0.64
0.40
SRM, Standardized Response Mean
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muscle and the muscle strength of the knee extensors (r = -0.79, p < 0.01). Echo intensity 
of the quadriceps muscle correlated negatively with the CMAS (ρ = -0.71, p = 0.001) and 
HMAS (ρ = -0.68, p = 0.03) scores (Table 7).
With respect to the muscle thickness, only the thickness of the quadriceps muscle 
correlated negatively with the muscle strength of the knee extensors (r = -0.73, p = 0.03), 
and no significant correlations were found for the sum score and other individual muscles.
Table 6   The longitudinal relationship between echo intensity and the clinical 
assessments
Assessments included β (95%CI)
Echo intensity composite sum score
Vignos 
Brooke
CMAS
HMAS
42
42
43
42
1.55 (1.18 ; 1.83)*
3.25 (1.22 ; 5.29)*
-.38 (-.61 ; -.16)*
-.39 (-.53 ; -.24)*
Echo intensity Biceps brachii muscle
Vignos
Brooke
Muscle strength elbow flexors
CMAS
HMAS
42
42
42
43
42
.41 (.27 ; .55)*
1.10 (.49 ; 1.72)*
-.48 (-.70 ; -.25)*
-.11 (-.16 ; -.06)*
-.11 (-.15 ; -.07)*
Echo intensity Forearm flexors
Vignos
Brooke
CMAS
HMAS
42
42
43
42
.49 (.39 ; .59)*
1.10 (.60 ; .1.62)*
-.12 (-.18 ; -.05)*
-.11 (-.15 ; -.07)*
Echo intensity Rectus femoris muscle
Vignos
Brooke
Muscle strength knee extensors
CMAS
HMAS
42
42
37
43
42
.30 (.14 ; .45)*
.46 (-.45 ; 1.37)
-.96 (-1.27 ; -6.44)*
-.11 (-.16 ; -.06)*
-.11 (-.14 ; -.08)*
Echo intensity tibialis anterior muscle
Vignos
Brooke
CMAS
HMAS
42
42
43
42
.38 (.23 ; .54)* 
.66 (.25 ; 1.08)*
-.09 (-.13 ; -.04)*
-.10 (-1.45 ; -.54)*
Regression coefficients (β) and 95% confidence intervals (95% CI) regarding the longitudinal relationship 
between quantitative echo intensity (z-scores) and the clinical assessments as derived from the GEE analyses. 
*p < .05
CMAS, Childhood Myositis Assessment Scale; HMAS, Hammersmith Motor Ability Scale
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Discussion
This study shows that echo intensity assessed with quantitative muscle ultrasound has 
significant relations with age and clinical parameters including functional grading scores, 
muscle strength, ambulatory status and motor ability. It establishes quantitative muscle 
ultrasound (QMUS) as a practical, quick, child-friendly and feasible tool for longitudinal 
follow up in Duchenne muscular dystrophy, not influenced by the patients’ condition, 
fatigability or cooperation.
 Our results demonstrate that in the youngest boys aged 4-6 years the echo intensity 
of the rectus femoris was already clearly abnormal (SD > 2) in 2 of the 4 boys while the 
echo intensity of the other muscles measured (biceps brachii, forearm flexors and tibialis 
anterior) was often still in the normal range. Conversely, the most distal muscles in our 
protocol still show a significant increase in echo intensity even after the age of 10 years. 
However, as most of the boys assessed in our study were 6-10 years old, extending these 
results to younger and older boys with DMD should be done with caution and requires 
further research. Nevertheless, the echo intensity sum score of the four muscles in our 
protocol increased in every age group with 2.2 SD per year. Our findings corroborate 
earlier evidence that echo intensities are higher in more severely affected, older, boys with 
DMD.13
 All muscles examined showed good responsiveness, indicating that one has a good 
chance of finding a significant difference in echo intensity when repeating the 
measurement after 1 year. We found the highest responsiveness values for the echo 
Table 7   Correlations between QMUS and age and the clinical assessments
Age* Vignos** Brooke** Muscle strength*
EF         KE
CMAS** HMAS**
Echo intensity
Composite sum score
Biceps brachii muscle
Tibialis anterior muscle
Rectus femoris muscle
Forearm flexors
0.69
0.62
0.64
0.50
0.76
0.85
0.76
0.74
0.68
0.82
0.71
0.65
0.55
0.49
0.66
             
-0.74       -0.73
-0.77       -0.72
-0.56      -0.63
-0.75       -0.79
-0.69       -0.62
-0.69
-0.58
-0.50
-0.71
-0.75
-0.66
-0.52
-0.48#
-0.68
-0.64
Correlation coefficients were derived from the cross-sectional study. Correlation coefficients are given in 
Pearson correlation coefficients (r)* for continuous data and in Spearman correlation coefficients (ρ)** for 
ordinal data. All correlations (except one#) were significant at the p ≤ 0.05 level. Correlations between muscle 
thickness and age and the clinical assessments are not shown as none of them, except the correlation between 
the muscle thickness of the quadriceps muscle and muscle strength of the knee extensors (r = 0.73, p <.05), 
was significant. 
QMUS, Quantitative muscle ultrasound; EF, elbow flexors; KE, knee extensors; CMAS, Childhood Myositis 
Assessment Scale; HMAS, Hammersmith Motor Ability Scale
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intensity sum score, rectus femoris and tibialis anterior muscle. The responsiveness to 
change of these muscle echo intensities was comparable to measures of muscle strength 
and motor function, and better than the coarser categories of functioning used in the 
Vignos and Brooke scales. Further research is recommended to investigate the relationship 
between QMUS and the 6MWT, which is the primary outcome measure in many clinical 
trials in boys with DMD.30 The responsiveness to change of the echo intensity of the upper 
extremity muscles was slightly less in our total cohort, but was also good in boys older 
than 8 years. This is in accordance with the fact that proximal muscles are affected later in 
DMD than the distal muscles.19
 Combined, our findings mean that muscle echo intensity is sensitive to the progressive 
changes in muscle architecture in DMD patients between 4 and 12 years, even when they 
use corticosteroids and even with the current set of four muscles not specifically chosen 
for DMD. It would be interesting to study whether other muscles, such as the gastrocnemius 
and proximal arm muscles (e.g. deltoid) are even more responsive to changes over time in 
boys who are going through life-events such as the transition from walking to wheelchair 
use. For example, the gastrocnemius muscle could be useful for ambulant boys, as MRI 
studies have shown that posterior compartments of the lower leg are affected earlier than 
anterior compartments (e.g. the tibialis anterior muscle).31,32 The deltoid muscle might be 
useful for wheelchair-dependent boys who start experiencing difficulties in reaching and 
lifting with their arms.
Counter-intuitively we found no signs of generalized disuse atrophy over time in our 
population of DMD boys. We expected atrophy as both cross-sectional morphometric 
and magnetic resonance imaging studies have shown that atrophy of severely affected 
muscles (such as the adductor magnus and rectus femoris) progresses with age.33,34 
However, only the muscle thickness of the biceps brachii decreased significantly with age 
in our longitudinal analysis and the other muscles did not. We did find a slight decrease in 
muscle thickness of the quadriceps muscle at baseline, but apparently this atrophy was 
not progressive. A previous cross-sectional ultrasound study also showed atrophy of the 
quadriceps without abnormalities in thickness in the other muscles in DMD patients 
compared to healthy subjects.7 A limitation of studying quadriceps muscle thickness with 
ultrasound is that with progression of the disease abnormalities it becomes impossible to 
visualize the bone echo of the femur because of the attenuation of ultrasound waves in 
the dense fibrotic and fatty tissue (Figure 2).35 In this study the thickness of the combined 
rectus femoris and vastus intermedius muscles could not be assessed in 25 % of the 
measurements because of this effect, even when a lower frequency transducer was used.
Data from DMD boys older than 12 years (shown in Figure 3) indicate that a ceiling effect 
might be present with respect to muscle echo intensity. Such a ceiling effect has been 
found in other measures of muscle strength and clinical functioning19, and was also 
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expected for echo intensity as muscles in DMD can only degenerate up to a certain point 
before they have become fully dystrophic and all muscle tissue has been replaced by fat 
and fibrosis. Although our data also indicated a possible ceiling effect, this was not 
significantly present in any of the four muscles assessed. This lack of significance might be 
explained by the small number of boys in the age group of 12 years and older, or , 
alternatively, it might mean that no significant ceiling effect is present in this age group, as 
such a ceiling effect was also not found in an earlier cross sectional study on muscle echo 
intensity of the elbow flexors in DMD patients up to 19 years.13 It deserves further 
investigation in different age-groups, including both children and young adult DMD 
patients, to establish which muscle group will reach this echo intensity ceiling at which 
point in the disease course. As most new therapies will likely and preferably be tested in 
the younger DMD patients, the possible presence of a ceiling effect at the end of the 
second decade of life will probably have limited practical consequences for using QMUS 
as a follow up tool in treatment trials.
Although our results show that QMUS can quantify and follow muscle changes during the 
course of DMD, and as such would be very suited as a practical and patient-friendly 
follow-up tool, its implementation in different centers is currently complicated by the 
need for specific normal values that have to be established for every different ultrasound 
machine. Although this can be achieved by using degradable phantoms (i.e. meat) with a 
conversion method described earlier24 or establishing one’s own normal values, these 
methods are a bit cumbersome and new developments in ultrasound technology are 
necessary that focus on the device-independent interpretation of echo intensities. Until 
then, we recommend the use of one and the same ultrasound device and settings for 
which normative data are available, especially when the QMUS technique is used as part 
of a clinical trial.
In conclusion, our results show that QMUS is a responsive outcome measure to assess 
disease severity in the follow-up of boys aged 4-12 years with DMD. As it is quick, 
non-invasive and reflects underlying pathological changes without the need for muscle 
biopsy and patient cooperation we recommend its use in future treatment trials and daily 
clinical care.
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Abstract 
Introduction: For late or non-ambulant children with a neuromuscular disorder no 
suitable endurance tests are currently available. We developed the Assisted Six-Minute 
Cycling Test (A6MCT) for the legs and arms and investigated its psychometric properties 
in healthy boys and boys with Duchenne muscular dystrophy (DMD). 
Methods: Ninety-nine healthy boys and 30 boys with DMD (12 wheelchair-dependent) 
performed the A6MCT. Seventy healthy boys additionally performed the Six-Minute Walk 
Test (6MWT), and 23 boys performed the A6MCT twice within 2 weeks. Boys with DMD 
also performed the Motor Function Measure (MFM). 
Results: The A6MCT was feasible for > 90% of all boys. Boys with DMD achieved less 
cycling revolutions than controls. The A6MCT was positively correlated with the 6MWT 
and was reproducible in healthy boys, and it correlated with disease severity in boys with 
DMD. 
Discussion: The A6MCT is a promising outcome measure for the follow-up of non- 
ambulant children with a neuromuscular disorder. 
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Introduction 
Neuromuscular disorders (NMD) in childhood are heterogeneous, but all have the general 
feature of progressive loss of muscle function. Although there is no cure for most NMD 
yet, promising treatments are now becoming available.1 To monitor disease progression 
and the effect of such new treatments,2 clinically meaningful outcome measures related 
to children’s abilities to function in daily life are needed. Endurance tests are often used as 
such an outcome measure in many clinical trials in children with NMD,1 because they have 
been proven to correlate with functioning in daily life.3, 4
Endurance exercise protocols for children with NMD can be divided into maximal (“all-out”) 
and submaximal tests.5 During “all-out” tests, children are motivated to reach their maximal 
mechanical power and aerobic peak, i.e. the highest volume of oxygen that can be 
consumed by the body per time unit. Such a maximum test is often not feasible for 
children with NMD, who cannot reach their aerobic peak capacity or maximum heart rate 
because of muscle weakness and local fatigue. A submaximal test that predicts rather 
than directly assesses the maximal exercise capacity is better suited for this group and has 
the additional advantages of being safer, more comfortable and less exhausting. 
Currently, the most frequently used submaximal test for children with NMD is the 
Six-Minute Walk Test (6MWT)3 that assesses the distance that a patient can quickly walk 
without running in six minutes. The 6MWT is easy to perform and feasible for ambulatory 
children with NMD6, although its responsiveness to measure changes over time might be 
limited as shown by relatively large standard deviations of the within-subject change in 
walked distance.7 However, for children with progressive NMD who are at the end of their 
ambulatory phase or are already wheelchair-dependent, no suitable submaximal endurance 
test is currently available. This is problematic for long-term follow up, and in a time that 
controlled treatment trials are also being developed for these older, more severely 
impaired patients there is a need for a feasible and reliable clinical outcome measure. 
The aim of our study was to develop a submaximal endurance test for both the legs (leg 
cycling) and arms (arm cranking) for children who are expected to lose their walking 
ability in the near future as well as children who have recently become wheelchair-dependent 
and have problems with lifting and reaching with their arms. We chose to develop a 
cycling test for both the arms and legs that can be performed by both ambulatory and 
wheelchair-confined children and has the additional advantage that participants are less 
at risk for falls. Although regular bicycle ergometers have the ability to adjust their 
mechanical power to the capacity of children with severe muscle weakness, the initial 
load and further increments are often still too hard to sustain for these patients, for when 
the bicycle ergometer displays no resistance the child is still cycling at more than 5 Watts.5 
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We therefore chose to use a motor-assisted device that would allow even very weak 
patients to perform the movements required for the tests.
In the first part of this paper we describe the development of our Assisted Six-Minute 
Cycling Test (A6MCT), a bicycle test for the legs and arms using a motor-assisted mobility 
trainer. In the second part we investigated the feasibility of the A6MCT in healthy boys and 
boys with Duchenne muscular dystrophy (DMD), which is the most common inherited 
muscular dystrophy affecting young boys and results in wheelchair-dependency at a 
mean age of ten years.8 Girls were not recruited to participate in this study, since DMD 
primarily affects males. For healthy boys, we also examined the relationship between the 
A6MCT and the commonly used 6MWT (construct validity), and we investigated whether 
the same test results are obtained when the test is repeated within a short period under 
the same circumstances (test-retest reliability). For boys with DMD, we investigated the 
relationship between the A6MCT and disease severity. 
Methods 
This study was approved by the Medical Ethics Committee Arnhem-Nijmegen, The 
Netherlands. All parents, and participants who were over 12 years of age, gave their written 
informed consent.
Part 1: Development of the A6MCT
Rationale and device
The A6MCT was developed in collaboration with several experts from the neuromuscular 
center of the Radboud University Nijmegen Medical Centre, including two rehabilitation 
physicians, one physiotherapist, three neurologists and clinical neurophysiologists and 
two biomedical engineers. For the motor-assisted bicycle ergometer device we chose to 
use a mobility trainer (KPT Cycla, Kinetic, France) that could be used with the patients’ 
personal (electric) wheelchair if necessary, so the patient did not need to be transferred to 
a regular home trainer. The decision for the specific type of mobility trainer used in our 
validation study was based on the availability of motor assistance, the constant assistance 
and resistance provided, the stability of the device on the floor layer and the possibility to 
easily alternate between leg and arm testing. Motor assistance was expected to allow for 
bicycle testing even when muscle strength was insufficient to achieve fully active 
movements. Furthermore, the device could be adapted to body height and the pedal 
distance could also be adjusted to limb length.  
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Duration and assistance
We aimed to develop a submaximal test (heart rate about 70% of the max heart rate) for 
both the legs and arms in a single-stage protocol. We chose a protocol length of 6 minutes 
in which children were free to choose their own speed, to match the commonly used 
6MWT which has been shown to be feasible and relevant for children with NMD.7 A 
protocol length of more than 6 minutes could diminish the chance of a suboptimal 
performance due to short attention span in some children.
In order to determine a feasible level of resistance (Wmax) for children with severe muscle 
weakness, we conducted a pilot study in three boys with DMD (two community walkers 
aged 9 and 10 years, and one household walker aged 9 years). Participants cycled in 
periods of 1 minute with a continuous speed of 65 rounds per minute (RPM) at several 
resistance levels ranging from level 1 (7.7 Watt) to level 10 (51.3 Watt). The same procedure 
was used for both legs and arms. A feasible resistance level was defined as a level that 
could be sustained for one minute cycling at 65 RPM without exhaustion. Overall physical 
fatigue was assessed using the OMNI scale for perceived exertion that grades the 
perceptions of physical exertion on a scale from 0 (not tired at all) to 10 (very very tired) 
and contains both verbal and pictorial descriptions.9 
 Results from the first part of this pilot study showed that boys with DMD were able to 
cycle with both legs and arms with a continuous speed of 65 RPM only at the lowest 
resistance level (7.7 Watt) for 1 minute without becoming exhausted (OMNI scale score ≤ 
6). However, in the second part of the pilot study, we asked the boys to continue cycling 
at their own speed for another six minutes, and they all had to terminate the test already 
after approximately 3 minutes. Therefore, we decided to adjust the protocol and to use 
fixed motor assistance (passive mode 1, no load speed 7RPM) instead of resistance. With 
this protocol, the boys were able to complete 6 minutes of cycling at their own constant 
velocity. Our pilot study among the 3 boys with DMD confirmed the feasibility of this 
A6MCT for both legs and arms. 
Final A6MCT protocol
The Assisted Six-Minute Cycling Test (A6MCT) for the legs and arms was performed using 
the motor assisted mobility trainer (KPT Cycla, Kinetic, France) in passive mode 1 with a 
no-load speed of 7RPM for every participant. After a short demonstration the participants 
were instructed to cycle as fast as possible and keep this up for 6 minutes. Starting 
positions for both the leg cycling and arm cranking protocols were standardized; see 
figure 1. For the A6MCT for the legs, the hip and knee of the bended leg were held in ~90° 
flexion, while the knee of the other leg was submaximally extended. For the A6MCT of the 
arms the pedal axis was a few centimeters (with a maximum of 5 cm) below shoulder level 
when the pedals were horizontal. The distance from the chair to the bicycle was 
determined by allowing participants to move their legs and arms over the submaximal 
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range of motion, which was produced a feeling of stretch but not pain (Figure 1). 
Participants were seated comfortably with the back supported by the back of the seat. 
Verbal encouragements from the instructor to maintain attention and to complete the 
test as well as possible were given every 15 s throughout the exercise (Appendix 1). The 
assessor was seated next to the participant and informed the participant about the time 
completed and left, and about the amount of revolutions cycled so far. Participants were 
allowed to rest if they were not able to continue cycling due to fatigue. In that case, they 
were also motivated to continue cycling as soon as possible. The primary test outcome 
was the number of revolutions achieved in 6 minutes. Revolutions per minute (cumulative) 
and resting periods were also recorded. 
Part 2: Validation of the A6MCT in healthy boys
Participants
Healthy boys, without limitations in arm or leg function, aged 6-16 years were recruited 
from three Dutch primary schools from May 2010 to April 2011. Age (years), height (m) and 
body weight (kg) were recorded. 
Feasibility
Healthy boys from the three different schools performed the A6MCT for the legs and arms 
and cycled at passive mode 1 with a no-load speed of 7RPM. The tests for the legs and 
arms were performed in random order to exclude bias due to fatigue. Participants rested 
ten minutes in a chair prior to each test to recover from the expected submaximal effort 
and to start each test with a resting heart rate. Heart rate (beats per minute, bpm) was 
Figure 1   Starting position of the Assisted Six-Minute Cycling Test for the legs and arms.  
This figure has been previously published in M. Jansen et al. (2010) 10. Permission was obtained from 
the original publisher, BioMedCentral, to reproduce the figure.
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assessed using a standard heart rate monitor (Onyx classic, Sigma, Germany) prior and 
after the A6MCT. We also assessed the perceived overall physical exertion using the OMNI 
scale for perceived exertion (see above: Duration and assistance) and recorded any signs 
of exercise intolerance (i.e. excessive muscle pain, extreme fatigue, dizziness, or an 
uncomfortable feeling). All assessments took place at the primary schools of the 
participants and were conducted by four researchers (MdJ, HC, FE, and MJ).
Construct validity
A subgroup of healthy boys from two primary schools also performed the Six-Minute 
Walk Test (6MWT) in addition to the A6MCT in order to examine the relationship between 
both endurance tests. The 6MWT was performed according to an adjusted protocol for 
DMD patients, as described by McDonald et al (2010).7 Participants were instructed to walk 
as fast as possible without running. The assessor walked ~1.5 m behind the participant 
and encouraged the participant every 15 s to keep exercising using standardized phrases. 
As the corridors of the primary schools involved in this study were only 20 m long, 
participants performed the 6MWT in a corridor with a marked test area of 20 m instead of 
the usual 25 m. Participants were allowed to rest or to stop if they were not able to 
continue. The distance walked at the end of the six-minute period was recorded in meters, 
together with the cumulative distance walked (per minute), rest periods needed and 
number of falls. 
Test-retest reliability
To study the test-retest reliability of the A6MCT, boys from the third primary school 
performed the A6MCT for the legs and arms twice with a two-week interval. Participants 
and researchers involved in this part of the study were blinded from previous test results 
during the second test day. 
Part 3: Validation of the A6MCT in boys with DMD
Participants
For validation of the A6MCT in Duchenne Musucular Dystrophy (DMD) we obtained test 
results from age-matched boys with DMD from the randomized controlled No Use is 
Disuse (NUD) study.10 We used only the baseline data from this study, meaning that 
participants had not yet received any physical training intervention. The NUD study 
included boys with DMD who were at the end of their ambulatory phase (needing ≥ 5 s 
to get up from the floor, unable to get up from the floor, unable to bicycle without 
assistance, and dependent on a wheelchair to move over a distance > 500 m), or had 
recently (within 1-2 years prior) begun full time use of a wheelchair. Full time users of a 
wheelchair, in this study defined as wheelchair-dependent boys, had to be able to touch 
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the top of their head with both hands, or had to be able to use a hand-operated wheelchair, 
indicating a moderate-to-good arm-hand function. Age (years), height (m) and body 
weight (kg) were registered. 
Feasibility
Procedures were similar to those described for healthy boys, and all boys intended to 
perform both the A6MCT for the legs and arms. However, in the NUD study the test order 
was standardized, and boys first performed the A6MCT for the legs and then for the arms. 
Furthermore, all assessments were performed by one researcher (MJ) and took place at 
the Department of Rehabilitation of the Radboud University Nijmegen Medical Centre. 
Relationship between the A6MCT and disease severity
The boys with DMD also performed the Motor Function Measure (MFM) as part of the 
NUD study, and the baseline results were used to assess the relationship between the 
A6MCT and disease severity. The MFM is a valid and reliable scale to assess motor function 
in both ambulant and wheelchair-dependent patients with a neuromuscular disorder.11 
The scale consists of 32 items in 3 dimensions: Dimension 1, Standing position and 
transfers (D1); Dimension 2, Axial and proximal motor function (D2); Dimension 3, Distal 
Motor Function (D3). Each item is scored on a 4-point Likert scale (generic grading: 0, does 
not initiate movement or starting position cannot be maintained; 1, partially completes 
the exercise; 2, completes the exercise with compensations, slowness or obvious 
clumsiness; 3, completes the exercise with a standard pattern). The scale has a maximum 
score of 96, and a higher score indicates better motor function. We calculated a percentage 
(%) of the maximum score for the total MFM score. 
Statistical analysis
Statistical analyses were performed using SPSS v. 16.0 for Windows (SPSS Inc., Chicago, IL, 
USA). A p-value of ≤0.05 was considered to be significant. 
Performance and feasibility
Performance on the A6MCT was described as mean ± standard deviation (SD) for 
continuous data (number of revolutions achieved and heart rate) and as median with 
range for ordinal data (OMNI scale) for healthy boys, the total group of boys with DMD, 
ambulatory boys with DMD and wheelchair-dependent boys with DMD. Healthy boys 
and boys with DMD, and also ambulatory and wheelchair-dependent boys with DMD, 
were compared using independent t-tests for continuous data (age, height, body weight, 
A6MCT, heart rate) and Mann-Whitney U tests for ordinal data (OMNI scale). The feasibility 
of the A6MCT for the legs and arms was determined by calculating the percentage of 
boys who were able to perform the test. We deemed that the test was feasible when at 
least 95% of the healthy boys and 90% of the boys with DMD would be able to perform 
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the A6MCT. The correlation between the A6MCT and age was investigated by calculating 
Pearson correlation coefficients (r) for both healthy boys and boys with DMD. Pearson 
correlation coefficients were interpreted as following: 0 to 0.25 - little to any correlation, 
0.26 to 0.49 - low correlation, 0.50 to 0.69 - moderate correlation, 0.70 to 0.89 - high 
correlation and correlations ≥0.90 - very high correlation.12
Construct validity in healthy boys
The relationship between the A6MCT and the 6MWT was examined by calculating 
Pearson correlation coefficients (r) and using stepwise linear regression analysis, as 
parametric normal distributions were confirmed by the Kolmogorov-Smirnoff test (p > 
0.05). Pearson correlation coefficients were interpreted as described above.12 Regression 
coefficients (β) and 95% confidence intervals (95% CI) were calculated from stepwise linear 
regression analysis. The 6MWT was the only independent variable in step one of the 
regression analysis, whereby the A6MCT was the dependent variable. Height was added 
as potential confounder in the second step of the regression analysis, since the 6MWT is 
positively related to height in healthy boys.7 We expected a moderate-to-high positive 
correlation between the A6MCT and the 6MWT, as both tests aim to measure submaximal 
endurance. 
Test-retest reliability in healthy boys
The test-retest reliability of the A6MCT (legs and arms) was first explored by examining 
whether any changes existed between the first and second assessment using paired 
t-tests. Next, intraclass correlation coefficients (ICC) were calculated and Bland-Altman 
figures including 95% limits of agreement (MeanDifference ± 1.96 * SDDifference) were 
generated.13, 14 ICCs were considered acceptable when they were above 0.70.15 
Relationship of the A6MCT with disease severity in boys with DMD
The correlation between the A6MCT and disease severity as expressed by the MFM was 
examined by calculating Spearman correlation coefficients (rho). Correlation coefficients 
were calculated for the total group of boys with DMD, but also separately for ambulatory 
and wheelchair-dependent boys. We expected a low-to-moderate positive correlation, as 
both outcome measures were expected to assess different aspects of disease severity (i.e. 
endurance versus motor function). 
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Results 
Validation of the A6MCT in healthy boys
Participant characteristics
Ninety-nine healthy boys with a mean age of 9.9 years participated in this study. 
 Characteristics of the healthy boys are shown in table 1. 
Feasibility and performance
Of the 99 healthy boys included in this study, 95 performed the A6MCT for the legs, and 
another 95 performed the A6MCT for the arms. The reasons for missing data were mainly 
a lack of time to perform both tests. Only one boy was unable to complete the A6MCT for 
the legs, because his feet tended to slip off the pedals. This means that the A6MCT was 
feasible for 99% of the healthy boys, without any signs of exercise intolerance. 
The mean number of revolutions achieved during six minutes of cycling was 843 ± 82 for 
the legs and 778 ±111 for the arms (Table 1). Figure 2 shows the constant cycling velocity 
(rounds per minute) which participants selected and maintained during the A6MCT for 
the legs and arms. Figure 3 shows the positive correlation between the number of 
revolutions achieved with the A6MCT for the legs and the arms (r = 0.64, p < 0.01), 
indicating that boys who achieved a high number of revolutions with the arms also 
achieved a high number of revolutions with the legs and vice versa. The mean heart rate 
Table 1   Subject characteristics and test results of healthy boys and boys with 
Duchenne  muscular dystrophy
n Healthy (n=99)
Mean ± SD (range)
n DMD (n=30)
Mean ± SD (range)
Demographics
Age (y) 98 9.9 ± 2.0 (6.4 ; 16.8) 30 10.5 ± 2.6 (6.4 ; 16.6) p = 0.02*
Body weight (kg) 98 35.0 ± 8.9 (18.0 ; 63.7) 30 45.5 ± 19.4 (18.3 ; 92.4) p < 0.01*
Height (m) 98 1.4 ± 0.1 (1.2 ; 1.9) 30 1.4 ± 0.2 (1.1 ; 1.8) p < 0.01*
A6MCT (revolutions)
Legs
Arms
95
95
843 ± 82 (604 ; 1016)
778 ± 111 (492 ; 1003)
29
28 
405 ± 152 (118 ; 714)
370 ± 120 (142 ; 574) 
p < 0.01*
p < 0.01*
6MWT (distance) 70 623 ± 72 (411 ; 829) NA NA NA
MFM (%) NA NA 30 66.2 ± 14.2 (32.3 ; 91.7) NA
* = Significant difference between healthy boys and boys with DMD at the 0.05 level. 
DMD, Duchenne muscular dystrophy; A6MCT, Assisted Six-Minute Cycling Test; 6MWT, Six-Minute Walk Test; 
NA, Not assessed; MFM, Motor Function Measure
357
The Assisted Six-Minute Cycling Test in neuromuscuclar disorders
prior to the A6MCT was 95 bpm for the legs and 96 bpm for the arms, and increased to a 
maximum of 161 bpm and 163 bpm, respectively (Table 2). Perceived exertion increased 
from 0 (not tired at all) to 4 (getting more tired) on a maximal scale of 0 (not tired at all) to 
10 (very very tired) during both the A6MCT for the legs and arms. As expected, the number 
of revolutions achieved with the A6MCT for the legs (r = 0.38, p < 0.01) and arms (r = 0.60, 
p < 0.01) increased moderately with age in healthy boys. 
Construct validity
Seventy healthy boys performed the A6MCT for both the legs and arms and the 6MWT. 
Two boys were excluded; one of them fell during the 6MWT and walked carefully thereafter 
(no injuries occurred), and another boy ran instead of walking. The mean walked distance 
at the 6MWT was 623 ± 72 m, with a max heart rate of 160 bpm and an OMNI scale for 
perceived exertion score of 3 (Table 2). Heart rate and OMNI scale scores at the end of both 
the A6MCT and 6MWT were comparable (Table 2).
Figure 2  Cumulative number of revolutions for the legs (A) and arms (B) assessed using 
the A6MCT, and cumulative distance (m) assessed using the 6MWT (C) per minute.  
Mean and SD are shown. Black lines represent healthy boys. Grey lines represent boys with Duchenne 
muscular dystrophy. 
A6MCT, Assisted Six-Minute Cycling Test ; 6MWT, Six-Minute Walk Test
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 The A6MCT for the legs (r = 0.58, p < 0.01) and the A6MCT for the arms (r = 0.65, 
p < 0.01) were moderately correlated with the 6MWT (Figure 4). This means that boys who 
walked further during the 6MWT also achieved a higher number of revolutions with the 
A6MCT compared to boys who walked a shorter distance.
 Results from the linear regression analysis confirmed the positive relationship 
between the A6MCT for the legs (β = 0.6, p < 0.01) and the arms (β = 1.0, p < 0.01) and the 
6MWT. After correction for height, the results were slightly different (A6MCT for the legs: 
β = 0.7, p < 0.01, A6MCT for the arms: β = 0.7, p < 0.01). Height was also positively related 
to the A6MCT for the arms (p = 0.01), indicating that tall boys achieved more revolutions 
with their arms than small boys, but not to the A6MCT for the legs (p = 0.08). 
Test-retest reliability 
Twenty-three (leg cycling) and twenty-two (arm cranking) boys performed the A6MCT 
twice within two weeks. With respect to A6MCT for the legs, the mean number of 
revolutions was 870 ± 93 for the first assessment and 875 ± 92 for the second assessment 
(mean difference = 4 ± 46, p = 0.70). For the A6MCT for the arms, boys achieved on average 
33 ± 46 revolutions more during the second assessment (mean number of revolutions = 
840 ± 118) compared to the first assessment (mean number of revolutions = 807 ± 117) 
Table 2   Subject characteristics and test results of healthy boys and boys with 
Duchenne  muscular dystrophy
Healthy DMD Significance
A6MCT legs
HR start
HR end
OMNI start
OMNI end
95.4 ± 12.3 
161.0 ± 21.5
0 (0 ; 6)
4 (0 ; 10)
100.5 ± 12.3 
155.4 ± 17.9
1 (0 ; 3) 
6 (0 ; 10)
p = 0.11
p = 0.27
p = 0.07
p = 0.03*
A6MCT arms
HR start
HR end
OMNI start
OMNI end
95.9 ± 12.0 
163.0 ± 22.3
0 (0 ; 10) 
4 (0 ; 10)
107.28 ± 12.3 
149.3 ± 17.5
2 (0 ; 8) 
6 ( 0 ; 10)
p < 0.01*
p < 0.01*
p < 0.01*
p = 0.02*
a6MWT
HR start
HR end
OMNI start
OMNI end
100.0 ± 13.9
160.1 ± 20.4
0 (0 ; 7) 
3 (0 ; 10)
NA
NA
NA
NA
NA
NA
NA
NA
* = Significant difference between healthy boys and boys with DMD. 
A6MCT, Assisted Six-Minute Cycling Test; 6MWT, Six-Minute Walk Test; HR, heart rate; OMNI, OMNI scale for 
perceived exertion; DMD, Duchenne muscular dystrophy; NA, Not assessed
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(p = < 0.01). Nevertheless, a high degree of correlation was found between the two 
assessments for both the legs (ICC = 0.88, 95% CI = 0.72 ; 0.95) and arms (ICC= 0.89, 95% CI 
= 0.76 ; 0.95). Bland-Altman plots confirmed the good test-retest reliability of the A6MCT 
for both the legs and arms by showing that only 1 or 2 data points (4.3 – 9.1%) were 
beyond the 95% limits of agreement and by showing that the difference in the number of 
revolutions achieved between the first and second assessment was not correlated with 
the mean number of revolutions for the two tests (legs: r = -.04, p = 0.87; arms: r = -0.31, 
p = 0.18) (Figure 5).  
Validation of the A6MCT in boys with DMD
Participant characteristics
Thirty boys with DMD (18 ambulant, 12 wheelchair-dependent) with a mean age of 10.6 
years were included in this study. Characteristics of the total group of boys with DMD are 
shown in table 1 and in table 3 for ambulatory and wheelchair-dependent boys separately. 
As expected, wheelchair-dependent boys were older and taller than ambulatory boys 
(p < 0.01). 
Feasibility and performance
Of the thirty boys with DMD who participated in this study, 29 (97%) performed the 
A6MCT for the legs, as one wheelchair-dependent boy, with an MFM score of 47%, had 
insufficient muscle strength, particularly of the hip flexors, to be able to perform the test. 
Of the other 29 boys who were able to perform the A6MCT for the legs, 93% (i.e. 27 of the 
29 boys), had an MFM score of ≥ 50%. The two boys who scored less than 50% at the MFM 
(32 and 41% respectively), achieved a relatively low number of revolutions with their legs 
(< 225). Another two boys did not perform the A6MCT for the arms due to problems with 
attention span. All other boys (100%) were able to complete the A6MCT for the arms. No 
periods of rest were needed during the tests, and no signs of exercise intolerance were 
reported. 
 As expected, boys with DMD achieved less revolutions with their legs (mean number 
of revolutions = 405 ± 152) and arms (mean number of revolutions = 370 ± 120) compared 
to healthy controls with only little overlap (p < 0.01) (Table 1). However, boys with DMD 
also cycled at a constant velocity throughout the tests (Figure 2), and the correlation 
between the A6MCT for the legs and arms was comparable as for healthy boys (Figure 3). 
Regarding the endurance parameters (Table 2), heart rates and OMNI scale scores for 
perceived exertion prior to the A6MCT for the arms were increased in DMD boys compared 
to healthy controls. After the A6MCT for the legs, the heart rate response (maximum of 155 
bpm) and increase in OMNI scale scores (mean OMNI score = 6) in DMD boys were 
comparable to healthy controls. Maximum heart rate at the end of the A6MCT for the arms 
was slightly lower in boys with DMD (maximum of 149 bpm) compared to healthy boys 
(p < 0.01). No signs of exercise intolerance were observed. The number of revolutions 
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achieved with the A6MCT for the legs(r = -0.18, p = 0.34) and arms (r = 0.22, p = 0.25) was 
not significantly correlated with age and was not significantly different for ambulatory and 
wheelchair-dependent boys (Table 3). 
Figure 3   Correlations between the A6MCT for the legs (A) and arms (B).  
The A6MCT for the legs and arms are positively correlated in both healthy boys (open circles) and 
boys with DMD (stars). 
A6MCT, Assisted Six-Minute Cycling Test; DMD, Duchenne muscular dystrophy
Table 3   Subject characteristics and test results of ambulatory and wheelchair- 
dependent boys with Duchenne muscular dystrophy
n Ambulatory (n=18)
Mean ± SD (range)
n Wheelchair (n=12) 
Mean ± SD (range)
Demographics
Age (y) 18 9.3 ± 1.7 (6.4 ; 11.6) 12 12.4 ± 2.6 (8.7 ; 16.6) p < 0.01*
Body weight (kg) 18 33.6 ± 8.6 (18.3 ; 49) 12 63.3 ± 17.3 (35.7 ; 92.4) p < 0.01*
Height (m) 18 135.0 ± 13.6 (114 ; 166) 12 158.3 ± 16.2 (131 ; 181) p < 0.01*
A6MCT (revolutions)
Legs
Arms
18
16
431.44 ± 147.9 (183 ; 714)
371.88 ± 110.8 (205 ; 555)
11
12
361.6 ± 154.4 (118 ; 670)
368.3 ± 135.6 (142 ; 574)
p = 0.24
p = 0.94
MFM (%) 18 75.0 ± 9.3 (54.2 ; 91.7) 12 52.8 ± 8.5 (32.3 ; 61.5) p < 0.01*
* = Significant difference between healthy boys and boys with DMD at the 0.05 level. 
DMD, Duchenne muscular dystrophy; A6MCT, Assisted Six-Minute Cycling Test; 6MWT, Six-Minute Walk Test; 
NA, Not assessed; MFM, Motor Function Measure
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Relationship with disease severity
The mean MFM score (percentage) was 66.2 ± 14.2 (range 32.3 – 91.7). Wheelchair-dependent 
boys (mean MFM % = 52.8 ± 8.5) had lower MFM scores than ambulatory boys (mean MFM 
% = 75.0 ± 9.3) (p < 0.01, Table 3). As shown in figure 6, the number of revolutions achieved 
with the A6MCT for the legs was positively correlated with the MFM in the total group of 
boys with DMD (ρ = 0.65, p < 0.01), the ambulatory boys (ρ = 0.72, p < 0.01), and the 
wheelchair-dependent boys (ρ = 0.74, p = 0.01). This means that the number of revolutions 
Figure 4  Correlations between the 6MWT and the A6MCT for the legs (A) and arms 
(B) in healthy boys.  
The A6MCT for the legs and the A6MCT for the arms are positively correlated with the 6MWT. 
A6MCT, Assisted Six-Minute Cycling Test; 6MWT, Six-Minute Walk Test
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achieved with the A6MCT for the legs decreased with a decrease in motor function. 
A similar positive correlation between the A6MCT for the arms and motor function was 
found for wheelchair-dependent boys (ρ = 0.84, p < 0.01). A trend for a positive correlation 
between the A6MCT for the arms and motor function was also found for the the total 
group of DMD patients (ρ = 0.32, p = 0.94) and for ambulatory boys (ρ = 0.46, p = 0.07), 
but this was not significant. (Figure 6)
Figure 5  Bland-Altman plots for the A6MCT for the legs (A) and arms (B) with the mean 
(solid line) and 95% limits of agreement (dotted lines) for comparisons between assessment 
1 and 2 in healthy boys.  
A6MCT, Assisted Six-Minute Cycling Test
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Discussion 
This study shows that the Assisted Six-Minute Cycling Test (A6MCT) for the legs and arms 
is a feasible, valid and reproducible endurance test for children and adolescents aged 6-16 
years. The A6MCT is the first ergometer test that can also be performed by wheelchair-de-
pendent children with a progressive neuromuscular disorder and shows comparable 
characteristics of endurance testing in healthy boys. The motor assistance enables children 
with severe muscle weakness to perform a submaximal endurance test that is related to 
their disease severity.
Figure 6  Correlations between the A6MCTfor the legs and arms and the total score of 
the Motor Function Measure (%) in boys with DMD.  
A6MCT, Assisted Six-Minute Cycling Test
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Our results demonstrate that the A6MCT with a fixed motor assistance level (no-load, 
speed 7RPM) is feasible for both healthy boys and boys with Duchenne muscular 
dystrophy (DMD). Ninety-nine percent of the healthy boys and 97% of the boys with DMD 
were able to perform the A6MCT for the legs. Our preliminary results suggest that the 
threshold value for being able to perform the A6MCT for the legs is a total MFM score of 
around 50% for boys with DMD. With respect to the A6MCT for the arms, all healthy boys 
and boys with DMD were able to perform the test. This is unique, as other ergometer tests 
are often too hard to sustain for children with severe muscle weakness due to their initial 
load and increments in resistance.16,17
The A6MCT provided a sensitive outcome measure to distinguish between healthy boys 
and boys with DMD in this study. Boys with DMD achieved significantly fewer revolutions 
with their legs and arms compared to healthy age-matched controls. There was very little 
overlap in performance; just 2 boys with DMD performed within 2 SD of the mean number 
of revolutions achieved by healthy boys for both the legs and arms. Our findings 
corroborate earlier evidence that boys with DMD have a lower functional capacity than 
healthy boys.7 
 Although wheelchair-dependent boys achieved slightly fewer revolutions with the 
A6MCT than ambulatory boys with DMD, we did not find a significant correlation with age 
as was shown by previous studies on the 6MWT.7 The absence of a negative correlation 
between the A6MCT and age in our study could be explained by the relatively 
heterogeneous phenotype of DMD in our study, i.e. we included ambulatory as well as 
wheelchair-dependent patients. Even within these two groups, we found a large variability 
in motor function with age. For example, 2 8-year old boys participated in this study; one 
was ambulatory and was relatively fit, whereas the other boy was already confined to a 
wheelchair. Previous studies also confirmed the heterogeneity of the DMD phenotype 
from the motor, respiratory and survival points of view.18 Longitudinal research is needed 
to investigate the responsiveness of the A6MCT. 
The validity of the A6MCT was confirmed by its relationship with the often-used 6MWT in 
healthy boys and its correlation with disease severity as shown by the MFM in boys with 
DMD. Although one could speculate that the motor assistance could be unnecessary and 
limit the performance of healthy boys, we found that healthy boys who walked further 
also achieved a higher number of revolutions with the A6MCT compared to boys who 
walked less far. This means that the distance cycled was related to the submaximal level of 
functional capacity. Reproducibility data from healthy boys showed that boys achieved 
on average 33 revolutions more during a second assessment for the arms, which was 
performed within two weeks after the first assessment. This can be explained by a learning 
effect. Dutch boys, even those with an NMD, are accustomed to bicycling with their legs 
(thus being trained), but not with their arms (thus being untrained).
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 For boys with DMD, the distance cycled with the legs decreased with a lower motor 
function, indicating that the A6MCT is also able to measure clinically meaningful changes 
over time. 
 Also the data of the wheelchair-dependent boys with DMD confirmed the positive 
correlation between the A6MCT for the arms and the MFM. The absence of a relationship 
between the number cycled with the arms and the MFM within the total group of boys 
with DMD and the subgroup of ambulatory boys was not entirely unexpected, as both 
tests assess two different aspects of disease severity (i.e. endurance and motor function). 
Furthermore, the MFM measures proximal motor functions, but the number of items 
which assess gross arm motor functions is limited, and it is well known that fine arm motor 
functions (such as writing) are relatively preserved in boys with DMD.19 No other arm 
function tests, except the practical but non-sensitive general Brooke scale for upper limb 
function20, exist for DMD patients. The A6MCT for the arms could therefore become a first 
test for the assessment of arm function in NMD patients. 
The submaximal nature of the A6MCT for the legs and arms was confirmed by the 
maximum heart rate of about160 bpm and the perceived exertion score of “getting more 
tired” in healthy boys. The relatively high start heart rates might be explained by the 
excitement of the healthy boys to participate in the study. Maximal heart rates were 
comparable to those reached during the 6MWT, and also to those reached by boys with 
DMD during the A6MCT for the legs (155 bpm) and arms (149 bpm). As no studies have yet 
reported the aerobic peak of boys with DMD, one could speculate that the A6MCT is more 
“all-out” for boys with DMD than for healthy boys. Maximum perceived exertion scores 
were only “tired” and not “very very tired”, indicating that boys exercised at a submaximum 
level.20 Future trials should investigate the relationship between the A6MCT, cardiac and 
pulmonary function. Increases in perceived exertion were comparable to healthy boys, 
and no signs of exercise intolerance were found, confirming the feasibility and safety of 
the A6MCT for boys with DMD. 
Outcome measures for use in clinical trials on DMD, especially those that investigate the 
effectiveness of new drug treatments, should be clinically relevant and present how 
participants feel and function in a proper time period. With respect to the A6MCT, the 
meaningfulness for the boys and their parents could be limited by the fact that cycling is 
less critical to human performance in daily life than walking. Arm cranking, however, could 
be correlated with arm abilities and should be studied further. Overall, the results of this 
first validation study are promising and support further research on the A6MCT for 
children with NMD, especially in a time that treatment trials are being developed for more 
severely impaired NMD patients. We recommend investigation of the relationship 
between the A6MCT and clinically relevant endpoints (such as the age at which ambulation 
or the ability to put on a t-shirt are lost) and the ability of the A6MCT to measure changes 
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over time. Additionally, we recommend investigation of the relationship between the 
A6MCT and the 6MWT in a larger group of NMD patients and a feasibility study among 
older, even more severely disabled children and young adults with NMD. We also 
recommend the establishment of normative data for healthy girls, though we do not 
expect any gender differences from the literature on the 6MWT.21 Finally, we recommend 
a practice test to reduce measurement errors due to an improvement in coordination and 
a reduction in anxiety.3 Assessors using the A6MCT should always remember the influence 
of children’s’ motivation to participate in the test and adhere to the standardized 
procedures of encouragements.  
In conclusion, our results show that the A6MCT for the legs and arms is a promising 
objective outcome measure to monitor disease progression and to evaluate effectiveness 
of treatments in children with severe muscle weakness who are either restricted walkers 
or wheelchair-dependent. 
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Appendix 1 Assisted Six-Minute Cycling Test
General procedures
Equipment
1) Mobile trainer (KPT Cycla, Sprofit, Kinetic);
2) Stopwatch;
3) Polar band;
4) OMNI scale for perceived exertion;
5) Height adjustable chair;
6) Height adjustable table;
7) Footstool. 
Set up 
1) The test should be performed in a quiet room, preferably without any family or 
friends in the room.
2) The mobile trainer should be placed against the wall to prevent moving.
3) Participants should be seated comfortably with their back supported by the back of 
the seat.
4) Assessor sits next to the participant. 
5) For the A6MCT for the legs, the hip and knee of the bended leg should be hold in 
~90° flexion, while the knee of the other leg is submaximally extended. 
6) For the A6MCT of the arms the pedal axis should be a few centimeters (with a 
maximum of 5 cm) below shoulder level when the pedals are horizontal.
7) The distance from the chair to the bicycle should be determined by allowing 
participants to move their legs and arms over the submaximal range of motion, 
which may cause a feeling of stretch but not pain.
8) Passive mode 1 of the mobility trainer should be used, i.e. no-load speed of 7RPM.
9) Show the number of revolutions at the mobility trainer display. 
Test procedure 
1) Briefly demonstrate the cycling exercise and allow a short practical test. 
2) A 10 minute rest period should be given prior to the test.
3) Record heart rate and level of perceived exertion. 
4) Set stopwatch to zero.
5) Read the following statement: “You will cycle as fast as possible and keep this up for 6 
minutes. Try to continue until I tell you to that you have finished. You are allowed to rest, but 
try to continue for the whole 6 minutes.”
6) The assessor should inform the participant about the time completed and left, and 
about the amount of revolutions cycled.
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7) The assessor records the number of revolutions every minute.
8) The assessor should give verbal encouragements to maintain attention and to 
complete the test 15 s throughout the exercise. 
9) Encouragements could be: 
a. “You’re doing a great job! Keep going!”
b. “Wow, you’re doing great! Keep going!”
c. “You’re doing great, only 3 minutes left! Keep going!”
10) At the final 10 seconds of the test, the assessor should count down.
11) Record the total number of revolutions cycled, heart rated and perceived exertion at 
6 minutes. 
Determining a valid test
1) A test is valid if the participant completes or discontinues the test due to fatigue. 
2) A test is invalid if the participant: 
a. Discontinuous the test due reasons other than fatigue (such as noncompliance, 
injury).
b. Didn’t follow the instructions. 
Scoring sheet
Name: Date of test: 
Date of birth: Examiner: 
Time 
(minutes)
Revolutions 
(cumulative)
Heart rate 
(beats per minute)
Fatigue
(OMNI score)
1
2
3
4
5
6
Number of revolutions at six minutes: Comments:
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Abstract
The progression of Duchenne muscular dystrophy (DMD) is expected to negatively 
influence the patients’ Health Related Quality of Life (HRQoL), but knowledge of the 
relationship with disease severity is limited. We investigated the relationship between 
HRQoL (KIDSCREEN-52 questionnaire) and disease severity (clinical assessments of body 
functions and activities) in forty boys with DMD (19 ambulant, 21 wheelchair-dependent) 
who were in different phases of the disease and underwent life-limiting events such as the 
loss of the ability to ambulate and the ability to lift the arms. Additionally, we compared 
boys’ HRQoL perceptions with that of their parents. HRQoL was similar to healthy peers 
and not influenced by disease severity, except for the physical domain. Parents scored 
much lower than the boys on the KIDSCREEN-52 domains “Self Perception”, Moods and 
Emotions” and “Bullying”. The latter finding needs attention in the management of DMD. 
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Introduction
Duchenne muscular dystrophy (DMD) is the most commonly inherited progressive 
muscular disorder in childhood that affects around 1/4000 live- born males. Boys with 
DMD become increasingly dependent in their daily activities due to progressive paresis 
and loss of functional abilities.1,2 They generally become wheelchair-dependent around 
the age of ten years and lose arm function around the age of 15 years. In the advanced 
stages of the disease, cardiac or respiratory failure eventually become life- threatening.3 As 
new therapies are being developed to increase the life expectancy of boys with DMD, 
there is an increased need for appropriate and valid outcome measures to evaluate to 
what extent disease and treatment affect the child’s health and well-being.4 The 
importance of a patients’ point of view on their health status is widely recognized and 
increasingly used as outcome measure.5 From this perspective, the international Food and 
Drug Administration (FDA) recommends the inclusion of a Health Related Quality of Life 
(HRQoL) assessment instrument as an outcome measure in all clinical trials.6
HRQoL is an individual’s perception of health and one’s position in life in the context of the 
culture and value systems in which they live in relation to their goals, expectations, standards 
and concerns.7 Because it is a broad definition, there is a great variety in the assessment and 
interpretation of HRQoL. HRQoL questionnaires often cover only a selection of the 
composing factors and aspects the broad definition of HRQoL. This means that HRQoL 
measures do usually not assess the entire HRQoL concept. Previous studies of disease 
progression and HRQoL in boys with DMD show disparities in the interpretation of HRQoL 
measurements (e.g. the quantity and extensiveness of the questionnaires or the use of 
proxy-report versus child report). Some studies had similar outcomes; Davis8, Baiardini9 and 
McDonald10 described a lower HRQoL in boys with DMD compared to healthy controls, 
particularly on the physical domain. Kohler3 focused on pulmonary function, the need for 
mechanical ventilation and physical disability and concluded that there was no correlation 
between these functions and HRQoL. HRQoL in relation to disease progression and activity 
level has received less research attention. In addition, proxy-reports may lead to biased 
results as parents tend to underestimate the HRQoL perceived by their sons.11 
In this study we explored a broad view on the HRQoL in boys with DMD in relation to 
disease progression, especially during the life-limiting events as losing the ability to walk 
and losing arm function. To study the spectrum of physical functioning as well as the 
functional abilities , we used the International Classification of Functioning disability and 
health (ICF)-model as a starting point. This model describes the “body functions” and 
“activities and participation” and records the impact of the environment on the person’s 
functioning by including contextual and environmental factors.12,13 The benefit of this 
classification is the inclusion of functional activities and participation, which reflect the 
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child’s activities regardless of his or her physical abilities. In addition, the ICF provides a 
basis for content of outcome measures such as HRQoL.14 A recent study using the ICF 
model to evaluate the HRQoL in boys with DMD found the level of participation in social 
activities was significantly lower after the age of 10 years, but that the HRQoL did not 
decrease in the older cohort.15 
The primary aim of this study was to broadly describe HRQoL in different disease severity 
groups (losing the ability to walk, being wheelchair-dependent but with a good arm 
function, and being wheelchair dependent and losing arm function) in boys with DMD, 
while simultaneously assessing the agreement between them and their parents. Our 
second aim was to examine the correlations between HRQoL and dimensions of the 
ICF model in boys with DMD. 
 For a broad view on HRQoL we used the KIDSCREEN-52 (KS-52). The KS-52 is a new 
European Generic measure of HRQoL in children aged 8 to 18 years. It was recently 
developed and assesses many different aspects of HRQoLin ten domains. It also contains 
self-report forms in addition to the parent report forms.16 There are norm values for 
culture/ European country, age and gender groups. The reliability and validity of the KS-52 
were found adequate.17,18
Methods
Design and Participants 
We analysed the cross-sectional baseline data of the No use is Disuse (NUD) study.2 The 
NUD study investigated the effects of assisted training in boys with DMD.
 The boys were distributed in three groups depending on their functional phase of 
the disease: boys who (1) were ambulatory; (2) had recently (1-2yrs) become wheelchair- 
dependent, most of the time, with good arm function, or (3) had already been wheel-
chair-dependent for several years (2-5yrs) with decreased arm function. This division was 
made with the aid of the Vignos and Brooke scales19, which will be explained in the 
outcome measures. We excluded the boys below eight years from our analysis, because 
they were not able to complete the KS-52. 
 Participants visited our department of Rehabilitation and underwent the clinical 
assessments by one certified examiner (MJ). Both parents and boys filled out the KS-52 at 
home (child and proxy-version) with instructions. Parents and boys over the age of 12 gave 
their written informed consent. This study was approved by our local ethics committee.
Outcome Measures
The primary outcome measure of this study is the KIDSCREEN-52 (=KS-52), which is a 
questionnaire that consists of 52 items measuring 10 domains of HRQoL: “physical well 
being”, “psychological well being”, “moods and emotions”, “self-perception”, “autonomy”, 
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“parent relation and home life”, “financial resources”, “social support and peers”, “school 
environment” and “social acceptance”. Each item is scored on a 5-point Likert scale (1: no 
agreement at all, 5: totally agree), a higher score per item indicates a better HRQoL. If a 
responder left more than 25% of the items unanswered in a domain, the domain was 
counted as a missing value.
 In a previous study of the KIDSCREEN-group of Ravens-Sieberer18 have developed 
reference values for a population sample from 13 European countries including the 
Netherlands, which consisted of 22.827 healthy children and children with “special 
healthcare needs”. Reference values were also obtained from proxy measures for caregivers 
and parents. A so-called t-value of 50 (range 45 to 55) was the mean score per item; a score 
above 55 meant a higher HRQoL, a score below 45 meant a lower HRQoL compared to the 
reference group.16 We used these reference values in our study to compare the HRQoL of 
boys with DMD to healthy controls.
The ICF model consists of the dimensions “body functions” and “activities and participation”, 
which will be translated in clinimetric secondary outcome measures. 
 Measures of body functions were muscle strength and endurance. Muscle strength 
of the shoulder abductors, elbow extensors, hip extensors, knee extensors and ankle 
dorsal flexors was measured bilaterally using the Medical Research Council Scale (MRC). 
The MRC is an ordinal scale that grades the muscle strength on a scale of 0-5; grade 0 
means that no movement is observed, grade 5 means maximum contraction against full 
resistance. The Assisted Six-Minute Cycling Test (A6MCT) for the legs and arms was used to 
assess endurance. The A6MCT has been validated for DMD and assesses the number of 
revolutions a boy can achieve during six minutes cycling while using motor-assisted 
mobility training equipment.20 
 Several outcome measures were used to assess the activity-level of the boys: the 
Vignos and Brooke functional scales, the Motor Function Measure (MFM), the Abilhand 
and the Dutch Pediatric Evaluation of Disability Inventory (PEDI).
 The Vignos and Brooke functional scales classify lower and upper extremity functioning 
of boys with DMD19. The Vignos scale scores the functional ambulatory status ranging from 
being able to walk the stairs without guardrails (0) to not being able to sit in a wheelchair (10). 
In this study, we considered boys with Vignos scores 1-6 as the ambulatory group (able to 
walk independently, with or without aids) and boys with Vignos scores 7-10 as wheel-
chair-dependent. Boys with a Vignos score of 7 are able to walk small distance with aids and 
support, however in practice, they use a wheelchair most of the time. For this reason we 
included them in the non-ambulatory group. The Brooke scale classifies the arm function 
ranging from the ability to raise the arms above the head (0) to not being able to raise the 
hands to the mouth (6). We considered Brooke 1-3 as good arm ability (3 means being able 
to raise a glass of water to their mouth) and Brooke 4-6 as decreased arm function (4 means 
being able to raise hands, but not a glass of water, to the mouth). 
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 The MFM measures the functional motor abilities of both ambulant and wheel-
chair-dependent patients with a neuromuscular disorder.21 The 32 items of the MFM are 
classified in three dimensions: (1) standing and transfers, consisting of 13 items; (2) axial 
and proximal motor function, consisting of 12 items; and (3) distal motor function, 
consisting of 7 items. Each item is scored on a scale from 0 (does not initiate movement) 
to 3 (completes the item with a standard pattern). We calculated a percentage with a 
higher score indicating a better motor function.
 The Abilhand questionnaire was used to measure the capacity to manage daily 
activities that require the use of the upper limbs. The questionnaire consists of 21 items 
which describe various activities (such as brushing teeth). The boys reported each activity 
“easy” (score 3), “difficult” (score 2) or “impossible” (score 1).22 For boys who had significant 
problems with moving their arms, we used the original, extended (adult) version of the 
Abilhand consisting of 56 items.23
 We used two domains of the PEDI structured interview24 to assess the general 
functional status of the boys: (1) “selfcare”, consisting of 73 items and (2) “ambulatory 
status” consisting of 64 items. The ambulatory status was not assessed in boys who had 
already been wheelchair-dependent for several years and had decreased arm function. 
Every item scored 1 point when the activity could be performed and 0 if the patient was 
unable to perform the activity. 
Statistical analysis
Statistical analyses were conducted using SPSS version 16.0 for Windows (SPSS Inc., 
Chicago, Illinois, USA). We used the KS-52 syntax, based on the Rasch model to convert the 
raw data into t-values to describe both self-reported and proxy-reported HRQoL in 
comparison to the healthy population. Paired t-tests were used to measure the agreement 
between boys with DMD and their parents. 
 Correlations between the HRQoL using the raw data of the KS-52 and the different 
ICF domains were analyzed with two tailed, non-parametric Spearman’s correlation 
coefficient (ρ). Correlation coefficients were interpreted as follows: 0 to 0.25: little to any 
correlation, 0.26 to 0.49: low correlation, 0.50 to 0.69: moderate correlation, 0.70 to 0.89: 
high correlation and correlations ≥0.90 indicated a very high correlation.25 Because of 
multiple comparisons we chose a p-value of <0.01 as statistically significant. 
Results
Forty boys with DMD, aged 8-20 years, participated in the study. Their characteristics are 
summarized in table 1. Nineteen boys were still ambulatory, while twenty-one boys were 
wheelchair-dependent. In the non-ambulatory group seven boys had a decreased arm 
function (Brooke ≥4), while 14 had a relative good arm ability (Brooke ≤3). 
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The response rate of the KS-52 was satisfactory (>75%). Only the response rate on the 
financial domain was below 50% (19 out of 40), and this domain was therefore excluded 
from further analysis. Two proxy-reports were missing because of a language barrier. 
Subscales of HRQoL in boys with DMD compared with their age-matched 
controls 
Only the physical domain of the KS-52 was lower in the total group (mean = 40, SD = 6) 
than the reference group (mean = 50, SD = 5). In the ambulatory group the mean on the 
physical domain was 43 (SD = 6), in the non-ambulatory group with a relatively good arm 
function the mean on the physical domain was 36 (SD = 6) and in the group with 
decreased arm function 38 (SD = 2). This means that the boys felt less energetic and 
experienced to perform less physical activities than their age-matched controls and the 
physical domain seem to be lower in the non-ambulatory group compared to the 
ambulatory group. There were no differences between the self-reports of the boys with 
DMD and their age-matched controls in any of the other domains.
Figure 1   Subscales of HRQoL in the total group. 
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Comparison of the subscales of HRQoL in boys with DMD to their parents 
Figure 1-4 show the comparisons between boys and parents on the different subscales of 
the KS-52 for the total group of boys with DMD (Figure 1) and the three subgroups (Figure 
2-4). There was a good agreement between the boys with DMD and their parents on 
most of the domains of the KS-52, except for the domains “moods and emotions”, 
“self perception” and “social acceptance”. The parental perception of the HRQoL was 
significantly lower on these domains than the perception of the boys with DMD, 
respectively t = 10.5 (p<0.00), t = 8.9 (p<0.00), t = 11.0 (p<0.00) in the total group.
Correlations between the subscales of HRQoL and the ICF dimensions
Table 2 provides an overview of all correlations between the KS-52 domains and 
ICF-dimensions in the total group of boys with DMD. A moderate negative correlation 
between the domain “parent relation and home life” and the A6MCT of the arms (ρ = 
-0.53, p = 0.01), which means that boys with DMD perceive their relation with their parents 
better when they have decreased endurance in their arms. 
Figure 2   Subscales of HRQoL in the ambulatory group. 
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 No other correlations were found between body functions and the KS-52 domains in 
all groups
 Two significant correlations were found on activity level in the total group. First, a low 
negative correlation exists between the “physical domain” and the Vignos scale in the 
total group (ρ = -0.45, p = 0.01), which indicates that if the ambulation decreases, the 
perceived physical abilities decrease (as a higher vignos scale is associated with a lower 
ambulatory score). Second, we found a low positive correlation (ρ = 0.45, p = 0.01) between 
the “physical domain” and the PEDI “selfcare” domain, which means when boys with DMD 
are less able to take care of themselves independently, they perceive their physical abilities 
lower. The KS-52 was not correlated to the Brooke scale, the MFM and the Abilhand in the 
total group and ambulatory group. 
 In the non-ambulatory group we found a moderate negative correlation between 
the domain “parent relation and home life” of the KS-52 and dimension 1 of the MFM 
(standing position and transfers) (ρ = -0.603, p = 0.01). Furthermore, a moderate negative 
correlation was found between the domain “Autonomy” of the KS-52 and dimension 3 of 
the MFM (distal motor capacity) in the non-ambulatory group (ρ = -0.639, p = 0.01).
Figure 3   Subscales of HRQoL in the non-ambulatory group with good arm abilities. 
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Figure 4   Subscales of HRQoL in the non-ambulatory group with decreased arm abilities. 
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Table 2   Subject characteristics and test results of healthy boys and boys with 
Duchenne  muscular dystrophy
Physical  
well being
Psychological 
bell being
Moods and 
motions
Self-perception Autonomy Parent relation and 
home life
Social support 
and peers
School envi-
ronment
Social 
acceptance
Body structures
MRC left/ right
Hip extensors
Knee extensors
Shoulder abductors
Elbow extensors
0.15(0.51) / 
0.22 (0.33) 
n=21
0.45 (0.03)/
 0.38 (0.08) 
n=22
0.03 (0.90)/
 -0.07 (0.77) 
n=22
0.45 (0.03)/ 
0.38 (0.08) 
n=22
0.26 (0.23)/ 
0.10 (0.65) 
n=23
0.28 (0.18)/ 
0.18 (0.40) 
n=24
0.01 (0.97)/ 
-0.10 (0.66) 
n=24
0.12 (0.58)/ 
0.12 (0.56) 
n=24
0.15 (0.51)/ 
0.19 (0.40) 
n=22
0.06 (0.78)/ 
0.32 (0.89) 
n=23
-0.12(0.60)/ 
-0.14 (0.54) 
n=23
0.07 (0.75)/ 
0.13 (0.55) 
n=23
0.11 (0.63)/ 
0.10 (0.64) 
n=23
0.12 (0.59)/ 
0.08 (0.72) 
n=24
-0.21(0.33)/ 
-0.26(0.21) 
n=24
-0.06(0.78)/ 
0.06(0.78)
n=24 
0.18 (0.42)/ 
-0.16 (0.49) 
n=22
0.04 (0.88)/ 
-0.16 (0.46) 
n=23
-0.72(0.4)/ 
-0.32 (0.14) 
n=23
-0.17(0.43)/    
-0.16(0.46) 
n=23
0.01 (0.97)/
 -0.14(0.52) 
n=23
-0.43 (0.84)/ 
0.27 (0.21) 
n=24
-0.33(0.12)/      
-0.38 (0.07) 
n=24
-0.35(0.09)/     
 -0.22(0.30) 
n=24
0.28 (0.19)/ 
0.04 (0.86) 
n=23
-0.09(0.69)/      
-0.08(0.70) 
n=24
-0.35(0.10)/      
-0.28(0.19) 
n=24
-0.15(0.48)/      
-0.15(0.47) 
n=24
0.33 (0.13)/ 
0.15 (0.52) 
n=22
0.20 (0.35)/ 
0.11 (0.61) 
n=23
-0.04(0.87)/      
-0.13(0.55) 
n=23
0.01(0.98)/ 
0.01(0.95) 
n=34
-0.11(0.63)/
0.31 (0.18) 
n=21 
0.10 (0.65)/ 
0.12 (0.61) 
n=22
-0.18(0.41)/    
 -0.06 (0.79) 
n=22
0.18 (0.42)/ 
0.08(0.73)  
n=22
A6MCT      Legs
                    Arms
0.49 (0.06) 
n=16
0.15 (0.53) 
n=19
0.89 (0.73) 
n=18
-0.32 (0.16) 
n=21
0.12 (0.65) 
n=17
0.03 (0.91) 
n=20
-0.05 (0.84) 
n=18
-0.34 (0.13) 
n=21
0.07 (0.79) 
n=17
-0.43 (0.06) 
n=20
-0.14 (0.59) 
n=18
-0.53 (0.01) 
n=21
-0.17 (0.07) 
n=18
-0.18 (0.44) 
n=21
0.08 (0.77) 
n=18
-0.21 (0.38) 
n=20
0.07 (0.78) 
n=17
-0.13 (0.96) 
n=19
Activities and participation
Vignos -0.45 (0.01) 
n=33
-0.09 (0.60) 
n=33
-0.18 (0.32)
n=33
-0.03 (0.86) 
n=33
-0.09 (0.62) 
n=32
0.02 (0.90) 
n=33
-0.23 (0.19) 
n=33
-0.25 (0.17) 
n=31
-0.05 (0.80) 
n=31
Brooke -0.34 (0.06) 
n=31
0.04 (0.84) 
n=33
0.21 (0.26) 
n=32
0.10 (0.57) 
n=33
0.14 (0.46) 
n=32
0.23 (0.20) 
n=33
-0.23 (0.21) 
n=33
-0.13 (0.50) 
n=32
0.04 (0.84)
 n=31
MFM (total) 0.24 (0.28) 
n=22
-0.34 (0.87)
n=24
-0.18 (0.42) 
n=23
0.00 (0.10) 
n=24
-0.29 (0.18) 
n=23
-0.37 (0.08) 
n=24
-0.33 (0.11) 
n=24
0.06 (0.78) 
n=23
-0.07 (0.76) 
n=22
Abilhand   Kids
                   Regular
0.28 (0.25)
 n=19
0.52 (0.19)
 n=8
-0.19 (0.44) 
n=20
0.33 (0.43) 
n=8
0.11 (0.66) 
n=20
0.11 (0.80) 
n=8
-0.31 (0.19) 
n=20
-0.22 (0.60)
 n=8
-0.24 (0.32) 
n=20
0.28 (0.51) 
n=8
-0.26 (0.28) 
n=20
0.09 (0.84) 
n=8
-0.24 (0.31) 
n=20
0.42 (0.30)
n=8
-0.10 (0.67) 
n=19
0.63 (0.10) 
n=8
0.09 (0.74) 
n=18
-0.20 (0.63) 
n=8
PEDI          Selfcare
                  Ambulation               
0.45 (0.01) 
n=31
0.47 (0.02) 
n=25
-0.04 (0.82) 
n=33
0.15 (0.46) 
n=27
-0.04(0.84) 
n=32 
0.00 (0.99) 
n=26
-0.12 (0.52)
n=33
0.08 (0.70)
n=27
-0.18 (0.92) 
n=32
0.03 (0.89) 
n=26
-0.04 (0.83) 
n=33
-0.10 (0.64)
n=27
0.27 (0.13) 
n=33
0.05 (0.79) 
n=27
0.25 (0.16) 
n=32
0.22 (0.28) 
n=26
0.02(0.94)      
n=31
0.16 (0.44) 
n=25
MRC, Medical Research Council Scale; NA, Not applicable; A6MCT, Assisted Six-Minute Cycling Test; MFM, 
Motor Fucntion Measure; PEDI, Dutch Pediatric Evaluation of Disability Inventory
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Table 2   Subject characteristics and test results of healthy boys and boys with 
Duchenne  muscular dystrophy
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0.23 (0.20) 
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n=33
-0.13 (0.50) 
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0.04 (0.84)
 n=31
MFM (total) 0.24 (0.28) 
n=22
-0.34 (0.87)
n=24
-0.18 (0.42) 
n=23
0.00 (0.10) 
n=24
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-0.37 (0.08) 
n=24
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0.33 (0.43) 
n=8
0.11 (0.66) 
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0.11 (0.80) 
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-0.24 (0.32) 
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0.28 (0.51) 
n=8
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0.09 (0.84) 
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-0.24 (0.31) 
n=20
0.42 (0.30)
n=8
-0.10 (0.67) 
n=19
0.63 (0.10) 
n=8
0.09 (0.74) 
n=18
-0.20 (0.63) 
n=8
PEDI          Selfcare
                  Ambulation               
0.45 (0.01) 
n=31
0.47 (0.02) 
n=25
-0.04 (0.82) 
n=33
0.15 (0.46) 
n=27
-0.04(0.84) 
n=32 
0.00 (0.99) 
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n=33
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n=32
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0.02(0.94)      
n=31
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MRC, Medical Research Council Scale; NA, Not applicable; A6MCT, Assisted Six-Minute Cycling Test; MFM, 
Motor Fucntion Measure; PEDI, Dutch Pediatric Evaluation of Disability Inventory
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Discussion
The first finding we want to emphasize is that except for the “physical domain”, the HRQoL 
is similar to their healthy peers and is not influenced by disease progression in boys with 
DMD in contrast to previous studies8-10,15 were the HRQoL was lower in comparison to 
healthy peers. We presume that part of the differences is explained by the use of 
child-reports and proxy-reports in our study and our large control group of the KS-52 
(n=22.827). Besides, the PedsQL used by Davis and Bendixen8,15 has limited domains and is 
not designed to a full range of functioning like the KS-52.
 This finding means that boys with DMD value their life positively, despite their 
limitations and disease progression. This forms a solid psychological basis in a continued 
search for life-lengthening therapies for boys with DMD and implies that when new 
therapies are applied, the HRQoL is not likely to improve (with the exception of physical 
domain), because it is similar to healthy peers at the start of a therapy. HRQoL assessment 
is a suitable instrument to evaluate whether or not a therapy has a negative impact on 
HRQoL. For example, too high expectations of a therapy might negatively influence 
HRQoL. Of course, it is a challenge to improve the physical domain.
 The second finding we want to emphasize is the difference in perceived HRQoL of 
boys with DMD and their parents on the domains “mood and emotions”, “self perception” and 
“social acceptance”. The parents grossly underestimate the perception of their sons’ happiness, 
the perception of their looks and the perceived support from their social network.
 We expected such an underestimation based on previous studies8,11, which found a 
poor to moderate agreement on all PedsQL domains, were the agreement on the social 
domain was poorest. In our study, we were able to further specify social sub domains to 
increase the insight on which level the agreement is lowest.
 We have two hypotheses for the difference in perceived HRQoL between boys and 
their parents at these domains; (1) the parents reflect on their own frame of reference by 
interpreting the limitations of their sons or (2) the parents are more sensitive to negative 
comments of the environment. In literature no research is done on this topic to support 
our presumptions yet. Eiser26 found some evidence that social support networks of 
families with a chronically sick child are smaller, denser and qualitatively lower from those 
of healthy families. 
 The poor agreement between the boys and their parents emphasizes the importance 
of self-report questionnaires when measuring HRQoL in boys with DMD. Besides, it is very 
important to inform parents about these differences. Hopefully, they will be comforted 
and involve their sons in therapy decisions.
 The third and last finding we want to discuss is that we did not find any strong and 
recurrent correlations between the KS-52 domains and the outcome measures of the ICF 
model. This means that despite the decrease in activities, the boys with DMD stay content 
with their life. Here we will discuss the correlations we did find. 
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 In the total group, the correlation between the “physical domain” of the KS-52 and 
the PEDI “selfcare” domain can be explained by decreased physical opportunities. We 
expected the low negative correlation between the Vignos scale and the “physical 
domain” , because the physical domain is the only HRQoL subscale which is influences by 
disease progression as mentioned before. 
 In the non-ambulatory subgroup we found two significant negative correlations on 
activity-level (MFM D1 and arm endurance) in relation to the KS-52 domain. This means 
that when the standing position and transfers of boys with DMD deteriorate or if the arm 
endurance decreases, they perceive a better understanding and more love from their 
parents and feel more happy at home. Biairdini9 also found that ill children receive more 
attention and support from their family and suggested that this is because caregivers are 
more worried and distressed about their children’s clinical conditions and they are more 
aware about the progressive nature. Besides, a moderate negative correlation between 
MFM D3 and the “autonomy” domain, which indicates that a decrease in distal motor 
function is associated with an increase in autonomy, meaning boys with DMD have 
enough time to themselves, to meet friends and to do the things they want in their free 
time. We think it is most likely that this association is not directly related to the disease 
progress in DMD but merely reflects growing up into adulthood. 
 Our study should be viewed in the light of its limitations. First, no specific outcome 
measure was used to assess participation-level in boys with DMD. At the start of the NUD 
study, no validated instrument was available to measure the participation-level separately 
in children, meanwhile such a questionnaire is developed and validated.27 Bendixen15 used 
a participation measurement in comparison with the HRQoL in boys with DMD. They 
emphasize further research is necessary as participation tends to decrease with age in 
boys with DMD. Their cohorts were divided based on age, while only three of the fifty 
participants were in the non-ambulatory phase. We recommend additional research 
including participation outcome measurements, based on life limiting events. Second, 
our study has a relatively small sample size, especially for analyzing subgroups. In a larger 
sample we expect significant positive correlations between activity-level and HRQoL 
domains could occur. Third, the KS-52 is not a disease specific questionnaire. As a result, 
one of the five items in the physical domain (“were you able to run well?”) was not 
appropriate for all boys. Then again, the differences between the boys with DMD and the 
healthy peers and between the different ambulation groups may become even bigger 
when using a disease specific instrument. The final limitation of this study is that the 
response on the financial domain of the KS-52 was very low. An explanation could be that 
the teenage boys with DMD are not usually responsible for their own financial situation.
 To conclude, boys with DMD have a stable HRQoL despite disease progression except 
for the physical domain. Information about the perceived HRQoL of boys with DMD to the 
parents is crucial as they tend to underestimate the HRQoL of their sons. 
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Abstract 
Background: “Use it or lose it” is a well known saying which is applicable to boys with 
Duchenne muscular dystrophy (DMD). Besides the direct effects of the muscular dystrophy, 
the increasing effort to perform activities, the fear of falling and the use of personal aids 
indirectly impair leg and arm functions as a result of disuse. Physical training could oppose 
this secondary physical deterioration. The No Use is Disuse (NUD) study is the first study in 
human subjects with DMD that will examine whether a low-intensity physical training is 
beneficial in terms of preservation of muscle endurance and functional abilities. The study 
consists of two training intervention studies: study 1 “Dynamic leg and arm training for 
ambulant and recently wheelchair-dependent boys with DMD and, study 2 “Functional 
training with arm support for boys with DMD who have been confined to a wheelchair for 
several years”. This paper describes the hypotheses and methods of the NUD study.
Methods: Study 1 is an explorative randomized controlled trial with multiple baseline 
measurements. Thirty boys with a DNA-established diagnosis of DMD will be included. 
The intervention consists of a six-months physical training during which boys train their 
legs and arms with active and/or assisted cycling training equipment. The primary study 
outcomes are muscle endurance and functional abilities, assessed with a Six-Minute 
Bicycle Test and the Motor Function Measure. Study 2 has a within-group repeated 
measurements design and will include ten boys with DMD who have already been 
confined to a wheelchair for several years. The six-months physical training program 
consists of 1) a computer-assisted training and 2) a functional training with an arm support. 
The primary study outcome is functional abilities of the upper extremity, assessed with 
the Action Research Arm Test. 
Discussion: The NUD study will fill part of the gap in the current knowledge about the 
possible effects of training in boys with DMD and will increase insight into what type of 
exercise should be recommended to boys with DMD. The study will finish at the end of 
2010 and results are expected in 2011. Trial registration The Netherlands National Trial 
Register1631. 
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Background 
Duchenne muscular dystrophy (DMD) is an inherited X chromosome-linked recessive 
myopathy which affects approximately 1/4200 live-born boys.1 DMD is characterized by a 
total, or near-total (<3%), absence of the cell membrane protein dystrophin. The absence 
of dystrophin results in a steady degradation of muscle fibers that causes progressive loss 
of muscle strength and functional abilities.2,3 Boys with DMD are usually confined to a 
wheelchair at the age of ten years4 and have a median life expectancy of thirty years with 
spinal surgery and assisted ventilation5. Although ongoing studies show promising 
therapies that target disease cause, there is still no curative (pharmaco)therapy available 
and, thus, treatment remains symptomatic. An important aim in the management of boys 
with DMD is to preserve functional abilities for as long as possible.6 Delaying the loss of 
functional abilities is relevant for all activities in daily life and may optimize independence 
in boys with DMD.
The loss of functional abilities is primarily the result of a progressive decrease in muscle 
strength and muscle endurance during the course of the disease.4,7 However, increasingly 
limited physical and social possibilities gradually cause a secondary reduction of physical 
activity. Indeed, the increasing amount of energy a certain activity costs, the increasing 
frequency of falling (with the need for help to stand up), and the developing fear of falling 
further reduce leg and arm activities, resulting in disuse of the musculoskeletal and cardio-
respiratory systems.8 The use of an electrical wheelchair limits arm functions (like reaching 
and lifting) even more, since a top blade and a central operating joy stick force boys to 
function within the confines of the wheelchair. As the increased sedentary lifestyle results 
in progressive disuse, secondary physical deterioration will occur in all boys with DMD. 
Disuse in DMD thus can be defined as the discrepancy between a boy’s potential capacity 
and his actual performance. To underscore the importance of disuse, previous studies 
have shown that the presence of hip, knee and elbow flexion contractures is strongly 
related to the onset of wheelchair dependence.4 Another example is that boys with DMD 
have a higher risk of bone fractures due to osteoporosis caused by unloading.9 Fractures 
as a result of falling are followed by a loss of ambulation in 20-40 percent of the cases.10,11 
In these aspects, the well-known saying “use it or lose it” is certainly applicable to boys 
with DMD. 
Physical training could oppose the secondary deterioration of muscle tissue and the loss 
of functional abilities as a result of disuse. However, the number of studies that examined 
the effects of training in DMD is limited, and only a few training studies are reported in 
human subjects with DMD. These studies focused on resisted exercises in ambulatory 
boys and concluded that sub-maximal resistance exercises had only limited positive 
effects on muscle strength and timed functional tests (such as the time it takes to walk 23 
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feet) but, importantly, they did not cause physical deterioration.12,13,14 Recent studies in 
mdx mice (an animal model for DMD) concluded that voluntary wheel running (dynamic 
training) had positive effects on muscle strength15 and fatigue resistance15,16,17. In addition, 
non-weight bearing low-intensity exercises (like swimming) had no detrimental effects in 
mdx mice.18 However, extrapolating data from animal studies to humans should only be 
done with great caution because of differences in phenotypic expression and 
biomechanical differences between humans subjects and animal models with muscular 
dystrophy.19 Based on the currently available evidence, and clinical experience, international 
guidelines recommend ambulatory boys to perform voluntary (eventually mechanical-
ly-assisted) active exercises (such as swimming) and to avoid eccentric exercises. 
Non-ambulant boys are advised to perform mobilizing passive or actively-assisted 
mobilizing exercises to maintain postural symmetry and sitting comfort.20 
 The mechanisms by which training may oppose the deterioration of muscle tissue is 
unclear. Muscle fibres in DMD are abnormally vulnerable to contraction-induced injury 
due to the absence of mechanical reinforcement of the sarcolemmal membrane.21 
Therefore, eccentric exercises should be avoided. On the other hand, work-induced 
damage can enhance muscle regeneration and repair23, and low-stress exercise may 
produce beneficial effects on myofiber contractility and energetic efficiency21. For 
example, low-intensity training decreased oxidative stress markers24 and caused a shift 
from fast-twitch muscle fiber type 2 to slow-twitch muscle fiber type 1 in mdx mice.16 
Slow-twitch muscle fibers are more resistant to muscle fiber degeneration.16,25 In addition, 
corticosteroids could support the beneficial effect of training in DMD, since steroids may 
prevent post-exercise deterioration of skeletal muscle.22 
The currently recommended voluntary exercises to maintain comfort and symmetry6 are 
widely used in daily practice and assume that low-intensity training is beneficial and not 
harmful for boys with DMD. However, these recommendations are mainly based on 
theory and there is a need for more research to justify these recommendations and to 
define the optimal exercise programs26. As we expect that a low-intensity training may 
slow-down the secondary decline of muscle endurance and functional abilities (Figure 1), 
we developed the No Use is Disuse (NUD) study protocol to answer the clinically relevant 
questions whether low-intensity physical training in boys with DMD is beneficial and does 
not cause further harm. The NUD study is the first to examine the effects of low-intensity 
physical training in human subject with DMD and will fill part of the gap in current 
knowledge about the possible effects of training in boys with DMD. The study consists of 
two training intervention studies: study 1 “Dynamic leg and arm training for ambulant and 
recently wheelchair- dependent boys with DMD and, study 2 “Functional training with 
arm support for boys with DMD who have been confined to a wheelchair already for 
several years”. This paper describes the hypothesis and methods of the NUD study. 
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Methods
Study 1 Dynamic leg and arm training
Design 
Study 1 is an explorative randomized controlled trial with multiple baseline measurements. 
Randomization is stratified according to the ambulatory status (ambulant / non-ambulant) 
of the boys and the boys are allocated to the intervention group or the control group in a 
2:1 ratio. The intervention group receives dynamic exercise treatment, whereas the control 
group receives usual care (no specific intervention) during 24 weeks. After this period, the 
control group will also receive the physical training. Randomization is performed by an 
independent statistician. Despite randomization, differences in baseline characteristics 
between the intervention group and the control group may still be present due to the 
relatively small number of participants. For this reason, multiple baseline measurements 
are performed that will allow us to do within-subject analyses as well. Assessments are not 
blinded, because it was considered virtually impossible to prevent the boys from revealing 
their group allocation to the assessor. 
Figure 1   Hypotheses.  
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Participants
Thirty ambulatory or recently wheelchair-dependent boys with a DNA-established 
diagnosis of DMD will be included (Figure 2). There are an estimated four hundred boys 
with DMD in the Netherlands. Inclusion and exclusion criteria are described in Table 1. 
Participants will be recruited from the Dutch Duchenne Parent Project (DPP) database. 
Members of the DPP will receive written information and a registration form. Additionally, 
we will place an advertisement on the website of the Vereniging Spierziekten Nederland 
(VSN), and rehabilitation physicians affiliated with the VSN will be asked to make potential 
participants aware of the NUD study. After registration, interested potential participants 
are visited by the primary investigator (MJ) at home for providing further information. 
Parents, and participants who are over 12 years of age, need to give written informed 
consent. The study protocol was approved by the Medical Ethics Committee Arnhem- 
Nijmegen, the Netherlands. 
Figure 2   Progress study 1 Dynamic leg and arm training.  
This flowchart is a preliminary version. Final numbers may change depending on eligibility as 
recruitment is not yet complete.
Assessed for eligibility (n= 41) 
Excluded  (n=10) 
   • Not meeting inclusion criteria (n=9) 
   • Declined to participate (n=1) 
   • Other reasons (n=0) 
Lost to follow-up (n=1, patient burden) 
Discontinued intervention (n=3) (reasons:   
patellar luxation, too young, patient burden) 
Allocated to intervention (n=19) 
 • Received allocated intervention (n=19) 
 • Did not receive allocated intervention (n=0)  
Lost to follow-up (n=0)  
Discontinued intervention (n=1) 
(reason: fatigue)  
Allocated to control group (n=10)  
 • Received allocated intervention (n=9) 
 • Did not receive allocated intervention (n=1) 
(reason: cardiomyopathy)  
Allocation 
Follow-Up 
Randomized (n=29)  
Enrollment 
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Intervention: dynamic leg and arm training
Boys train their legs and arms with bicycle training equipment (KPT Cycla, Kinetic, France). 
As this type of training equipment can be used actively or with electrical motor support, 
it allows a combination of active and passive bicycle training. Physical training is additional 
to any regular therapy or daily physical activity that boys already take part in, yet all 
possible co-interventions are registered. 
Boys train at home or at school (depending on their preferences) during 30-min sessions 
(15 min leg and 15 min arm training), five days per week during 24 weeks. They are 
instructed to cycle with a continuous speed and stimulated to reach 700-1000 revolutions 
with both their legs and arms during each training session without getting too tired. 
Cycling characteristics are standardized (see Chapter 3, Figure 1) and crank-arm length is 
adjusted to the child’s height (e.g. a short crank-arm length for small legs and arms). Boys 
are free to choose when they would like to train, their training sequence (first arms or legs) 
and whether they want a break between the two 15 min training sessions or not. However, 
these training agreements are decided beforehand and registered in a training contract 
to which they should adhere. Additionally, the boys are recommended to train while 
watching television to make the training more pleasurable. 
Table 1   Inclusion and exclusion criteria study 1
Inclusion criteria Exclusion criteria
A DNA-established diagnosis of DMD
Boys who are at the end of their ambulation 
phase, and:
- need ≥5 sec. to get up from the floor or
- are not able to get up from the floor or
- are not able to bicycle without assistance
- are dependent on a wheelchair to move over a 
long distance (>500m)
Boys who recently became wheelchair-dependent 
(approximately 1-2 years after they stopped 
walking), and:
- are able to touch the top of their head with 
both hands without assistance or
- are able to use a hand-operated wheelchair
Other disabling diseases influencing 
mobility
Boys with a clinical symptomatic 
cardiomyopathy
Boys <6 years old 
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Based on general training principles and based on the results from previous training 
studies in boys with DMD and in animal models of DMD, the training intensity is low to 
moderate. Intensity is determined by an adjusted and modified Six-Minute Bicycle 
ergometer Test (see study outcomes). Boys are encouraged to reach as many revolutions 
as possible during this sub-maximal test. The number of revolutions is an indication for 
training intensity (level of electrical assistance). After six minutes of rest, boys cycle for 
three more minutes at the indicated training intensity. During this period, they should be 
able to cycle with a continuous speed of 60 revolutions per minute (RPM) with a perceived 
level of exertion ranging from ‘a little tired’ to ‘getting more tired’, as assessed with the 
OMNI Scale of perceived exertion.27 The primary investigator will check the training 
intensity once again during a 15 min training session within two weeks after the start of 
the intervention period. This control is carried out in a home setting, so that training 
posture can be checked as well. When boys are not able to bicycle at a continuous speed 
of approximately 60 RPM without having pain or maintaining the level of ‘getting more 
tired’, the training intensity will be lowered. 
As described above, training intensity is based on the ability to bicycle at a continuous 
speed and perceived exertion. Intensity is, thus, not based on peak heart rate, which is 
common in the literature on physical exercise training. The reason for this is twofold. 
Firstly, boys with DMD have a higher resting heart rate (110±12 beats/min) compared to 
healthy controls (94±7beats/min ).28 Additionally, boys with DMD are often forced to 
terminate a bicycle ergometry test while their peak heart rate is only 120-130 beats/min, 
since the main limiting factor during ergometry seems to be not their oxygen transport 
but their ‘peripheral’ capacity (muscle endurance, anaerobic power and muscle strength).7
Boys are instructed to send their daily number of revolutions and their perceived levels of 
exertion to the primary investigator by a postal questionnaire once every two weeks, 
together with an overstrain questionnaire. Parents and their boys are informed by 
telephone when compliance is inadequate or when other problems (such as signs off 
overstrain: see adverse events) are identified and children are encouraged to resume the 
training or to adjust the training intensity. 
Study outcomes 
Study outcomes include measurements at the levels of body functions and structures, 
activities and participation as defined by the International Classification of Functioning, 
Disability and Health (ICF).29 Environmental characteristics (school type and home status) 
are assessed at baseline. Demographic variables (age, weight and arm span), the use of 
medication (such as corticosteroids), any co-interventions and daily amount of physical 
activity are registered during each session.
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The assessments of boys in the intervention group are conducted during the baseline 
period (T0: at baseline; T1: after 4 weeks; T2: after 8 weeks), the training period (T3: after 12 
weeks; T4: after 24 weeks) and the follow-up (T5: 4 weeks after the end of the training; T6: 
24 weeks after the end of the training). The assessments of boys in the control group are 
conducted during the baseline period (T0: at baseline; T1: after 4 weeks; T2: after 8 weeks), 
the control period (T3: after 12 weeks; T4: after 24 weeks), the subsequent training period 
(T5: after 12 weeks of training; T6: after 24 weeks of training) and during the follow-up (T7: 
4 weeks after the end of the training). Assessments take place at the department of 
Rehabilitation of the Radboud University Nijmegen Medical Centre (T0, T2, T4, T6), but also 
at home (intervention group: T1, T3, T5; control group: T1, T3, T5, T7) to reduce the practical 
burden on the participants. All data are collected by the (trained) primary investigator 
(MJ). (Figure 3) 
Primary outcomes
Bicycle ergometry: Six-Minute Bicycle Test 
Muscle endurance, in this study defined as ‘the ability to sustain a power without the 
occurrence of peripheral fatigue’, is assessed with an adjusted and modified bicycle 
ergometer test for both the lower and upper extremities. Bicycle ergometry has been 
used in many studies to examine the (an)aerobic performance in healthy children and 
children with disabilities, and several exercise protocols are available. However, these 
protocols are not feasible for boys with DMD, since large muscle groups are affected in 
DMD and initial load and subsequent increments of load are often too hard to sustain for 
these patients.7,30 Muscle endurance is, therefore, examined with a recently developed 
motor- assisted (passive mode 1, no-load speed 7 RPM) Six-Minute Bicycle Test by which 
boys are instructed to cycle as fast as possible i.e. to make as many cycling revolutions as 
possible. Boys start with a test for their legs and, thereafter, perform the same (arm 
cranking) test with their arms. 
Figure 3   Measurements study 1.  
BP, Baseline period; IP, Intervention period; FU, Follow-up; CP, Control period
0 4 8 20 32 36 44 56 60
BP I P FU
T O T 1 T 2 T 3 T 4 T 5 T 6
Time(weeks)
Intervention group
Measurement
Control group BP C P W P FU
Measurement T O T 1 T 2 T 3 T 4 T 5 T 6 T 7
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The occurrence of muscle fatigue during bicycle ergometry is assessed objectively with 
bipolar surface electromyography (sEMG), since peripheral fatigue is reflected as an 
increase in the amplitude and a decrease in the median frequency of the sEMG signal.31,32 
These parameters were found to be responsive to changes in muscle endurance during 
an exercise program.33,34 Electrodes are placed unilaterally (right leg, right arm) on the m. 
rectus femoris, m. vastus medialis, m. biceps femoris, m. tibialis anterior, m. biceps brachii, 
m. triceps brachii and m. deltoideus. Electrode placement procedures will follow the rec-
ommendations for Sensor and Sensor Placement Procedures for surface electromyogra-
phy.35 Data will be registered with an EFA system (Twente Medical Systems International). 
The occurrence of muscle fatigue is also assessed subjectively with the OMNI Scale for 
perceived exertion.27 The OMNI Scale is reliable and valid over a wide range of dynamic 
exercise intensities in children.27,36 
Motor Function Measure 
The MFM is a recently developed instrument to assess motor function in ambulant and 
non-ambulant patients with neuromuscular diseases (NMD) aged 6-62 years.37 The MFM has 
shown excellent internal consistency and good to excellent intra- and interrater reliability in 
French neuromuscular patients.37 Vuillerot et al.38 showed that the MFM is able to measure 
changes in motor function over time in boys with DMD. An ongoing study examines validity 
and applicability of the MFM in rehabilitation institutes in the Netherlands. 
Secondary outcomes
Table 2 shows an overview of the secondary study outcomes and their psychometric 
properties. 
Adverse events
All adverse events will be recorded. The study will be terminated prematurely for an 
individual participant when training is excessive and remains excessive after a reduction 
of the training intensity. Signs for overstrain are: excessive muscle pain during the training, 
prolonged post-exercise muscle pain, a severely uncomfortable feeling during or after the 
training and extreme (muscle) fatigue (OMNI scale > 6). 
Sample size 
The average rate of decline (mean and standard deviation (SD)) of muscle endurance and 
functional abilities in boys with DMD, as assessed with bicycle ergometry and the Motor 
Function Measure (MFM), is unknown. Therefore, no sample size can be calculated for these 
primary outcomes. However, it is anticipated that multiple baseline measurements will increase 
the chance of finding statistically significant changes in the selected outcome measures. For 
reasons of convenience, and because this RCT should be regarded as a first explorative study, 
we decided to include 20 boys in the intervention group and 10 boys in the control group. 
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Analysis 
A two-way analysis of variance (ANOVA) will be used to examine the effects of dynamic 
leg and arm training on the primary outcomes. Secondary outcomes will be treated 
similarly or by non-parametric analyses dependent on the type of outcome (interval or 
ordinal). Data will be analyzed with SPSS version 16.0 and an alpha level of 0.05 will be 
used to decide on statistical significance. 
Study 2 Functional training with arm support
Design
Study 2 has an observational one-group design using repeated measurements, because 
we anticipate that it will not be possible to recruit a sufficient number of boys for an RCT 
in the Netherlands. This problem is related to the fact that boys with DMD who have been 
confined to a wheelchair already for several years often experience many barriers, such as 
a lack of time due to therapy obligations and homework. It is also virtually impossible for 
them to do without their electric wheelchair for a couple of days to build up the required 
arm support for this study. In addition, the number of boys at this stage in the course of 
DMD is low (i.e. an estimated 120 boys in the Netherlands) and, it is expected that some of 
these boys already use an arm support, which is an exclusion criteria for participation. 
Participants 
Ten wheelchair-dependent boys with a DNA-established diagnosis of DMD will be 
recruited in the same way as the participants of study 1 (Figure 4). Inclusion and exclusion 
criteria are described in table 3. Participants will receive written information and will be 
visited by the primary investigator at home for providing further information. Both parents 
and participants will need to give written informed consent. The study protocol was 
approved by the Medical Ethics Committee Arnhem-Nijmegen, the Netherlands. 
Intervention 
The six-months physical training consists of 1) a computer-assisted training and 2) a 
functional training of the non-dominant arm and hand (i.e. the hand one does not use for 
writing) with a mechanical or an electrical arm support (Dynamic Arm Support Top/Help, 
Focal, Tilburg, the Netherlands) (Figure 5). Boys who are unable to touch their nose with a 
mechanical arm support (due to insufficient muscle strength) will receive an electrical arm 
support. The arm support transposes shoulder movements into movements of the 
forearm and hand, which increases functional abilities and joint range of motion in boys 
with DMD. During the first baseline measurement (T0), boys will try to fit the arm support 
under supervision of an experienced representative of Focal (the manufacturer of the TOP 
arm support) and the primary investigator. Training of the non-dominant arm is additional 
to any regular therapy. All co-interventions will be registered. 
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Figure 4   Progress study 2 Functional training with arm support.  
This flowchart is a preliminary version. Final numbers may change depending on eligibility as recruitment 
is not yet complete.
Assessed for eligibility (n=13)  
Excluded  (n=5 ) 
• Not meeting inclusion criteria (n=5)  
• Declined to participate (n=0) 
 • Other reasons (n=0)  
Lost to follow-up (n=0) 
Discontinued intervention (n=0)
Allocated to intervention (n=8) 
 • Received allocated intervention (n=8)  
 • Did not receive allocated intervention (n=0) 
Allocation 
Follow-Up 
Enrollment 
Table 3   Inclusion and exclusion criteria study 2
Inclusion criteria Exclusion criteria
A DNA-established diagnosis of DMD
Boys who have been wheelchair-dependent for 
a few years (approximately 2-5 years after they 
stopped walking)
Boys who have problems with reaching and lifting 
movements with their arms, and:
-are unable to touch the top of their head (at least 
with one hand)
-are still able to use their hands for some daily 
activities
Other disabling diseases influencing 
mobility
Boys who are able to stand
Boys >20 years old 
Boys who already use an arm support
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Computer-assisted training 
Boys play “Furballhunt” (developed by Roessingh Research and Development B.V. (M.A. 
Jannink), Enschede, the Netherlands) to practice targeted forward and sideward reaching 
movements (ipsi- and contra-lateral) as well as lifting movements during five days per 
week. Furballhunt is a computer game that was originally developed to improve arm 
function in children with cerebral palsy using a virtual reality environment. Furballhunt is 
based on motion capture technology and uses a webcam (in this study: Logitech 
QuickCam E3500) to detect gross shoulder and elbow movements. Birds (“Furballs”) fly 
from their bird- house to a tree branch while the boy holds his hand in front of his navel. 
Boys have to touch the Furball when it sits down on a tree branch. The faster boys chase 
away Furballs, the higher their score. A virtual reality computer game is considered to be a 
motivational tool for training in children.39 
Boys play five games of Furballhunt (30 Furballs per game, 30 sec of rest between games) 
per day at home. The number of tree branches (3), game speed (5/10), the number of 
Furballs (30) and the sequence of games are standardized. Training intensity is low to 
moderate, which means that boys are allowed to perceive their exertion as ‘getting a little 
tired’ or ‘getting more tired’ as assessed with the OMNI Scale.27 Intensity is adjusted to the 
physical abilities of the boy by varying the position of the tree branches, which represent 
the targets to move to. Boys are instructed to move their arm over the full range of motion, 
which may cause a feeling of stretch but not pain. 
Figure 5  Image of a Top/Help Dynamic Arm Support (DAS).  
Courtesy of Focal Meditech BV, Tilburg, the Netherlands.
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 Boys report their training frequency in a diary and complete an overstrain questionnaire 
once every two weeks. Parents and their boys are informed by telephone when 
compliance is inadequate or when other problems (such as signs of overstrain: see adverse 
events) are identified. Boys are encouraged to resume the training and to adjust the 
training intensity, when appropriate. The date, training time and reaction times are saved 
on the computer, so that compliance and performance can be checked afterwards by the 
primary investigator.
Functional training 
Boys should eat at least one meal with the arm support twice every week. In addition, they 
are instructed “to use the arm support as much as possible every day”. Boys keep a written 
record of all activities they perform with the arm support in a three-day diary once every 
two weeks (two weekdays, one weekend day). 
Study outcomes
Study outcomes include measurements at the levels of body functions and structures, 
activities and participation of the ICF.29 Environmental characteristics (school type and 
home status) are assessed at baseline. Demographic variables (age, weight, arm span), the 
use of medication (such as corticosteroids) and any co-interventions are registered during 
each session. 
After a two-month period for baseline measurements (T0: at baseline; T1: after 4 weeks; T2: 
after eight weeks) to obtain information about the stability of the course of DMD, training 
with the arm support takes place for six months. Assessments take place after 12 weeks 
(T3) and 24 weeks (T4) training. Finally, one extra measurement will be done after 12 more 
weeks (T5) to evaluate to what extent the possible effects of training have lasted. Data is 
collected by the primary investigator (MJ) at the department of Rehabilitation of the 
Radboud University Nijmegen Medical Centre (T2, T4), but also at home (T0, T1, T3, T5) to 
reduce the practical burden on the participants. (Figure 6)
Figure 6  Measurements study 2.  
BP, Baseline period; IP, Intervention period; FU, Follow-up
0 4 8 20 32 56
BP I P FU
T O T 1 T 2 T 3 T 4 T 5
Time (weeks)
Measurement
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Primary outcome
Action Research Arm Test (ARAT)  
As no suitable measure of arm motor function has been validated for children with NMD, the 
functional abilities of the upper extremity (reaching, lifting and manipulating) are assessed 
bilaterally with the Action Research Arm Test (ARAT).40 The ARAT is a standardized tool for the 
assessment of arm motor function and capacity (both distally and proximally) and consists 
of 19 items in four dimensions: grasp, grip, pinch and gross movements. The ARAT has shown 
to be reliable40,41, valid40,41,42 and suitable to detect changes over time42 in stroke patients. 
The ARAT is performed and scored following standardized procedures as described by 
Yazbatiran.41 The non-dominant arm is assessed both with and without arm support. 
Secondary outcomes
Table 2 shows an overview of the secondary study outcomes and their psychometric 
properties. Both the dominant and non-dominant arms are assessed. The non-dominant 
arm is assessed both with and without arm support.
Adverse events
All adverse events will be recorded. The study will be terminated prematurely for an 
individual participant when training is excessive and remains excessive after a reduction 
of the training intensity. Signs for overstrain are: excessive muscle pain during the training, 
prolonged post-exercise muscle pain, a severely uncomfortable feeling during or after the 
training and extreme (muscle) fatigue (OMNI scale > 6). 
Sample size
This is a first explorative study that will give an indication of the effect of functional training 
with arm support on the functional abilities of the upper extremity in boys with DMD. In 
this perspective, no realistic power calculation can be made. By using a design with 
multiple measurements at baseline we anticipate to find statistically significant effects of 
the proposed therapeutic intervention in ten boys with DMD. 
Analysis 
A one-way analysis of variance (ANOVA) of time will be used to examine the effects of 
functional arm training with arm support on the primary outcome (ARAT). Secondary 
outcomes will be treated similarly or by non-parametric analyses dependent on the type 
of outcome (interval or ordinal). Data will be analyzed with SPSS version 16.0 and an alpha 
level of 0.05 will be used to decide on statistical significance. 
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Discussion 
This paper presents the research questions, hypotheses and methods of the No Use is 
Disuse (NUD) study in the Netherlands. The NUD study examines the effects of 
low-intensity dynamic physical training in boys at different stages in the course of 
Duchenne muscular dystrophy (DMD). It is expected that these dynamic exercises will be 
beneficial and will not impose a risk of muscle or other injury to the boys. This hypothesis 
is based on the (limited amount of) evidence that is available about physical training in 
children with neuromuscular diseases (NMD). In addition, the study was designed with the 
extensive input from several experts in the field of NMD in children (1 pediatric physio-
therapist, 2 occupational therapists, 1 rehabilitation physician, 1 exercise physiologist, 1 
neurologist, 1 clinical neurophysiologist and 1 epidemiologist). We will discuss the most 
relevant issues and decisions concerning 1) training (intensity), 2) outcome measures and 
3) strategies to optimize therapy compliance. 
Training (intensity)
Boys in both studies are instructed to train five days per week during 24 weeks. Although 
this training frequency is high, it was chosen to elicit as much ‘daily physical activity’ as 
possible in every boy. Many boys with DMD, especially those who are confined to a 
wheelchair, have a sedentary lifestyle28 and do not engage in 60 min of moderate daily 
physical activity as recommended by the WHO for children to reduce their risk of chronic 
diseases.43 On the other hand, as boys with DMD already have a chronic disease, their 
physical limitations have to be taken into account to prevent exercise-induced physical 
deterioration.44 Nevertheless, the level of daily low-intensity physical activity as prescribed 
in this study is thought to be safe and effective in reducing disuse atrophy and excessive 
functional loss. 
Although training-induced improvements of muscle functions can normally be expected 
after six weeks of physical training26, we have chosen a training period of 24 weeks. This 
relatively long training period is considered necessary, as the disease progression is 
relatively slow, and the expected training effects over time probably small. We also assume 
that if boys are able to adhere to the training regime during these 24 weeks, it will be 
feasible for them to incorporate physical training in daily life afterwards. 
Boys in study 2 train reaching and lifting movements, since reaching is one of the tasks 
with a high priority in potential users of an arm support.45 Boys train their non-dominant 
arm as this arm is used less than the dominant arm in functional acitivities.46 Therefore, 
training effects are expected to be larger for the non-dominant arm. Nevertheless, it may 
be difficult for boys to perform activities (like eating and scratching) with their non- 
dominant arm. 
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Study outcomes 
In this study, reliable functional scales are used, such as the MFM, as well as timed tests 
that have clinically meaningful endpoints47 and that are sufficiently sensitive to detect 
therapy related gains.38 Indeed, outcome measures should be reliable and sensitive to 
allow for an adequate power in trials with a relatively small sample size. As no suitable 
ergometry test or arm motor function test is available for (non-ambulant) boys with NMD, 
a Six-Minute Bicycle test and the ARAT have been selected as primary outcomes. Pilot 
studies showed that the applied Six-Minute Bicycle test was feasible for both ambulant 
and recently wheelchair-dependent boys with DMD. The ARAT proved to be useful in a 
wheelchair-dependent boy with DMD as well (unpublished data). In addition, we used an 
upper extremity protocol to quantitatively measure arm motor function48 with an eight 
camera motion analysis system (Vicon Motion Systems, Ltd, Oxford, UK). It has been shown 
that such a system can accurately measure task performance with an upper-limb orthosis.45 
Arm motor function has never been measured quantitatively before in boys with DMD, 
which may be of value because of its continuous properties and presumably greater 
sensitivity to change.49 
Strategies to increase therapy compliance 
From a previous study, it can be concluded that home-based cycling programs for 
children are feasible and show good adherence rates.50 A home-based program allows 
boys to train at times that are convenient for them and reduces travel time. However, a 
home-based program requires great discipline from boys and their families, and several 
aspects need attention to optimize therapy compliance. One of these aspects, according 
to the Social Cognitive Theory51, is that the social environment (e.g. family and school) is 
essential for a change in health behavior. Therefore, to optimize therapy compliance, 
parents are asked to stimulate their boys by reminding them to perform their exercises. In 
addition, siblings can be role models by being physically active themselves. Other 
strategies that are used to enhance behavioral change and optimize therapy compliance 
are specific goal setting52 and reduction of perceived barriers.53 For this reason, as 
described previously, all boys sign a training contract including an agreement on the 
training moments. The barriers that boys or their parents might perceive are discussed 
beforehand. In addition, the boys in study 1 are recommended to train while watching the 
television to make the training more pleasurable. 
Expected products 
The NUD study is the first clinical trial that examines the effects of low-intensity physical 
training on muscle endurance and functional abilities in boys with DMD. It will be a start 
to fill the current gap in our knowledge about the efficacy of physical training in these 
boys and will increase our insight into what type of physical training should be 
recommended. Although the NUD study focuses on children with DMD, the results may 
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be (partly) applicable to other neuromuscular disorders in childhood. Results of the NUD 
study are expected by the end of 2010. 
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Abstract 
Background: Physical training might delay the functional deterioration caused by disuse 
in boys with Duchenne muscular dystrophy (DMD). The No Use is Disuse (NUD) study is 
the first explorative, randomized controlled trial (RCT) in boys with DMD to examine 
whether assisted bicycle training is feasible, safe and beneficial.
Methods: Ambulatory and recently wheelchair-dependent boys with DMD were 
allocated to the intervention or control group. The intervention group received assisted 
bicycle training of the legs and arms during 24 weeks. The control group received the 
same training after a waiting period of 24 weeks. The primary study outcomes were the 
Motor Function Measure (MFM) and the Assisted Six-Minute Cycling Test (A6MCT). Group 
differences were examined by an analysis of covariance (ANCOVA). 
Results: Thirty boys (mean age 10.5±2.6 year, 18 ambulant and 12 wheelchair-dependent) 
were allocated to the intervention (n=17) or the control (n=13) group. All boys in the 
intervention group (except one) completed the training. After 24 weeks the total MFM 
score remained stable in the intervention group, whereas it had significantly decreased in 
the control group (∆=4.9, 95%CI=2.2 to 7.6). No significant group differences were found 
for the A6MCT. No serious adverse events were observed.
Conclusions: Our results suggest that assisted bicycle training of the legs and arms is 
feasible and safe for both ambulant and wheelchair-dependent children and may decline 
the deterioration due to disuse. Progressive deterioration, however, may compromise the 
design of trials for DMD.
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Introduction 
Duchenne muscular dystrophy (DMD) is the most common debilitating neuromuscular 
disorder affecting 1/3500 live-born boys.1 Although symptomatic treatments, such as cor-
ticosteroids and respiratory ventilation, have extended the life expectancy of boys with 
DMD into adulthood, boys still become wheelchair-dependent around the age of ten 
years and also lose their upper-limb functions.2,3 Therefore an important aim in the 
management of DMD is to delay the loss of functional abilities, which is relevant for both 
activities of daily living (ADL) and physical aspects of health-related quality of life. 
The loss of functional abilities is primarily the result of a progressive decrease in muscle 
strength and muscle endurance during the course of DMD.4,5 However, increasingly 
limited physical and social activities gradually cause a discrepancy between a boy’s 
potential capacities and his actual performance. For example, the increasing amount of 
energy needed to ambulate and the increasing risk of falling will make boys move less and 
make them opt for wheelchair mobility. Confinement to a wheelchair will lead to 
secondary deterioration of the musculoskeletal and cardiorespiratory systems.5 Another 
example is the loss of arm function that is accelerated after the onset of wheelchair-de-
pendency by forcing the boys to function within the confines of the wheelchair.6 This 
leads to secondary physical deterioration or ‘disuse’. 
Physical training might delay the secondary functional deterioration as a result of disuse 
as long as eccentric exercises and exhausting high-resistance exercises are avoided.7,8 
Current international guidelines therefore recommend regular sub-maximal activities for 
boys with DMD. 9 However, the number of randomized controlled trials (RCTs) that have 
examined the effects of physical training in muscle diseases is limited to three trials 
conducted in adults.10 Based on these trials, no specific training advice can be given. Even 
fewer studies have examined the effects of physical training in boys with DMD and none 
of these were conducted using a controlled design. These studies mainly focused on 
resistance exercises in ambulatory boys and concluded that although sub-maximal 
resistance exercises did not cause any harm, they had only limited beneficial effects.11-13 In 
contrast, previous studies in mdx mice (an animal model for DMD) concluded that 
dynamic exercises (such as voluntary wheel-running) had beneficial effects on muscle 
strength and fatigue resistance.14,15 Dynamic exercises (bicycle training) also improved 
endurance and strength in patients with Becker Muscular Dystrophy, a milder variant of 
DMD.16 However, these patients were all adults. Therefore no RCTs have been published 
concerning the effects of dynamic, active-assisted training in children with DMD. 
Based on previous studies in adults and mdx mice and on clinical experience, it was 
hypothesized that a dynamic physical training would be feasible and safe and would 
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counteract the secondary functional decline caused by disuse in boys with DMD. An RCT 
was therefore conducted that compared assisted bicycle training with no intervention 
(usual care) in children who were at the end of their ambulatory phase or who had recently 
been confined to a wheelchair: the No Use is Disuse (NUD) study.17 We chose assisted 
bicycle training instead of bicycle training without support, because even the smallest 
resistance can be too hard to sustain for patients in whom large muscle groups are 
affected.18 This is also the first study to use assisted training in DMD, since previous 
(uncontrolled) trials all examined the effect of resistance training. 
Methods
An extensive description of the NUD study has previously been published.17 No deviations 
from the original protocol were made. 
Participants
An RCT with multiple baseline measurements was conducted between January 2009 and 
January 2011 among boys with a DNA-established diagnosis of DMD. Boys were eligible if 
they were in their late ambulatory phase and showed a labored gait and/or had difficulties 
with rising from the floor. Boys were included if they needed more than 5 seconds to rise 
from the floor, or were not able to rise from the floor, or were not able to cycle without 
electric assistance, or needed a wheelchair to move over a long (>500m) distance. Wheel-
chair-dependent boys were eligible if they were able to touch the top of their head with 
both hands or were able to use a hand-operated wheelchair. Exclusion criteria were: age 
<6 years, a clinical cardiomyopathy, and other disabling diseases influencing mobility. 
Approval was obtained from the regional Medical Ethics Committee. Parents and 
participants who were over 12 years of age provided informed consent. The trial was 
registered with the Netherlands National Trial Register, number 1631.
Randomization and masking
Stratified randomization (ambulant versus wheelchair-dependent) was used to allocate 
participants to either the intervention or the control group in a 2:1 ratio. After a baseline 
period of 8 weeks, the intervention group received assisted bicycle training, whereas the 
control group received usual care during 24 weeks. Usual care means that boys were 
allowed to continue their activities including physiotherapy, but they did not receive any 
specific intervention. The control group received the same training after the 24-week 
waiting period. The intervention and control group were followed up until 56 and 60 
weeks after study entry, respectively. Participants and outcome assessor were not blinded 
to treatment allocation, but had no information about previous test results at each 
assessment.
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Sample size
No historical data were available at the start of this study in 2008.19 The sample size was 
therefore not based on statistical analysis. We arbitrarily chose to include 20 to 30 
participants. This seemed a realistic number of participants to recruit in the Netherlands in 
view of an estimated number of ~100 eligible boys with DMD aged 7 to 13 years old. Boys 
were recruited from the Dutch Duchenne Parent Project (DPP) database and by 
advertisements on the websites of the Dutch Association for Neuromuscular Diseases 
(VSN) and DPP between January 2009 and January 2010. 
Procedures
Intervention
The intervention consisted of an assisted-bicycle-training program of five days per week 
during 24 weeks. In each session, participants cycled 15 minutes with both their legs and 
arms using a mobility trainer with electrical motor support (KPT Cycla, Kinetic, France). The 
mobility trainer could be used with a participant’s own (electric) wheelchair. We chose 
assisted bicycle training instead of bicycle training without support, because even the 
smallest resistance can be too hard to sustain for patients in whom large muscle groups 
are affected (assistance was at least 6 rounds per minute if no active movement).18 
Participants were instructed to cycle at a constant speed (~65 RPM) and to keep this up for 
15 minutes without getting overexerted as assessed with the OMNI scale for perceived 
exertion (OMNI>6).20 This means that participants had to be able to cycle at an exertion 
ranging from ‘a little tired’ to ‘getting more tired’. The mobility trainer recorded the time 
and number of revolutions. Starting positions for both leg-cycling and arm-cranking were 
standardized21, i.e. for leg-cycling the hip and knee of the bended leg were held in 90° 
flexion, while the knee of the other leg was submaximally extended. The feet were placed 
in a heel cup with straps. For arm cycling, the pedal axis was a few centimeters (with a 
maximum of 5 centimeters) below shoulder level when the pedals were horizontal. The 
distance from the chair to the bicycle was decided by allowing the participants to move 
their legs and arms over the submaximal range of motion, which was allowed to produce 
a feeling of stretch but not pain. Participants were seated in a comfortable position with 
the back supported and they were recommended to watch television while cycling to 
make training more pleasurable. Participants trained at home or at school (depending on 
their preferences). Parents and/or teachers were instructed to assist the boys. Training 
intensity and posture were monitored and if necessary adjusted by the primary investigator 
(MJ).
Assessments
Figure 1 shows the subsequent clinical assessments (T0–T8) with the primary endpoint at T4. 
Multiple baseline measurements (T0-T2) were performed to control for initial severity and 
disease progression. All assessments were performed by the primary investigator (MJ) 
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at a university hospital (T0, T2, T4, T6), but also at home (other assessments) to reduce the 
burden for the participants and families.
Outcome measures
The primary outcome measures were the MFM22 and the Assisted Six-Minute Cycling Test 
(A6MCT).21 The MFM assesses the functional abilities and consists of 32 items in 3 
dimensions: Dimension 1= standing position and transfers (D1); Dimension 2= axial and 
proximal motor function (D2); Dimension 3= distal motor function (D3). We calculated the 
percentage of the maximum score for the total score and for the three dimensions 
separately, with a higher score indicating a better motor function. The A6MCT for both the 
legs and the arms was used to assess endurance (at T0, T2, T4 and T6), in which participants 
were instructed to make as many revolutions as possible in 6 minutes.
 Secondary outcome measures were the Pediatric Evaluation of Disability Inventory 
(PEDI)23, timed tests (rise from floor, 10m run, nine-hole peg test), muscle strength, passive 
joint range of motion (ROM) and quantitative muscle ultrasound (QMUS). Muscle strength 
of the hip extensors, knee extensors, ankle dorsiflexors, shoulder abductors and elbow 
extensors was scored bilaterally with the Medical Research Council (MRC) scale24. We 
calculated a total sum score, a sum score for the lower limb, and a sum score for the upper 
limb. ROM was recorded bilaterally for knee extension, ankle dorsiflexion and elbow 
extension and we calculated a sum score for each joint.25 QMUS was used to calculate the 
echo intensity (EI) of the biceps brachii muscle, the forearm flexors, the rectus femoris 
muscle and the tibialis anterior muscle.26 The EI is a grey value quantified by a histo-
gram-based analysis that shows the infiltration of connective tissue and fat. In boys with 
DMD, muscle EI increases with age and disease severity.27 EI’s were expressed as z-scores 
(i.e. the number of SD from the mean of the reference group) and were then integrated in 
a total sum score, and a sum score for the lower and upper limb. Age (years), co-interven-
tions (e.g. physiotherapy), and corticosteroid use (in the Netherlands: 10 days on 10 days 
off schedule of 0.75 mg/kg) were recorded as well. 
Figure 1  Clinical assessments during the study period.  
BP, Baseline period; IP, Intervention period; FU, Follow-up; CP, Control period
0 4 8 20 32 36 44 56 60
BP I P FU
T O T 1 T 2 T 3 T 4 T 5 T 6
Time (weeks)
Intervention group
Measurement
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Adverse events
During the intervention period, participants who received the assisted bicycle training 
were monitored for signs of overexertion by means of a postal questionnaire once every 
two weeks and home visits by the primary investigator (MJ). The questionnaire focused 
on excessive muscle pain, any severely uncomfortable feeling during or after the training, 
and (extreme) fatigue. Parents and their boys were informed by telephone when 
compliance was insufficient or when other problems (such as signs of overstrain) were 
identified. Parents were also instructed to call or email the investigator if their boys had 
significant pain or fatigue. In that case, the training intensity was adjusted. The study 
terminated prematurely for a participant if training remained excessive after a reduction 
of the training intensity. 
Statistical analysis
Participants were analyzed as treated. Group differences for the primary outcome 
measures were examined by an analysis of covariance (ANCOVA), using group (intervention 
versus control) as the independent factor, and the multiple baseline assessments (T0-T2), 
corticosteroid use, and ambulatory status as covariates. Multiple baseline assessments 
(T0-T2) were added as covariates, as paired t-tests showed small changes in total MFM 
score over time already between T0 and T1 (-2.7 (4.3), 95%CI=0.09 to 5.30), and T0 and T2 
(-2.9 (3.6), 95%CI=0.74 to 5.11) for the control group, and also between T1 and T2 (1.7 (2.3), 
95%CI=0.39 to 3.04), and T0 and T2 (-2.5 (2.0), 95%CI=1.41 to 3.66) for the intervention 
group. However, a high degree of correlation was found between T0 and T2 for both the 
control (Intraclass Correlation Coefficient (ICC) = 0.96, 95%CI=0.88 to 0.99) and intervention 
(ICC=0.99, 95%CI=0.97 to 0.99) groups. 
 The same ANCOVA statistics were performed to establish effects for the individual 
dimensions of the MFM, the primary outcomes at T3 and the secondary outcomes at T3 
and T4. Effect sizes (ES) were calculated to investigate the clinical relevance of the observed 
differences by dividing the group differences between the time effect T2-T4 by the pooled 
SD at T2. Interpretation of the ES is: 0.20-0.50: small; 0.50-0.80: moderate; and ≥0.80: large.28 
Non-parametric Wilcoxon rank-sum tests were used to evaluate the effect of training on 
the time to rise from floor and 10m run at T4, as these data did not show a normal 
distribution and groups were small because only a limited number of boys were able to 
perform the tests. Boys who were unable to perform the tests were coded with an unre-
alistically high score (100 seconds). In addition, 2 boys lost the ability to walk 10m and to 
rise from the floor in the control group, and 1 boy lost the ability to walk 10m and to rise 
from the floor in the intervention group during the study period. 
 Changes during the follow-up period for the intervention group were determined by 
comparing means at the end of the training to those 4 weeks (short-term) and 24 weeks 
later (long-term) using paired t-tests. Paired t-tests were also used to calculate the changes 
during the training period of the control group. All statistical analyses were performed 
126
Chapter 6
using SPSS v. 16.0 for Windows (SPSS Inc., Chicago, IL, USA) with a significance level set at 
p<0.05. 
Results
Participants
Figure 2 shows the participant flow through the study. Thirty boys (18 ambulant, 12 
wheelchair-dependent) were allocated to the intervention (n=17) or control group (n=13). 
Two out of the thirty wheelchair-dependent boys were not randomized, but directly 
allocated to the intervention group, because the study duration was ending. Another two 
Figure 2  Participant flow through the study.  
This figure shows the participant flow through the study. Thirty boys were allocated to the intervention 
(n=17) or control group (n=13). Of the 17 boys in the intervention group, only one participant discontinued 
the training and he was excluded from the analysis. No patients from the control group were lost to 
follow-up during the waiting period.
Assessed for eligibility (n=40)
Allocated to intervention (n=17)
Received allocated intervention (n=17)
Excluded (n=10)
Not meeting inclusion critera (n=9)
Declined to participate (n=1)
Randomized (n=26)
Directly allocated to the intervention
(n=2) and control group (n=2)
Allocated to control (n=13)
Discontinued intervention (logistic
problems) (n=1/17)
Analysed (n=16)
Follow-up until T6 (n=11/16)
Lost to follow-up until T6 (logistic
reasons) (n=5/16)
Lost to follow-up during waiting period
(n=0)
Analysed (n=13)
Intervention after waiting list (n=9/13)
No interevention after waiting list
(recent diagnosis of a cardiomyopathy,
cognitive problems, luxated patella,
fatigue) (n=4/13)
Discontinued intervention (n=1/9)
Analysed (n=8/9)
Enrollment
Allocation
Follow-up
Analysed at
the primary
endpoint (T4)
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(ambulant) boys were originally allocated to the intervention group, but were replaced to 
the control group within two weeks after trying the intervention. The intervention 
appeared to be unfeasible for them due to cognitive problems for one young boy, and 
motivation problems and a patella luxation for another boy. Of the 17 boys in the 
intervention group, only one wheelchair-dependent participant discontinued the training 
and the assessments after 12 weeks, due to logistic problems imposed on his family, and 
he was excluded from the analysis. No patients from the control group were lost to 
follow-up during the waiting period. The mean age in the intervention group was 10.8 
(SD=2.4) years and in the control group 10.5 (SD=2.8) years (p=0.803) at baseline. Eight 
boys were ambulant and 9 were wheelchair-dependent in the intervention group, 
compared to 10 and 3 in the control group respectively (p=0.098). In the intervention 
group 14 boys used corticosteroids compared to 9 in the control group. The clinical char-
acteristics did not differ substantially between the two groups at baseline (T0-T2) (Table 1). 
Feasibility and compliance
The 16 participants of the intervention group trained on average four (range 3-5) times 
per week) and achieved 550-1050 (mean~800) cycling revolutions with the legs (median 
OMNI score 3) and 600-1100 (mean~800) revolutions with the arms (median OMNI score 3). 
One wheelchair-dependent participant (total MFM score 47%) was able to perform the 
bicycle training with the arms only. Three boys only participated in arm bicycle training 
due to a lack of time or a limited attention span. One boy cycled only 6 instead of 15 
minutes with his arms due to exhaustion (OMNI>6), even with maximal assistance. 
Primary outcome measures T2-T4
The functional abilities were 4.9% higher in the intervention than in the control group at 
T4, after correcting for the ambulatory status and corticosteroid use at T2 and for the total 
MFM score at T0-T2 (∆ 4.9, 95%CI=2.2 to 7.6). This means that the total MFM score remained 
stable in the intervention group, whereas it decreased in the control group. In the 
intervention group, the same results were found for the D1 (∆=7.0, 95%CI=2.0 to 11.9) and 
D3 (∆=5.4, 95%CI=0.9 to 9.9), but not for the D2 of the MFM. The D3 already showed a 
training effect at T3 (∆=5.8, 95%CI=0.8 to 10.8). Overall, the intervention group showed an 
ES 0.5 for the total MFM scores, an ES 0.4 for the D1, and an ES 0.8 for the D3. No training 
effects were found for the A6MCT for the legs (∆=5.6, 95%CI=-56.2 to 67.3) and the arms 
(∆=13.8, 95%CI= -60.7 to 88.3). (Table 1, Figure 3)
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Table 1   Between-group differences at T3 and T4 (primary endpoint) 
Mean (SD)
Baseline period
Mean (SD)
Training/ Control period
Secondary endpoint:
Between-group
differences at T3*
Primary endpoint:
Between-group 
differences at T4*
T0 T1 T2 T3 T4 ∆ (95% CI) p ∆ (95% CI) p
Primary outcome measures
MFM (%)
- Total 
- D1
- D2
- D3
Intervention
Control
Intervention
Control
Intervention 
Control
Intervention 
Control
65.1 (15.6)
n=15
70.9 (13.7)
n=13
26.0 (29.7)
n=15
43.0 (27.3)
n=13
92.2 (13.8)
n=16
90.0 (9.0)
n=13
92.3 (7.4)
n=16
90.1 (7.6)
n=13
66.8 (13.3)
n=14
68.1 (15.3)
n=13
28.2 (28.4)
n=14
37.9 (25.9)
n=13
94.4 (7.7)
n=16
87.0 (13.9)
n=13
92.3 (5.1)
n=16
91.9 (7.6)
n=13
64.8 (15.0)
n=17
67.9 (13.4)
n=13
28.1 (27.8)
n=17
36.9 (24.3)
n=13
90.0 (12.7)
n=17
87.6 (10.9)
n=13
89.9 (7.9)
n=17
91.6 (6.8)
n=13
64.3 (15.3)
n=15
65.4 (17.1)
n=10
27.4 (26.3)
n=15
34.6 (28.2)
n=10
89.1 (15.7)
n=16
5.3 (15.7)
n=10
92.3 (8.7)
n=16
88.6 (8.2)
n=10
65.6 (16.9)
n=16
61.5 (13.0)
n=13
29.0 (29.2)
n=16
27.8 (22.1)
n=13
90.3 (15.3)
n=16
83.5 (13.8)
n=13
91.4 (7.6)
n=16
86.4 (8.0)
n=13
-0.04 (-3.4 to 3.3)
0.9 (-5.2 to 7.0) 
-4.1 (-8.6 to 0.5)
5.8 (0.8 to 10.8)
0.979
0.764
0.076
0.025†
4.9 (2.2 to 7.6)
 
7.0 (2.0 to 11.9)
2.3 (-1.4 to 6.1)
5.4 (0.9 to 9.9)
0.002†
0.008†
0.211
0.021†
A6MCT (Revolutions)
- Legs
- Arms
Intervention
Control
Intervention
Control
434.7 (164.8)
n=12
405.4 (113.2)
n=8
403.0 (111.7)
n=16
351.5 (110.7)
n=8
NA
NA
NA
NA
397.1 (143.8)
n=16
415.2 (158.3)
n=13
378.7 (149.2)
n=16
319 (122.9)
n=12
NA
NA
NA
NA
442.0 (124.3)
n=14
407.0 (187.4)
n=11
444.4 (107.6)
n=14
349.9 (131.9)
n=9
NA
NA
NA
NA
5.6 (-56.2 to 67.3)
13.8 (-60.7 to 88.3)
0.848
0.697
Secondary outcome Measures
PEDI (Scale scores) 
- Selfcare
- Mobility
Intervention 
Control
Intervention
Control
74.8 (13.2)
n=16
72.3 (13.6)
n=13
57.6 (15.0)
n=15
62.7 (11.0)
n=13
NA
NA
NA
NA
76.1 (13.4)
n=17
72.9 (12.8)
n=13
59.0 (18.0)
n=17
60.2 (13.2)
n=13
NA
NA
NA
NA
77.1 (14.1)
n=15
72.4 (14.7)
n=11
55.8 (13.0)
n=15
57.7 (15.2)
n=11
NA
NA
NA
NA
4.1 (-2.2 to 10.4)
1.6 (-3.6 to 6.0)
0.192
0.523
6129
Assisted bicycle training in Duchenne muscular dystrophy
Table 1   Between-group differences at T3 and T4 (primary endpoint) 
Mean (SD)
Baseline period
Mean (SD)
Training/ Control period
Secondary endpoint:
Between-group
differences at T3*
Primary endpoint:
Between-group 
differences at T4*
T0 T1 T2 T3 T4 ∆ (95% CI) p ∆ (95% CI) p
Primary outcome measures
MFM (%)
- Total 
- D1
- D2
- D3
Intervention
Control
Intervention
Control
Intervention 
Control
Intervention 
Control
65.1 (15.6)
n=15
70.9 (13.7)
n=13
26.0 (29.7)
n=15
43.0 (27.3)
n=13
92.2 (13.8)
n=16
90.0 (9.0)
n=13
92.3 (7.4)
n=16
90.1 (7.6)
n=13
66.8 (13.3)
n=14
68.1 (15.3)
n=13
28.2 (28.4)
n=14
37.9 (25.9)
n=13
94.4 (7.7)
n=16
87.0 (13.9)
n=13
92.3 (5.1)
n=16
91.9 (7.6)
n=13
64.8 (15.0)
n=17
67.9 (13.4)
n=13
28.1 (27.8)
n=17
36.9 (24.3)
n=13
90.0 (12.7)
n=17
87.6 (10.9)
n=13
89.9 (7.9)
n=17
91.6 (6.8)
n=13
64.3 (15.3)
n=15
65.4 (17.1)
n=10
27.4 (26.3)
n=15
34.6 (28.2)
n=10
89.1 (15.7)
n=16
5.3 (15.7)
n=10
92.3 (8.7)
n=16
88.6 (8.2)
n=10
65.6 (16.9)
n=16
61.5 (13.0)
n=13
29.0 (29.2)
n=16
27.8 (22.1)
n=13
90.3 (15.3)
n=16
83.5 (13.8)
n=13
91.4 (7.6)
n=16
86.4 (8.0)
n=13
-0.04 (-3.4 to 3.3)
0.9 (-5.2 to 7.0) 
-4.1 (-8.6 to 0.5)
5.8 (0.8 to 10.8)
0.979
0.764
0.076
0.025†
4.9 (2.2 to 7.6)
 
7.0 (2.0 to 11.9)
2.3 (-1.4 to 6.1)
5.4 (0.9 to 9.9)
0.002†
0.008†
0.211
0.021†
A6MCT (Revolutions)
- Legs
- Arms
Intervention
Control
Intervention
Control
434.7 (164.8)
n=12
405.4 (113.2)
n=8
403.0 (111.7)
n=16
351.5 (110.7)
n=8
NA
NA
NA
NA
397.1 (143.8)
n=16
415.2 (158.3)
n=13
378.7 (149.2)
n=16
319 (122.9)
n=12
NA
NA
NA
NA
442.0 (124.3)
n=14
407.0 (187.4)
n=11
444.4 (107.6)
n=14
349.9 (131.9)
n=9
NA
NA
NA
NA
5.6 (-56.2 to 67.3)
13.8 (-60.7 to 88.3)
0.848
0.697
Secondary outcome Measures
PEDI (Scale scores) 
- Selfcare
- Mobility
Intervention 
Control
Intervention
Control
74.8 (13.2)
n=16
72.3 (13.6)
n=13
57.6 (15.0)
n=15
62.7 (11.0)
n=13
NA
NA
NA
NA
76.1 (13.4)
n=17
72.9 (12.8)
n=13
59.0 (18.0)
n=17
60.2 (13.2)
n=13
NA
NA
NA
NA
77.1 (14.1)
n=15
72.4 (14.7)
n=11
55.8 (13.0)
n=15
57.7 (15.2)
n=11
NA
NA
NA
NA
4.1 (-2.2 to 10.4)
1.6 (-3.6 to 6.0)
0.192
0.523
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Table 1   Continued 
Mean (SD)
Baseline period
Mean (SD)
Training/ Control period
Secondary endpoint:
Between-group
differences at T3*
Primary endpoint:
Between-group 
differences at T4*
T0 T1 T2 T3 T4 ∆ (95% CI) p ∆ (95% CI) p
Secondary outcome Measures
Timed tests (seconds)
- Rise from floor
- 10m run
- 9HPT
MRC (sum scores)
- Total
- Lower limb
- Upper limb
ROM 
(limitation in degrees)
- Knee ext
- Ankle dfl
- Elbow ext
Intervention 
Control
Intervention 
Control
Intervention 
Control
Intervention 
Control
Intervention
Control
Intervention 
Control
Intervention
Control
Intervention
Control
Intervention
Control
6.3 (4.6)
n=7
8.8 (5.3)
n=8
6.4 (1.7)
n=6
8.2 (2.2)
n=8
21.0 (4.3)
n=16
24.6 (4.0)
n=13
31.0 (5.5)
n=14
31.4 (4.4)
n=11
17.8 (4.5)
n=15
17.5 (3.2)
n=11
13.5 (2.4)
n=15
13.3 (2.2)
n=12
26.9 (27.4)
n=16
6.8 (14.9)
n=11
16.3 (25.2)
n=16
5.9 (8.0)
n=11
15.3 (21.2)
n=16
5.5 (10.4)
n=11
9.3 (9.6)
n=7
11.5 (6.5)
n=8
NA
NA
19.6 (2.9)
n=14
23.9 (5.6)
n=13
31.4 (4.9)
n=13
30.7 (5.1)
n=13
17.3 (3.4)
n=13
17.8 (3.0)
n=13
14.1 (2.1)
n=13
12.8 (2.5)
n=13
21.2 (26.5)
n=15
10.8 (26.2)
n=13
20.0 (25.1)
n=15
6.9 (12.5)
n=13
11.7 (14.8)
n=15
8.1 (16.5)
n=13
9.3 (12.4)
n=7
11.5 (5.8)
n=8
6.4 (2.3)
n=7
8.8 (2.6)
n=9
21.3 (4.9)
n=15
22.9 (6.4)
n=13
0.6 (6.0)
n=13
29.3 (5.3)
n=12
16.8 (4.0)
n=13
17.2 (3.2)
n=13
13.8 (2.7)
n=13
12.4 (2.5)
n=12
35.0 (37.5)
n=12
7.1 (17.6)
n=12
21.7 (30.6)
n=12
7.9 (13.0)
n=12
15.0 (19.2)
n=12
5.4 (9.9)
n=12
5.4 (2.4)
n=6
9.5 (7.0)
n=5
NA
NA
20.0 (3.4)
n=16
23.3 (5.7)
n=10
30.5 (5.3)
n=15
31.4 (4.2)
n=8
16.7 (5.1)
n=15
18.0 (2.6)
n=8
13.9 (2.2)
n=15
13.1 (1.8)
n=9
26.3 (35.7)
n=15
8.3 (19.7)
n=9
22.3 (27.3)
n=15
8.3 (15.2)
n=9
14.0 (19.0)
n=15
6.7 (13.2)
n=9
4.8 (1.6)
n=6
21.1 (18.0)
n=6
7.4 (3.9) 
n=8
7.3 (1.8) 
n=6
20.4 (5.0)
n=16
22.4 (5.0)
n=13
31.6 (1.4)
n=14
28.6 (5.7)
n=12
17.6 (3.6)
n=14
16.7 (3.6)
n=12
13.7 (2.4)
n=15
11.9 (2.4)
n=12
30.8 (38.1)
n=15
17.3 (35.7)
n=13
22.7 (29.1)
n=15
14.6 (17.8)
n=13
15.7 (22.3)
n=15
13.5 (20.1)
n=13
4·1
NA
-2.4 (-5.9 to 1.0)
1.3 (-0.5 to 3.0)
-0.2 (-0.8 to 1.2)
0.9 (0.0 to 1.8)
-3.0 (-9.7 to 3.7) 
-0.7 (-7.5 to 6.0)
-1.4 (-6.7 to 3.9)
0·788‡
NA
0.153
0.132
0.643
0.047†
 
0.345
0.816
0.575
16.3
-0.7‡
0.6 (-3.1 to 2.4)
1.4 (-0.3 to 3.1)
1.0 (-0.1 to 2.1)
0.8 (-0.1 to 1.7)
-1.0 (-8.8 to 6.7)
-2.9 (-12.9 to 7.1)
-2.3 (-6.9 to 2.3)
0.961‡
0.522‡
0.784
0.098
0.082
0.077
0.780
0.540
0.303
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Table 1   Continued 
Mean (SD)
Baseline period
Mean (SD)
Training/ Control period
Secondary endpoint:
Between-group
differences at T3*
Primary endpoint:
Between-group 
differences at T4*
T0 T1 T2 T3 T4 ∆ (95% CI) p ∆ (95% CI) p
Secondary outcome Measures
Timed tests (seconds)
- Rise from floor
- 10m run
- 9HPT
MRC (sum scores)
- Total
- Lower limb
- Upper limb
ROM 
(limitation in degrees)
- Knee ext
- Ankle dfl
- Elbow ext
Intervention 
Control
Intervention 
Control
Intervention 
Control
Intervention 
Control
Intervention
Control
Intervention 
Control
Intervention
Control
Intervention
Control
Intervention
Control
6.3 (4.6)
n=7
8.8 (5.3)
n=8
6.4 (1.7)
n=6
8.2 (2.2)
n=8
21.0 (4.3)
n=16
24.6 (4.0)
n=13
31.0 (5.5)
n=14
31.4 (4.4)
n=11
17.8 (4.5)
n=15
17.5 (3.2)
n=11
13.5 (2.4)
n=15
13.3 (2.2)
n=12
26.9 (27.4)
n=16
6.8 (14.9)
n=11
16.3 (25.2)
n=16
5.9 (8.0)
n=11
15.3 (21.2)
n=16
5.5 (10.4)
n=11
9.3 (9.6)
n=7
11.5 (6.5)
n=8
NA
NA
19.6 (2.9)
n=14
23.9 (5.6)
n=13
31.4 (4.9)
n=13
30.7 (5.1)
n=13
17.3 (3.4)
n=13
17.8 (3.0)
n=13
14.1 (2.1)
n=13
12.8 (2.5)
n=13
21.2 (26.5)
n=15
10.8 (26.2)
n=13
20.0 (25.1)
n=15
6.9 (12.5)
n=13
11.7 (14.8)
n=15
8.1 (16.5)
n=13
9.3 (12.4)
n=7
11.5 (5.8)
n=8
6.4 (2.3)
n=7
8.8 (2.6)
n=9
21.3 (4.9)
n=15
22.9 (6.4)
n=13
0.6 (6.0)
n=13
29.3 (5.3)
n=12
16.8 (4.0)
n=13
17.2 (3.2)
n=13
13.8 (2.7)
n=13
12.4 (2.5)
n=12
35.0 (37.5)
n=12
7.1 (17.6)
n=12
21.7 (30.6)
n=12
7.9 (13.0)
n=12
15.0 (19.2)
n=12
5.4 (9.9)
n=12
5.4 (2.4)
n=6
9.5 (7.0)
n=5
NA
NA
20.0 (3.4)
n=16
23.3 (5.7)
n=10
30.5 (5.3)
n=15
31.4 (4.2)
n=8
16.7 (5.1)
n=15
18.0 (2.6)
n=8
13.9 (2.2)
n=15
13.1 (1.8)
n=9
26.3 (35.7)
n=15
8.3 (19.7)
n=9
22.3 (27.3)
n=15
8.3 (15.2)
n=9
14.0 (19.0)
n=15
6.7 (13.2)
n=9
4.8 (1.6)
n=6
21.1 (18.0)
n=6
7.4 (3.9) 
n=8
7.3 (1.8) 
n=6
20.4 (5.0)
n=16
22.4 (5.0)
n=13
31.6 (1.4)
n=14
28.6 (5.7)
n=12
17.6 (3.6)
n=14
16.7 (3.6)
n=12
13.7 (2.4)
n=15
11.9 (2.4)
n=12
30.8 (38.1)
n=15
17.3 (35.7)
n=13
22.7 (29.1)
n=15
14.6 (17.8)
n=13
15.7 (22.3)
n=15
13.5 (20.1)
n=13
4·1
NA
-2.4 (-5.9 to 1.0)
1.3 (-0.5 to 3.0)
-0.2 (-0.8 to 1.2)
0.9 (0.0 to 1.8)
-3.0 (-9.7 to 3.7) 
-0.7 (-7.5 to 6.0)
-1.4 (-6.7 to 3.9)
0·788‡
NA
0.153
0.132
0.643
0.047†
 
0.345
0.816
0.575
16.3
-0.7‡
0.6 (-3.1 to 2.4)
1.4 (-0.3 to 3.1)
1.0 (-0.1 to 2.1)
0.8 (-0.1 to 1.7)
-1.0 (-8.8 to 6.7)
-2.9 (-12.9 to 7.1)
-2.3 (-6.9 to 2.3)
0.961‡
0.522‡
0.784
0.098
0.082
0.077
0.780
0.540
0.303
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Primary outcome measures T4-T6 
Eleven of the 16 participants that completed the intervention were followed up until T6. 
Five participants were lost to follow-up due to logistic reasons. The total MFM score had 
decreased on average by 2.5% (p=0.02) from T4 to T5 and by 5·7% (p=0.01) from T4 to T6. 
The D1 (-5.6%, p=0.02) and D2 (-6.6%, p=0.02) also showed a decline at T6, but the D3 
(-4.3%, p=0.09) remained relatively stable. No significant changes in A6MCT scores were 
found for the legs (p=0.06) or the arms (p=0.71). (Table 2)
Secondary outcome measures
No significant group differences were found for the PEDI, timed tests, muscle strength, 
ROM and echo intensity at T4 (Table 1). However, 3 boys lost the ability to walk 10m and 2 
boys lost the ability to rise from the floor in the control group, whereas in the intervention 
group none of the boys lost the ability to walk 10m and only 1 boy lost the ability to rise 
Table 1   Continued 
Mean (SD)
Baseline period
Mean (SD)
Training/ Control period
Secondary endpoint:
Between-group
differences at T3*
Primary endpoint:
Between-group 
differences at T4*
T0 T1 T2 T3 T4 ∆ (95% CI) p ∆ (95% CI) p
Secondary outcome Measures
Echo intensity  
(sum z-scores)
- Total
- Lower limb
- Upper limb
Intervention
Control
Intervention 
Control
Intervention 
Control
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
18.9 (7.5)
n=15
19.5 (6.7)
n=10
11.0 (3.7)
n=15
10.8 (3.1)
n=10
7.9 (4.0)
n=15
8.7 (4.3)
n=10
NA
NA
NA
NA
NA
NA
18.8 (7.6)
n=15
21.3 (5.3)
n=12
10.8 (3.7)
n=15
11.6 (3.1)
n=12
8.0 (4.1)
n=15
9.7 (3.3)
n=12
NA
NA
NA
NA
NA
NA
-1.3 (-5.3 to 2.6)
-5.2 (-3.0 to 1.9) 
-0.5 (-2.8 to 1.7)
0.484
0.660
0.629
*Between-group differences represent differences between the intervention and control group at T4, and 
these differences are adjusted for the clinical assessments (MFM, A6MCT, PEDI, timed tests, MRC, ROM or echo 
intensity) at T0-T2 as well as for corticosteroid use and ambulatory status at T2. 
†Significant difference between the intervention and control group at the 0.05 level.
‡Non-parametric Wilcoxon Rank-sum tests were used; no 95%CI were, therefore, calculated.
Abbreviations: MFM, Motor Function Measure; A6MCT, Assisted Six-Minute Cycling Test; NA, Not assessed. 
PEDI, Pediatric Evaluation of Disability Inventory; 9HPT, Nine-hole peg test; MRC, Medical Research Council; 
ROM, passive joint range of motion; ext, extension; dfl, dorsiflexion
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from the floor during the training period. With respect to ROM, knee extension was more 
limited in the intervention group compared to the control group at baseline (p=0.03). 
However, ROM remained relatively stable in the intervention group during the training 
period, whereas (although not significantly) it increased from 7.1 to 17.3 for knee extension, 
from 7.9 to 14.6 for ankle dorsiflexion, and from 5.4 to 13.5 for elbow extension in the 
control group. This was the same for the echo intensity assessed with QMUS: although not 
significantly, the total score decreased with 0.1 z-score in the intervention group whereas 
it increased with 0.8 z-score in the control group. 
Training effects in the control group after the waiting period 
Nine of the 13 participants in the control group participated in the assisted bicycle training. 
One wheelchair-dependent participant had to be excluded prior to the start of the 
training because of a recent diagnosis of symptomatic cardiomyopathy. Three ambulant 
Table 1   Continued 
Mean (SD)
Baseline period
Mean (SD)
Training/ Control period
Secondary endpoint:
Between-group
differences at T3*
Primary endpoint:
Between-group 
differences at T4*
T0 T1 T2 T3 T4 ∆ (95% CI) p ∆ (95% CI) p
Secondary outcome Measures
Echo intensity  
(sum z-scores)
- Total
- Lower limb
- Upper limb
Intervention
Control
Intervention 
Control
Intervention 
Control
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
18.9 (7.5)
n=15
19.5 (6.7)
n=10
11.0 (3.7)
n=15
10.8 (3.1)
n=10
7.9 (4.0)
n=15
8.7 (4.3)
n=10
NA
NA
NA
NA
NA
NA
18.8 (7.6)
n=15
21.3 (5.3)
n=12
10.8 (3.7)
n=15
11.6 (3.1)
n=12
8.0 (4.1)
n=15
9.7 (3.3)
n=12
NA
NA
NA
NA
NA
NA
-1.3 (-5.3 to 2.6)
-5.2 (-3.0 to 1.9) 
-0.5 (-2.8 to 1.7)
0.484
0.660
0.629
*Between-group differences represent differences between the intervention and control group at T4, and 
these differences are adjusted for the clinical assessments (MFM, A6MCT, PEDI, timed tests, MRC, ROM or echo 
intensity) at T0-T2 as well as for corticosteroid use and ambulatory status at T2. 
†Significant difference between the intervention and control group at the 0.05 level.
‡Non-parametric Wilcoxon Rank-sum tests were used; no 95%CI were, therefore, calculated.
Abbreviations: MFM, Motor Function Measure; A6MCT, Assisted Six-Minute Cycling Test; NA, Not assessed. 
PEDI, Pediatric Evaluation of Disability Inventory; 9HPT, Nine-hole peg test; MRC, Medical Research Council; 
ROM, passive joint range of motion; ext, extension; dfl, dorsiflexion
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boys had to be excluded within about 2 weeks after trying the training due to cognitive 
problems, a luxated patella, and a combination of fatigue and logistic problems. One 
participant fractured his femur during a fall at home unrelated to the training after 5 
months of training. Eight out of nine participants therefore completed the 24-weeks 
training. The data of these remaining 8 control subjects showed an absence of functional 
decline during the training period comparable to the intervention group as assessed with 
the MFM, whereas no training effect was found for the A6MCT (Table 3). 
Adverse events
No serious adverse events were observed or reported. During the training phase, postural 
adjustments were made in 3/24 participants who reported pain at the lateral side of the 
knee or foot due to an external rotation of the hip during training. In addition, 1 ambulant 
boy in the intervention group had an inversion trauma of his ankle after 12 weeks of 
training and subsequently stopped walking but he continued cycling. Another, wheel-
Figure 3  Individual differences in total MFM scores between T2 and T4.  
Individual differences between the total MFM scores at T2 and T4 are shown for each participant in the 
intervention (black bars) and control (grey bars) group. 
MFM, Motor Function Measure
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chair-dependent, boy fractured his femur after 12 weeks of training. This boy continued 
cycling with his arms and he re-continued cycling with his legs after 3 weeks of 
immobilization. Injuries were unrelated to the training activities. 
Table 2   Primary outcome measures at T4, T5 and T6 for the intervention group  
(n=11)*
Mean (SD)
T4
(n=11)
T5
(n=10)
T6
(n=11)
Mean difference 
between
T4 and T5
Mean difference 
between
T4 and T6
MFM (%)
- Total 
- D1
- D2
- D3
69.6 (12.5) 
32.6 (27.8)
97.5 (2.6)
93.5 (3.9)
67.1 (12.2)
30.8 (27.0)
95.6 (4.9)
91.9 (5.5) 
64.6 (14.7)
27.0 (28.6)
90.9 (9.0)
89.2 (6.8)
-2.5 (2.7), p = 0.02†
-1.9 (7.4), p = 0.43
-1.7 (3.3), p = 0.14
-1.9 (4.0), p = 0.17
-5.7 (5.2), p = 0.01†
-5.6 (6.4), p = 0.02†
-6.6 (8.1), p = 0.02†
-4.3 (7.5), p = 0.09
A6MCT  
(Revolutions)
- Legs
- Arms
478.0 (93.3)
487.2 (97.0)
NA
NA
447.3 (91/7)
494.8 (103.6) 
NA
NA
-30.7 (42.6), p = 0.06
7.6 (58.0), p = 0.71
*Data of the participants who were lost to follow-up were excluded from the analysis. 
†Significant difference at the p < 0.05 level.
Abbreviations: MFM, Motor Function Measure; A6MCT, Assisted Six-Minute Cycling Test; NA, Not assessed
Table 3   Training effect of the control group after the waiting period (n=8)* 
Mean (SD) 
T4 T5 T6 Mean difference 
between
T4 and T5 
Mean difference 
between
T4 and T6
MFM (%)
- Total 
- D1
- D2
- D3
66.0 (13.2)
34.0 (24.8)
87.8 (8.6)
88.1 (8.8) 
68.2 (15.5)
35.3 (28.5)
89.6 (11.7)
92.3 (8.8)
68.2 (14.7)
34.0 (26.1)
89.6 (11.2)
95.2 (5.1)
2.2 (4.4), p = 0.20
1.3 (8.6), p = 0.69
2.1 (6.8), p = 0.41
4.2 (3.1), p = 0.01†
2.2 (4.3), p = 0.19
0.0 (5.8), p = 1.00 
1.7 (4.7), p = 0.33 
7.1 (5.1), p = 0·01†
A6MCT 
(Revolutions)
- Legs
- Arms
470.8 (164.5)
399.6 (94.2) 
NA
NA
474.0 (161.5)
409.3 (177.6) 
NA
NA
3.3 (71.8), p = 0.90
9.7 (124.7), p = 0.84
*Participants in the control group performed the same assisted bicycle training as the intervention group after 
a waiting period. Those who did not complete the training were excluded from the analysis. 
†Significant difference at the p < 0.05 level.
Abbreviations: MFM, Motor Function Measure; A6MCT, Assisted Six-Minute Cycling Test; NA, Not assessed
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Discussion
The NUD study is the first trial in children with DMD testing the effects of assisted physical 
training on functional decline using a randomized controlled design. The results indicate 
that assisted bicycle training of the arms and the legs during 24 weeks significantly delays 
functional deterioration as tested with the MFM. The results also show that a low-intensity 
dynamic exercise training is feasible and safe even in boys who are in their late ambulatory 
phase or are wheelchair-dependent. If anything, the results contradict the current opinion 
that exercise training accelerates disease progression. 
Previous studies have focused on resistance exercises and did not show clear training- 
induced benefits.11-13 We found that assisted bicycle training prevented a 6.3% functional 
deterioration from the total MFM score (100%) during the intervention period as observed 
in the control group over a period of 24 weeks. This decline was larger than the 5.8% 
decrease of the MFM during 1 year reported previously by Vuillerot et al. (2010).19 In that 
study participants were aged 6 to 32 years and also included individuals who were in their 
early ambulatory and late nonambulatory stage. The present study only included 
restricted walkers and boys who had recently become wheelchair-dependent who show 
a faster functional decline than ambulatory boys who are still in a relatively stable phase. 
Remarkably, the beneficial effects of training appeared to be strongest and most stable 
for the distal motor functions (D3 of the MFM). This is hardly surprising, as distal muscles 
are affected later than proximal muscles in DMD.27 The beneficial effects on standing and 
transfers (D1 of the MFM) were smaller and disappeared fairly rapidly after cessation of the 
training. These observations support the notion that the adage “use it or lose it” is certainly 
applicable to boys with DMD. 
In this study, the training-related preservation of standing, transfers, and distal motor 
functions was not paralleled by a preservation in axial motor functions (D2 of the MFM). 
This result was hardly surprising, as the bicycle training (where participants sat in a chair) 
placed no special demands on the axial muscle groups. We did not find an effect on 
overall endurance (as assessed with the A6MCT) either, which was most likely due to the 
low training intensity and the use of external electric support by the mobility trainer. The 
aim of the assisted bicycle training was to reduce the amount of secondary physical 
inactivity caused by disuse rather than to improve it by means of an endurance training 
with increasing demands. This probably also explains why no group differences were 
found with respect to secondary outcome measures such as strength. We believe that the 
assisted bicycle training may primarily preserve musculoskeletal flexibility and, thus, 
functional abilities, which is supported by the unchanged ROM of the ankle and elbow in 
the intervention group. It may also maintain cerebral representations of motor programs 
for both the arms and the legs, leading to preservation of functional skills. The training 
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does not impose serious demands on muscle strength or aerobic capacity. Cardiovascular 
endurance training aims at performing at 70-80% of the maximum heart rate, which 
might not be reached in our study. Aerobic training guided by heart rate is difficult in boys 
with DMD as their peak heart rate is hard to determine due to limited peripheral capacity 4. 
In future studies, the mechanisms underlying the preservation of functional abilities in 
relation to training need to be further investigated. 
This study is the first explorative RCT in children with muscle disease investigating the 
effects of physical training. It is also the first study that used assisted exercises instead of 
resistance training, which is often too hard to sustain for these children. We observed a 
high compliance level in most participants. This is encouraging as it suggests that this 
type of training can indeed be implemented in everyday life. However, a limitation is the 
fact that analysis was performed as treated, i.e. only those participants who adhered to 
the study protocol were included. We did not use an intention-to-treat analysis, because 
of the difficulty in handling missing data. A frequently used method to deal with missing 
data is carrying the last observation forward. This principle, however, is questionable in 
progressive muscle diseases. Nevertheless, missing data on the primary endpoints were 
limited to one drop-out in the intervention group. Furthermore, a limitation of this study 
is that randomization was incomplete. Two boys were directly allocated to the intervention 
group, because the study duration was ending. Another two boys were replaced to the 
control group after trying the intervention, because the training was unfeasible for them 
due to cognitive and motivation problems. A third limitation of this study is that we were 
not able to perform adequate test-retest reliability procedures on the primary outcome 
measure that showed a beneficial effect of training, i.e. the MFM. We opted for multiple 
baseline measurements with intervals of 4 weeks to control for initial severity and 
progression. This time interval might be too long to examine the variability of the MFM, as 
DMD progresses rapidly. Another limitation of this study is that both participants and the 
assessor were not blinded, since this was considered impossible. The assessor had to 
coach the participants and had to monitor for signs of overexertion during the training 
period. Participants and assessor were, however, uninformed about previous test results at 
each assessment. Nevertheless, memories from previous assessments cannot be entirely 
ruled out. However, the assessor was not able to remember the exact test scores of all 30 
boys who were assessed with 4 to 12 weeks intervals. All assessments were performed by 
the same investigator to reduce inter-rater unreliability. 
In conclusion, this study indicates that assisted bicycle training of the legs and arms is 
feasible and safe for both ambulant and wheelchair-dependent boys with DMD and that 
prolonged physical training can delay the secondary functional deterioration due to 
disuse in these children. Carrying out an intervention study in a progressive disorder such 
as DMD is however difficult due to the phenotypic variability, and further research is 
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required to support the results of this study and to enable clearly defined exercise 
protocols. Preferably, clinical trials should use stratified randomization to allocate their 
participants to either the intervention or control group according to the DMD phenotype: 
the common DMD form (ambulation is lost at a mean age of 9.3 years), the severe DMD 
form (ambulation is lost at a mean age of 7.1 years), or the milder DMD form (ambulation 
is lost at a mean age of 12.0 years).29 If it is not possible to use stratified randomization, then 
researchers could limit the inclusion to one DMD subtype to reduce the phenotypic 
variability. To detect a decrease in disease progression, four to six times fewer boys are 
needed in a clinical trial including boys with the severe DMD form compared to a trial 
including boys with the common DMD form.29 The cost-effectiveness of training should 
also be investigated, as it is hypothesized that the incorporation of assisted bicycle training 
in daily life can reduce the frequency of physiotherapy and can shift the role of the phys-
iotherapist towards a coach and assessor in the management of DMD, at least during the 
relatively stable stages of the disease. It is expected that boys should start training early in 
their disease course, as disuse could start at a young age in DMD. 
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Abstract
Purpose: Patients with Duchenne muscular dystrophy (DMD) develop progressive loss of 
arm function, which severely limits the patient’s activities of daily living and independence. 
Although regular moderate-intensity activities are recommended to prevent secondary 
complications of physical inactivity, conventional resistance exercises are often too 
strenuous for patients with DMD. We conducted a feasibility study with a multiple N=1 
design to investigate the feasibility and safety of upper limb training with dynamic arm 
support (DAS) for DMD patients who are unable to lift their arms against gravity. 
Method: Eight participants (age 12-20 years) performed reaching movements with their 
non-dominant arm for 24 weeks by playing a virtual reality computer game and 
performing activities of daily living while using DAS. The dominant (untrained) arm of 
each participant served as a reference. 
Results: Six of the eight participants completed the entire training program (the other 
two participants discontinued training due to practical reasons). No serious adverse 
events were reported. Among the four participants who completed the program, the 
trained arm retained more motor function than the untrained arm. 
Conclusions: The findings indicate that boys with DMD who have impaired arm function 
can train their upper limb with DAS to improve motor function.
7145
Upper limb training in Duchenne muscular dystrophy
Introduction
Duchenne muscular dystrophy(DMD) is the most common childhood neuromuscular 
disorder (NMD), affecting 1 in 3500 live male births.1 DMD is caused by a loss of the 
dystrophin protein, which causes progressive muscle fibrosis, loss of muscle strength and 
loss of muscle function.2 Although there is currently no cure, improved symptomatic 
treatments have increased the mean life expectancy of patients with DMD to the early 
thirties.3 As a result of this increased life expectancy, there is now a growing population of 
older, wheelchair-dependent patients with severely impaired arm function and associated 
limitations in activities of daily living (ADLs) such as grooming and dressing. 
The decline in arm function in patients with DMD is primarily a result of the disease; 
wasting of the shoulder muscles causes an inability to lift the arms by the age of 13-15 
years.4 This inability to lift the arms limits the patients to reaching forward and sideward 
only. This decline in arm function can also be accelerated by environmental and behavioral 
factors. For example, using an electric wheelchair with a top blade and central operating 
joystick allows the patient to function within the confines of the wheelchair only. This can 
cause a discrepancy between the patient’s true capacity and their performance (i.e., 
disuse), which can reduce the level of physical activity for the upper limb and reduce arm 
function even further. The negative consequence of disuse is underscored by the 
increasing difference in strength and motor function between the dominant and 
non-dominant hands over time—specifically, the non-dominant hand is used less and 
becomes less useful than the dominant hand.5,6 From this point of view, the adage “use it 
or lose it” clearly applies to patients with DMD.
The current international guidelines regarding physical activity for DMD patients 
recommend regular gentle, functional activity in order to avoid secondary complications 
due to physical inactivity.7 However, these recommendations are based on only a limited 
amount of evidence. Although three non-controlled trials found that low-resistance 
exercises were safe for ambulatory boys with DMD, these exercises had only a limited 
positive effect on muscle strength and function.8-10 Another limitation of resistance 
exercises is that they are often impractical for wheelchair-dependent boys, as even the 
lowest resistance level can be too heavy to sustain or can rapidly exhaust their weak 
muscles.11 Finally, strenuous high-resistance exercises and eccentric exercises can cause 
myofibrillar disruption in patients with DMD.12 
A recent randomized controlled trial found that assisted bicycle training is both feasible 
and safe for ambulatory and recently wheelchair-dependent patients with DMD.13 
Moreover, this training program prevented 6.3% of the functional deterioration that 
occurred without this intervention. In this study, boys trained their legs and arms using a 
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mobility trainer with electrical motor support. Although assisted training provides training 
opportunities to patients with DMD who have been confined to a wheelchair for several 
years, arm cranking may not be possible for patients who cannot lift their arms. We 
hypothesized that training with dynamic arm support (DAS) may be a viable solution for 
these patients. DAS provides horizontal and vertical external mechanical support for weak 
muscles via non-powered (e.g., counterweights) or powered components and increases 
the active range of motion for joints.14
The aim of this study was to investigate whether DAS-assisted upper limb training is 
feasible and safe for wheelchair-dependent patients with DMD who are unable to lift their 
arms against gravity. We expected that patients would be able to practice reaching 
movements, which have high priority in patients with a neuromuscular disorder15, with a 
DAS without causing harm. Because no previously published study has used DAS to train 
upper limb function in patients with DMD, and because the safety is a concern with 
exercise in DMD patients, we elected to perform a feasibility study with a multiple N=1 
design. The goal of this study was to determine whether this type of assisted training is 
safe and can help patients with DMD. In addition, we measured—albeit to a limited 
extent—the effect of DAS-assisted upper limb training on motor function.
Methods
Design
This study was a feasibility study with a multiple N=1 design. Each participant acted as his 
own internal control (i.e., the participant’s untrained arm served as the reference for the 
trained arm). A detailed description of the study protocol has been published previously.16 
The study was approved by the regional Medical Ethics Committee. The participants and/
or legal guardians provided written informed consent. The study was registered with the 
Netherlands Trial Register (trial number 1631).  
Participants
Wheelchair-dependent boys with DMD who were unable to touch the top of their head 
with at least one hand but were still able to use their hands for tabletop activities such as 
writing were eligible for this study. At the start of recruitment, an estimated 120 boys with 
DMD within the Netherlands were in this stage of the disease. Boys were excluded if they 
were unable to touch their nose while using the DAS, as this movement was required for 
several daily activities, including feeding, which was part of the intervention. In addition, 
boys who had previously used DAS were excluded. Boys were recruited from the Dutch 
Duchenne Parent Project database. Recruitment started 1 January, 2009 and ended 31 
December 2009. 
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Procedure
After an eight-week period (T0-T2; see Figure 1) in which baseline information was 
collected regarding the stability of the patient’s disease course, each participant was 
provided with a powered or non-powered DAS device (Dynamic Arm Support Top/Help, 
non-powered or powered versions, Focal Meditech BV, Tilburg, the Netherlands) for their 
non-dominant arm. At baseline (T2), the participants began a 24-week training program 
for their non-dominant arm using DAS. Participants performed forward and sideward 
reaching movements by playing a computer game and by performing regular daily 
activities such as eating. For this study, we chose to train the non-dominant arm, as this 
arm is often used less than the dominant arm in daily activities and thus may experience 
more disuse than the dominant arm; thus, we expected any potential training effects to 
be more pronounced. Efficacy was assessed after 12 weeks (T3) and at the primary 
endpoint of 24 weeks of training (T4). A final follow-up assessment was performed 12 weeks 
after the end of the training (T5). For the complete timeline of the study, see figure 1. 
Dynamic arm support (DAS) 
The DAS Top/Help device originally been developed to be an assistive device. It has a 
weight-bearing construction mounted beneath the user’s arm (see Chapter 5, Figure 5). 
The device aims to provide an active range of motion-assisting movements in the 
horizontal and vertical planes. The “Top” part of the DAS device consists of an axis with 
several rotation points, a forearm fitting, and a connection to the wheelchair. The “Help” 
part of the DAS device uses a mechanical spring mechanism (mechanical arm support) or 
an electric actuator (electric arm support) to facilitate vertical displacements. Participants 
who were unable to touch their nose with the help of a mechanical arm support received 
an electric arm support. 
Figure 1  Study design.  
The participants were provided with a dynamic arm support at T2. 
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Computer-assisted training
The participants practiced DAS-assisted forward and sideward reaching movements 
five days per week by playing the virtual-reality computer game “FurballHunt”1 without 
becoming overexerted (as assessed using the OMNI scale).FurballHunt is controlled by 
motion capture technology using a webcam to detect gross arm movements.17 
Functional training
The participants were also instructed to eat at least two meals per week while using the 
DAS device. In addition, they were instructed to use DAS as much as possible while 
performing daily activities that involved reaching movements of the arms (for example, 
turning on the lights). 
Feasibility and safety assessments
We monitored whether participants were able to complete the entire training program in 
accordance with the protocol, without any signs of overexertion. This was assessed via a 
questionnaire completed once every two weeks and home visits by the primary 
investigator (MJ) after 2 and 12 weeks of training. The participants recorded their training 
sessions in a journal and kept written records of the primary activities that they performed 
with the DAS device. The questionnaire regarding overexertion focused on excessive 
muscle pain, a feeling of severe discomfort feeling, and exhaustion (OMNI score18 >6). 
Efficacy assessments 
All assessments were performed by the primary investigator (MJ) either at the hospital 
(for assessments in T2 and T4) or at the participant’s home (for the other assessments). 
Both the dominant (untrained) and non-dominant (trained) arms were assessed. The 
non-dominant arm was assessed without DAS; in addition, to gain information regarding 
the benefits of training with the device, the non-dominant arm was assisted with DAS at 
baseline (T2). 
The primary outcome was the Action Research Arm Test (ARAT), a standardized tool for 
assessing arm motor function and capacity in stroke patients.19,20 At the time of the study, 
no validated arm motor function test for assessing boys with DMD was available. We 
calculated the total ARAT score (range 0-57) as well as the score of subscale D (gross arm 
movements, range 0-9), with a higher score indicating better function. An adjustable- 
height table is needed to properly administer the test execution, and because such a 
stable was usually not available in the participant’s home, the total ARAT was measures at 
T0, T2 and T4. 
1 “Furballhunt is developed by Roessingh Research and Development. 
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The secondary outcome measures were Dimension 3 (distal motor function) of the Motor 
Function Measure (MFM D3) to assess motor function21, the Nine-Hole Peg Test (9HPT) to 
assess finger dexterity22, and the Jebsen Taylor Hand Function Test (referred to here as the 
Jebsen Test) to assess hand function23; these measured were collected at T2 and T4. 
Although the 9HPT and Jebsten Test assess primarily hand function, both tests force 
participants to lift and/or reach with their arms. At the end of the training period (T4), the 
participants also received a questionnaire designed to collect information regarding their 
DAS training experiences. 
Statistical analysis
This was a feasibility study with a multiple N=1 design; therefore, the feasibility, safety and 
effectiveness of the DAS training program are described separately for each participant. 
The effectiveness of training was measured by calculating the change in the untrained 
and trained arms from T2 to T4; assessment T2 was chosen as our baseline value because 
T2 was closest to the time in which the participants received their DAS device and began 
training. In addition, the immediate effectiveness of using the DAS was assessed by 
comparing the results of the non-dominant arm without and with DAS at baseline (T2). 
Results
Participants
Thirteen boys were initially assessed for eligibility. Five were excluded because they were 
unable to touch their nose even with the use of DAS. Thus, eight boys (age 12-20 years, 
with wheelchair dependence for 3-10 years) were first assessed for their baseline 
parameters and then provided with a DAS, after which they began training. The 
participants’ score on the Brooke scale24 ranged from 3 (cannot raise hands above the 
head, but can raise an 8-ounce glass of water to the mouth) to 5 (able to use the hands for 
some daily activities only). A full overview of the participants’ characteristics is presented 
in table 1. 
Effectiveness of the Dynamic Arm Support (DAS) 
All eight participants were provided with a DAS device for their non-dominant (left) arm. 
Six participants received an electrical arm support, and two participants (who had only 
been fully wheelchair-dependent for 3 to 3.5 years) received a mechanical arm support 
(Table 1).  
 At baseline (T2), when using the DAS, the total ARAT score increased by 11-17 points 
for four of the eight participants, whereas the total ARAT score was either unchanged or 
decreased by up to 14 points for the other four participants. We found that the 
configuration of the ARAT testing board interfered with the use of the DAS device. This 
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effect was most pronounced for the participants who scored relatively high (>20) without 
using the DAS. With respect to subscale D, this score increased by 1-4 points for seven of 
the eight participants. The score decreased by 2 points for the eighth participant; this 
participant was unable to touch the top of his head with DAS, although he was able to 
touch the top of his head without DAS. Thus, the DAS device hindered this movement for 
this participant. The scores for all eight participants are summarized in table 2. 
 Similar to changes in the ARAT scores, the baseline (T2) MFM D3 and 9HPT scores 
were also improved with DAS (Table 2). On the other hand, the Jebsen Test scores did not 
improve with the DAS (with the exception of one item—the time required to pick up and 
drop small common objects) (Table 2). As occurred when performing the ARAT, the Jebsen 
Test board interfered with the DAS device, and maximum elbow extension was restricted 
by the mechanical construction of the device. This effect was most pronounced for the 
items that required reaching movements (for example, turning cards and moving objects). 
Feasibility and safety of the DAS-assisted training program
Of the eight participants who began training, two did not complete the program; one boy 
had an unexpected three-month stay abroad, and the other boy obtained a new 
wheelchair (without the DAS installed). The remaining six participants finished the training 
program and practiced computer-assisted training 3-5 times per week. One boy had 
fewer training sessions because his computer broke, and he was unable to play during the 
first eight weeks. In addition to the computer-assisted training sessions, use of the DAS 
Table 1   Characteristics of the participants (N=8)
ID Age 
(years)
Years 
wheelchair-
dependent
Cortico-
steroids
Brooke
(range 
0-6)
DAS Compliance
1 12.1 3 Yes 3 Mechanical 5x p/w
2 15.4 5 Yes 5 Electrical 4x p/w
3 12.1 4 No 4 Electrical Inadequate*
4 20.0 7 No 5 Electrical 3x p/w
5 14.1 3.5 Yes 3 Mechanical 4x p/w
6 15.9 7 Yes 3 Electrical 3x p/w
7 18.9 10 No 5 Electrical Inadequate† 
8 15.0 4 Yes 3 Electrical Inadequate‡ 
*Social support was limited, and the computer broke during the study. 
† Unexpected trip for 3 months; lost to follow-up.  
‡ New wheelchair without DAS; lost to follow-up.  
DAS, Dynamic Arm Support; p/w, per week
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Table 2   Function test scores with and without DAS at baseline (T2)
ARAT MFM, 
D3 (%)
9HPT
(sec)
Jebsen
(sec)
Total
(range 
0-57)
Scale D
(range 
0-9)
J1 J2 J3 J4 J5 J6
ID 1
Without
With
Difference
19
31
12
3
7
4
66.7
71.4
4.8
28.7
32.1
3.3
ND
ND
NA
ND
ND
NA
ND
ND
NA
ND
ND
NA
ND
ND
NA
ND
ND
NA
ID 2
Without
With
Difference
9
20
11
3
4
1
66.7
66.7
0
49.1
49.8
0.7
8.4
21.6
13.2
U
28.7
NA
U
67.0
NA
6.8
6.2
-0.6
13.2
12.2
-1.0
U
U
NA
ID 3
Without
With
Difference
24
23
-1
3
4
1
71.4
76.2
4.8
40.6
32.0
-8.6
13.6
23.6
10.0
20.2
18.6
-1.7
41.3
44.2
2.9
7.5
6.7
-0.8
5.3
10.9
5.6
9.0
15.1
6.2
ID 4
Without
With
Difference
21
21
0
4
5
1
66.7
61.9
-4.8
83.0
47.6
35.4
42.6
22.7
-19.9
54.6
21.8
-32.9
37.9
24.3
-13.7
7.8
6.3
-1.4
26.7
23.5
-3.3
39.8
33.5
-6.3
ID 5
Without
With
Difference
54
40
-14
7
5
-2
66.7
76.2
9.5
21.8
25.1
3.2
5.7
7.3
1.6
8.2
9.2
1.0
24.3
24.4
0.1
3.8
6.9
3.1
4.9
4.4
-0.6
8.3
7.5
-0/8
ID 6
Without
With
Difference
20
19
-1
4
4
0
66.7
76.2
9.5
35.6
41.7
6.0
8.4
14.2
5.8
15.8
14.5
-1.3
47.0
U
NA
4.5
5.2
0.7
8.4
6.7
-1.7
20.0
21.3
1.3 
ID 7
Without
With
Difference
2
19
17
0
3
3
57.1
62.0
4.8
164
ND
NA
U
ND
NA
U
ND
NA
79.0
ND
NA
U
ND
NA
U
ND
NA
U
ND
NA
ID 8
Without
With
Difference
8
19
11
0
4
4
62.0
66.7
4.7
41.3
36.3
-5.0
8.5
19.7
11.1
28.5
23.9
-4.6
35.4
80.0
54.6
4.1
5.3
1.2
5.5
11.7
6.2
8.7
16.6
7.9
ARAT, Action Research Arm Test; MFM, Motor Function Measure; 9HPT, Nine-Hole Peg Test; Jebsen, Jebsen 
Taylor Hand Function Test; J1, Turning cards; J2, Small objects; J3, Feeding; J4, Stacking; J5, Light objects; J6, 
Heavy objects; ND, Not determined; U, Unable to perform; NA, Not applicable
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ranged from seldom to 2 hours a day for the following activities: eating and drinking (7/8 
participants), horizontal and vertical reaching activities such as turning on the computer 
or a light (1 participant), and using a pin-card (1 participant). The use of DAS by the 
participants is summarized in table 1.
 No signs of serious overexertion were reported by the participants. One participant 
reported pain in his shoulder during the training; he reported that his shoulder was painful 
when he reached forward and moved his arm above 90º of anteflexion. When we adjusted 
this participant’s training program (the participant was instructed not to raise his arm 
above shoulder height), the pain disappeared and he completed the training program. 
Effects of the DAS-assisted training program 
Of the six participants who completed the program, four had a larger decrease in ARAT 
score in the untrained arm compared to the trained arm; for the other two participants, 
the untrained arm scores decreased slightly less than the trained arm after 24 weeks of 
training (T4). This more pronounced decrease in the untrained arm was particularly 
pronounced for the participant who was still able to raise a glass to his mouth at baseline; 
similar results were obtained for subscale D of the ARAT for this participant. The remaining 
five participants had no differences between their trained and untrained arm with respect 
to subscale D at T3 or T4. These scores are summarized in table 3. 
 With respect to the secondary outcomes, none of the participants had a decrease in 
MFM D3 score for the trained arm after 24 weeks of training (T4). For the untrained arm, 
however, four participants had a decrease in MFM D3 score (the change in score for these 
four participants ranged from -4.8 to -9.5%); the other two participants had no change. 
The 9HPT score decreased for the trained arm for two participants and decreased for the 
untrained arm for three participants. Finally, the Jebsen Test revealed no notable 
differences between the trained and untrained arms, with the exception of the item in 
which the participants had to pick up and drop small common objects—at T4, two 
participants lost the ability to pick up the objects with their untrained arm, although they 
retained the ability with their trained arm. The secondary outcomes are summarized in 
table 3. 
Follow-up 12 weeks after the end of the training 
Of the six participants who completed the training program, five participants were 
followed until 12 weeks after the end of the training program (T5), and two of the 
participants had continued to use the DAS device, but without specific training. The sixth 
participant was lost to follow-up due to a scoliosis surgery. Twelve weeks after training, 
Dimension 3 of the ARAT had not decreased for any of the participants for either the 
trained or untrained arm. Similar results were obtained for the MFM D3 and 9HPT tests at 
T5. The follow-up data are summarized in table 4. 
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Participants’ experiences 
The participants reported that they found DAS useful for the following activities and 
movements: lifting their arm, scratching their face, moving their arm beyond the tray of 
the wheelchair, and feeding themselves. However, the DAS limited their ability to reaching 
down and to open a door. In addition, eating with a fork or spoon was challenging, as the 
DAS device did not allow the full range of supination movements. Sitting at a table while 
using the DAS device was also problematic because of interference between the device 
and the table. Nevertheless, six of the eight participants requested to keep the DAS at the 
end of the study; these six participants were the patients who were unable to lift their 
arms against gravity without DAS and had received electrical support. Although all of the 
Table 3   Effects of 24 weeks of training with dynamic arm support (N=6)
ARAT MFM, 
D3 
(%)
9HPT
(sec)
Jebsen
(sec)
Total Scale D J1 J2 J3 J4 J5 J6
ID 1
Trained 
Untrained 
6
-16
1
-4
4.8
-4.8
5.6
2.4
ND T2
ND T4
ND T2
ND T4
ND T2
ND T4
ND T2
ND T4
ND T2
ND T4
ND T2
ND T4
ID 2
Trained 
Untrained 
-2
-4
-2
-2
0
-9.5
0.4
-17.0
U T4
2.5
U T2/T4
10.3
U T2/T4
U T2/T4
-1.8
-1.7
U T4
-2.3
U T2/T4
U T2/T4
ID 3
Trained 
Untrained 
-13
-21
-2
-2
0
-4.8
-7.2
1.1
-3.3
-0.7
0.8
U T4
U T4
U T4
-1.7
-3.3
5.4
1.3
2.3 
2.0
ID 4
Trained 
Untrained 
0
-9
0
0
0
0
-8.0
-4
19.9
-4.9
-21.6
U T4
U T4
U T4
-0.7
-2.6
U T4
U T4
U T4
-10.7
ID 5
Trained 
Untrained 
-14
-8
-1
-1
4.8
0
-4.8
-10
-0.6
0.8
-1.7
-4.0
-7.5
-1.9
-2.0
-4.4
-0.4
-1.6
-2.8
-1.1
ID 6
Trained 
Untrained 
-2
2
0
0
0
-4.8
-4.1
14.4
-0.6
-4.8
-0.5
1.3
9.5
U T4
0.8
0.8
0.6
-5.1
U T4
U T4
Data are individual differences in scores between T2 (start of training) and T4 (primary endpoint) for the trained 
and untrained arms. 
ARAT, Action Research Arm Test; MFM, Motor Function Measure; 9HPT, Nine-Hole Peg Test; Jebsen, Jebsen 
Taylor Hand Function Test; J1, Turning cards; J2, Small objects; J3, Feeding; J4, Stacking; J5, Light objects; J6, 
Heavy objects; ND, Not determined at the indicated assessment(s); U, Unable to perform at the indicated 
assessment(s)
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participants liked the computer-assisted training at the start of the training, none of the 
participants found the game attractive after 24 weeks of training. 
Case narratives
ID 1: Participant 1 was a 12-year-old boy who had been fully wheelchair-dependent for 
three years at the start of the study. He was still able to raise a glass of water to his mouth, 
and he was provided with a mechanical DAS device. The DAS increased his arm and hand 
motor function as assessed with the ARAT, MFM and 9HPT tests. He completed the entire 
training program with good compliance (i.e., he performed the computer-assisted training 
an average of 4-5 times per week). He reported that the DAS device hindered his ability to 
reaching the table surface because of interference between the device and the table. 
Opening a door and reaching down were difficult as well because his arm fell out of the 
forearm support. Nevertheless, he ate once a week with DAS, and he reported that 
scratching his face and lifting objects (such as a glass) were easier with DAS. After 24 weeks 
Table 4   Follow-up after the end of the training 
Test/
ID
ARAT MFM, D3 (%) 9HPT
(sec)
Total Scale D
ID 1
Trained Untrained ND
ND
0
0
0
4.8
-3.1
-4.2
ID 2
Trained Untrained ND
ND
0
0
-9.5
4.8
11.5
20.6
ID 3
Trained Untrained ND
ND
0
0
0
9.5
12.1
-2.1
ID 4
Trained Untrained ND
ND
M
0
0
-4.8
-13.0
3.0
ID 5
Trained 
Untrained 
ND
ND
0
0
4.7
0
4.8
6.0
ID 6
Trained Untrained ND
ND
M
M
M
M
M
M
Data are individual changes between T4 (primary endpoint) and T5 (follow-up) for the trained and the 
untrained arm. ARAT, Action Research Arm Test; MFM, Motor Function Measure; 9HPT, Nine-Hole Pegtest; 
M, Missing; ND, Not determined (assessment was conducted at home)
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of training, his ARAT and MFM D3 scores were either unchanged or increased; in contrast, 
the scores for his untrained arm had decreased considerably, particularly with respect to 
the ARAT. 
ID 2: Participant 2 was 15-year-old boy who had been confined to an electric wheelchair 
for five years at the start of the study. This patient only had function remaining in his hands 
and was provided with an electric DAS device. The device increased his gross arm 
movements as assessed with the ARAT, and it allowed him to complete the feeding and 
lifting small objects tasks of the Jebsen Test (which were not possible without support). 
He completed the training program and performed the computer game four times per 
week. In additionally, he ate once every two weeks with his DAS, but reported that it was 
difficult to eat with his non-dominant hand (the trained arm). After 24 weeks of training, 
his MFM D3 score decreased for the untrained arm, but not the trained arm. At the end of 
the study, the participant requested to keep the DAS device to use for his dominant arm, 
but he did not wish to continue using the computer game. 
ID 3: Participant 3 was a 12-year-old boy who had been fully wheelchair-dependent for 
four years at the start of the study. He was able to raise his hand—but not a glass—to his 
mouth. He was provided with an electric arm support, which increased his hand function 
as assessed with the MFM and 9HPT, but hindered his gross arm movements. Thus, the 
DAS device interfered with the board required to perform the ARAT and 9HPT tests. In 
addition, the DAS limited his elbow extension (which was needed to perform the reaching 
tasks of the Jebsen Test), thereby increased the time needed to complete the tasks. The 
participant completed the training program, but with moderate compliance during the 
first eight weeks of training due to technical problems with his computer. Nevertheless, 
he ate once a week with the DAS—which was difficult for him—with his non-dominant 
(trained) hand. The participant lost the ability to perform the feeding and lifting small 
objects tasks of the Jebsen Test with his untrained arm, whereas he was still able to 
complete these tasks test with his trained arm. 
ID 4: Participant 4 was a 20–year old male (the oldest participant) who had been wheel-
chair-dependent for seven years at the start of the study. He was unable to bring his hands 
to his mouth. The DAS helped him lift his hand, which was reflected in the decreased time 
needed to perform the Jebsen Test tasks “Turning cards”, “Feeding”, and “Small objects”. 
The participant used the DAS approximately two hours per day for eating, drinking, and 
other reaching and lifting activities such as turning on the light. We found no clear 
differences in arm function between the trained and untrained arms after 24 weeks of 
training; however, his scores were already low at baseline. 
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ID 5: Participant 5 was a 15-year-old boy who had been wheelchair-dependent for 3.5 
years at the start of the study. He was still able to lift a glass to his mouth. He was provided 
with a mechanical arm support, which limited his gross arm movements. In fact, his own 
compensatory movements were more helpful in terms of performing the clinical 
assessments than the DAS device. The participant performed the computer-assisted 
training an average of four times per week, but he rarely used the DAS to perform 
functional activities. After 24 weeks of training, there were no clear differences between 
his trained and untrained arms with respect to change in arm function. 
ID 6: Participant 6 was nearly 16 years of age at the start of the study. Although he was still 
able to lift a glass to his mouth, this effort exhausted him, and he was provided with an 
electric arm support. Although the DAS device hindered his gross arm movements, the 
device made eating easier, and he used the DAS device every day for eating. Furthermore, 
he performed the computer-assisted training with DAS approximately three times per 
week. After 24 weeks of training, he lost the ability to perform the feeding task of the 
Jebsen Test with his untrained arm, whereas he was still able to perform this task with his 
trained arm.
ID 7: Participant 7 was an 18–year-old boy who had been confined to a wheelchair for ten 
years at the start of the study. He had useful hand function, but he was unable to lift his 
hand to his mouth. He was provided with an electric arm support that was on a moveable 
frame, as the corridor in his house was too small to enable him to maneuver his wheelchair 
when the device was attached. The DAS increased his arm function considerable as 
assessed with the ARAT. The participant did not complete the training program, and he 
was lost to follow-up because he went on an unexpected trip for three months. 
ID 8: Participant 8 was a 15-year-old boy who had been fully wheelchair-dependent for 
four years at the start of the study. He was able to lift his hand—but not a glass—to his 
mouth. He was provided with an electric DAS, which increased his gross arm movements. 
However, he did not use the device for daily activities primarily because the participant 
did not want to use the DAS at school (he feared that his peers would think it was not 
“cool”). He did not complete the training program because halfway through the study, he 
received a new wheelchair that was not equipped with a DAS device (i.e., we would have 
needed to transfer to the old wheelchair to use the DAS). Surprising, the participant 
requested to keep the DAS at the end of the study, stating that the device allowed him to 
use an Automated Teller Machine (ATM).  
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Discussion
This feasibility study revealed that patients with DMD who have impaired arm function 
can safely participate in assisted training. Thus, patients who are unable to lift their arms 
against gravity are able to practice reaching forward and sideward movements by playing 
a virtual reality computer game while using a DAS device. Furthermore, we found 
indications that assisted training may slow the loss of arm motor functions. Because 
delaying loss of motor function is important to boys with DMD who wish to maintain their 
activities of daily living (ADLs), our findings indicate that upper limb training with assistance 
warrants further research. 
The Top/Help DAS device was moderately effective for our training purposes; DAS 
increased gross arm motor functions (such as the ability to lift the hand to the mouth) in 
seven out of eight participants and allowed the participants to train without the help of a 
physiotherapist. This finding is in agreement with previous studies that reported that 
several ADLs can be improved with DAS.25,26 The only participant who had a decrease in 
gross arm motor function after using the DAS was still able to lift a glass to his mouth 
without the device. The DAS prevented him from placing his hand on his head, an action 
that he could perform using his own compensatory strategies (i.e., without DAS). This is 
similar to previous reports that also showed that stronger children prefer their own 
compensatory strategies to overcome their limitation.14,27 In addition, hand function—
which is associated with muscle strength and range of motion28—did not improve using 
DAS, with the exception of the task in which the participant was required to pick up and 
drop small objects. This lack of improved hand function is in contrast to previous findings14, 
which can be explained by that fact that the DAS device interfered with the equipment 
required for the hand function test. In addition, some hand functions (such as picking up 
beans with a spoon) were difficult to perform with the DAS, as the participants found it 
difficult to stabilize their hand with the device. Finally, the DAS prevented full elbow 
extension and supination, which are needed to perform the reaching tasks. 
 The assisted training program was determined to be feasible for six of the eight 
participants. Two of the participants did not complete the entire training program for 
practical reasons. The remaining six participants completed the training with moderate 
compliance (they performed the computer-assisted training 3-5 times per week). Only 
two of the participants were fully compliant with the functional training program and ate 
at least one meal twice a week with the DAS device. The other participants used the DAS 
less frequently, primarily because they found it difficult to use their non-dominant (i.e., the 
trained) arm to perform ADLs. In addition, the participants who were still able to lift a glass 
to their mouth without DAS preferred to use their own compensatory strategies, which is 
similar to previous reports. Compliance might be improved by providing more stimulating 
computer games and/or by providing a DAS that assists the arm through its entire range 
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of motion. Future clinical trials on functional arm training should also consider to train the 
dominant arm rather than the non-dominant arm, since it is often not appropriate to train 
this arm. 
Four of the six participants who completed the program had more deterioration of arm 
motor functions for the untrained arm than for the trained arm as assessed with the ARAT. 
In addition, none of the participants showed a decline on the distal motor function 
dimension of the MFM with the trained arm, whereas the untrained arm deteriorated in 
four participants and remained stable in the other two participants. Previous studies using 
gentle resistance exercises in DMD patients also found no disease acceleration due to 
training8-10, but they reported limited benefits. However, a recent study found that assisted 
bicycle training for the legs and arms delayed the secondary functional deterioration that 
can occur due to disuse among ambulatory and recently wheelchair-dependent boys.13 
We hypothesize that training may be less beneficial to older patients, who typically have 
less remaining muscle mass.29 Therefore, patients should ideally begin training early in the 
course of the disease. 
Because this was the first study of upper limb training with DAS in patients with DMD, we 
performed a feasibility study with a multiple N=1 design. Our study had a relatively small 
sample size (eight patients), and we did not compare our results with a control group. The 
external validity of our study is therefore limited, and the results should be interpreted 
with caution.30 Larger, controlled trials are needed to expand these results and to further 
address the question of whether training with DAS can delay loss of arm motor function. 
These trials should include validated outcome measures of gross arm motor functions 
that are responsive to small changes over time. The primary outcome measure in our 
study (ARAT scores) was not completely compatible with the DAS device used, as the 
testing kit required for performing the tasks interfered with the device. This forced 
participants to use an unnatural movement pattern to perform the test when using the 
DAS. The MFM, a secondary outcome, was compatible with the DAS device, although this 
test has only a limited number of items for investigating shoulder movements.21 No other 
suitable outcome measures of gross arm movements in DMD patients were available at 
the start of this study.31 The recently developed Performance of the Upper Limb (PUL) can 
be useful to evaluate arm function in future clinical trials, since this tool assesses proximal 
as well as distal arm motor functions.32 Its responsiveness to measures changes over time 
should however first be confirmed. 
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Implications for research 
•	 Duchenne muscular dystrophy is a severe neuromuscular disorder leading to muscle 
weakness and loss of functional abilities
•	 Regular physical training is recommended to avoid secondary complications of physical 
inactivity, but training with resistance is often too hard for patients with severe muscle 
weakness 
•	 This feasibility study showed that assisted upper limb training with dynamic arm 
support is a feasible and safe alternative to wheelchair-dependent patients 
•	 Further research is required to determine whether an assisted upper limb training with 
dynamic arm support can delay the secondary functional deterioration 
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Summary
Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy in 
childhood and affects approximately 1 in 5000 newborn boys. Mutations in the DMD 
gene cause an absence of the functional protein dystrophin resulting in fragile muscle 
fibers and muscle wasting. Boys with DMD become wheelchair-dependent at the age of 
9 to 10 years and soon thereafter they lose the ability to lift their arms against gravity. 
There is no cure for DMD yet and disease management is still symptomatic. An important 
aim in the rehabilitative management of DMD is to delay the loss of functional abilities 
such as walking. The loss of functional abilities is primarily the result of muscle wasting 
due to the disease, but it is also caused by ‘disuse’ secondary to a sedentary life style. For 
example, the increasing amount of energy needed to ambulate will (further) reduce the 
level of physical activity and, thus, cause secondary muscle wasting (‘disuse atrophy’). 
International guidelines on physical training recommend boys with DMD to participate in 
regular ‘gentle activities’ to avoid disuse atrophy and other secondary complications of 
physical inactivity. However, these recommendations are vague and based on limited 
evidence. As for training, conventional resistance exercises will often be exhausting for the 
weak muscles of boys with DMD. So, in order to preserve optimal physical capacities, 
assisted physical training in which dynamic support is provided by a mechanic or electric 
device, such as an electric bicycle, could be a viable and safe solution for them. In the 
studies that constitute this thesis it was aimed to develop a feasible assisted physical 
training and to evaluate the effectiveness of this training in both ambulatory and wheel-
chair-dependent boys with DMD. 
General introduction
Chapter 1 is the general introduction and provides background information on DMD. It 
gives a short overview of the pathophysiology, clinical progression, and treatment 
(including physiotherapy). It discusses the ‘disuse’ phenomenon, the possible role of 
physical training, and the need for new, validated clinical outcome measures that can 
monitor disease progression in both ambulant and wheelchair-dependent boys with 
DMD. Furthermore, it describes the aim and two main research questions of this thesis: 
1)  Are quantitative muscle ultrasound (QMUS) , the Assisted Six-Minute Cycling Test 
(A6MCT) and the KIDSCREEN-52 valid and/or responsive outcome measures to 
evaluate the effects of a physical training intervention in boys with DMD?
2)  Is assisted physical training feasible, safe and effective to delay the functional 
deterioration in ambulatory and wheelchair-dependent children with DMD? 
The general introduction ends with a description of the outline of this thesis. Part 1 of the 
main body of this thesis describes the development and validation of the three outcome 
measures that were used to evaluate the effectiveness of assisted physical training, i.e. 
QMUS to assess muscle histology (chapter 2), the A6MCT to assess physical endurance 
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(chapter 3) and the KIDSCREEN-52 to assess Health Related Quality of Life (HRQoL) (chapter 
4). In part 2, the protocol (chapter 5) and results (chapters 6 and 7) of two physical training 
programs are reported that together constitute the “No Use is Disuse (NUD) study” in boys 
with DMD. After part 2, the main findings of all studies are addressed in a general 
discussion, including their strengths and limitations. In addition, suggestions for future 
research are given.  
Part 1 Outcome measures for Duchenne muscular dystrophy 
The aim of chapter 2 was to determine whether QMUS can be used as a follow-up tool in 
clinical trials for DMD. QMUS is a muscle imaging technique that reflects the dystrophic 
process by quantifying echo intensity (i.e. the mean grey level of ultrasound images) and 
muscle thickness. The echo intensity of boys with DMD shows a homogenous increase in 
echogenicity as a result of intramuscular fibrosis and fatty infiltration. It was hypothesized 
that quantitatively assessed echo intensity and muscle thickness are responsive enough 
to measure progressive changes in muscle structure over time and that these changes are 
associated with clinical disease progression and loss of function. In this study a longitudinal 
ultrasound/QMUS follow-up of the changes of two lower and two upper extremity 
muscles was performed in 18 boys with DMD. Additionally, the QMUS changes were 
compared with changes in clinical disease progression in 11 of these boys. Assessments of 
clinical disease progression included: the Vignos and Brooke functional rating scales, 
quantitative muscle strength testing, the Childhood Myositis Assessment Scale, and the 
Hammersmith Motor Ability Scale. The participating boys were aged 3.7 to 15.1 years; 15 
of them were ambulatory and three where wheelchair-dependent. They each underwent 
a median of 4.5 QMUS measurements during a median follow up of 27.5 months. The 
results confirmed the hypothesis that muscle echo intensity significantly increased with 
clinical disease progression. The echo intensities of the rectus femoris and tibialis anterior 
muscles showed the highest responsiveness in our cohort, indicating that one has a good 
chance of finding a significant difference in echo intensity when repeating the 
measurement after one year. Somewhat counterintuitively, no significant decrease in 
muscle thickness was observed over time. Altogether, the results of this study establish 
QMUS for measuring echo intensity as a practical, child-friendly and valid tool for the 
longitudinal study and follow-up of boys with DMD. 
Chapter 3 describes the development and validation of the A6MCT. The most frequently 
used submaximal endurance test for children with a neuromuscular disorder is the 
6-Minute Walk Test (6MWT) that assesses the distance that a patient can quickly walk 
without running in 6 minutes. Endurance tests are the primary outcome measure in 
ongoing clinical trials in children with a neuromuscular disorder, because they correlate 
with functioning in daily life. The 6MWT is, however, not feasible for patients with 
Duchenne who are at the end of the ambulatory phase or who are wheelchair-depen-
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dent. While controlled treatment trials are currently being developed for more severely 
affected children with DMD, no other suitable submaximal endurance test is yet available 
for this population, since standard bicycle ergometer use is too hard to sustain for affected 
muscles. In this perspective, the A6MCT was developed to assess submaximal endurance 
in children with severe muscle weakness. The A6MCT is a cycling test for the legs and arms 
using a motor-assisted mobility trainer with a no-load speed of 7 revolutions per minute 
(RPM). First, the development of the A6MCT is described. In the second part, the feasibility 
of the A6MCT is reported in healthy boys and in boys with DMD. For healthy boys, also the 
test-retest reliability was examined as well as the construct validity by showing the 
relationship between the A6MCT and the 6MWT. For boys with DMD, the relationship 
between the A6MCT and disease severity as assessed with the Motor Function Measure 
(MFM) was determined. The results showed that the A6MCT for the legs was feasible for 
99% of the healthy boys and 97% of the boys with DMD. The A6MCT for the arms was 
feasible for all healthy boys and boys with DMD. Only two boys with DMD did not perform 
the A6MCT for the arms due to problems with their attention span. As expected, boys 
with DMD achieved fewer cycling revolutions than healthy boys. In healthy boys, the 
A6MCT was reproducible and positively correlated with the 6MWT for the legs (r = 0.58, p 
< 0.01) and arms (r = 0.65, p < 0.01). In the entire group of boys with DMD, the A6MCT for 
the legs positively correlated with the MFM (ρ = 0.65, p < 0.01). In the wheelchair-depen-
dent subgroup, the A6MCT for the arms also positively correlated with the MFM (ρ = 0.84, 
p < 0.01). It was concluded that the A6MCT is the first ergometer test that can be performed 
by wheelchair-dependent children with severe muscle weakness due to a progressive 
neuromuscular disorder. It also seems to be a promising test for the longitudinal study and 
follow-up of children with neuromuscular disorders who are likely to lose their ability to 
walk. 
Chapter 4 explores HRQoL in boys with DMD. HRQoL is an individual’s perception of 
health and one’s position in life. Authorities recommend the inclusion of a HRQoL 
assessment in clinical trials, because this increases insight in the perceptions of patients 
regarding their own health status. This chapter has a threefold aim. First, the composing 
factors of HRQoL were examined in 40 boys with DMD who were ambulant (n=19) or 
wheelchair-dependent with either good arm function (n=14) or decreased arm function 
(n=7). Then, the HRQoL perceptions of the boys were compared with the perception their 
parents had of them. Finally, the relationship between HRQoL, bodily functions and 
activities was determined. DMD was expected to negatively influence HRQoL, which then 
could be positively influenced by a new intervention. In this study, the KIDSCREEN-52 
questionnaire was used to assess generic HRQoL of the boys and the proxy reports of 
their parents. The results of boys with DMD were compared with reference values of 
healthy age-matched Dutch boys. The results showed that boys with DMD perceived only 
their physical well-being to be lower compared to healthy controls. No clear correlations 
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between HRQoL, bodily functions and activities were found. This pattern of results 
indicates that, generally speaking, HRQoL is not negatively influenced by the existence of 
DMD or its progression. Parents, however, scored their sons much lower on the domains 
“Self perception”, “Moods and emotions”, and “Bullying” than the boys themselves. 
Because parents tend to underestimate the HRQoL of their sons with DMD, it seems 
important to counsel them about the preserved self-perceived HRQoL of these boys. 
Part 2 Physical training in Duchenne muscular dystrophy 
In chapter 5, the research questions, hypotheses en methods of the NUD study are 
presented. The NUD study is the first randomized controlled trial (RCT) in boys with DMD 
that examined whether low-intensity assisted physical training is beneficial in terms of 
preservation of muscle endurance and/or functional abilities. It was hypothesized that 
regular assisted physical activity would counteract the secondary functional deterioration 
as result of disuse. The NUD study consisted of two sub-studies that investigated the 
feasibility, safety and effectiveness of (1) dynamic leg and arm training for ambulant and 
recently wheelchair-dependent boys with DMD and (2) functional training with arm 
support for boys with DMD who had already been confined to a wheelchair for several 
years.
 Study 1 (see chapter 6) was an RCT with multiple baseline measurements. It aimed to 
include 30 boys with DMD who were allocated to the intervention or control group. After 
a baseline period of eight weeks to control for initial disease severity and progression, the 
intervention group received assisted bicycle training for the legs and the arms, whereas 
the control group received usual care (no specific intervention) for 24 weeks. Boys in the 
intervention group trained 5 times per week, 15 minutes with their legs and 15 minutes 
with their arms using a mobility trainer with electric motor support . The training was 
performed at home or at school. The motor assistance was at least 7 RPM if no active 
motion was delivered. Boys were instructed to cycle at a continuous speed of approximately 
65 RPM at an exertion ranging from “a little tired” to “getting more tired”. Perceived 
exertion was assessed with the OMNI scale for perceived exertion. Boys in the control 
group received the same training after the control period. The intervention and control 
groups were followed up until 56 and 60 weeks, respectively, after study entry. The 
primary outcome measures were muscle endurance and functional abilities assessed with 
the A6MCT and MFM, respectively. Secondary outcome measures were the Pediatric 
Evaluation of Disability Inventory (PEDI), timed tests, muscle strength, range of joint 
motion, and QMUS. Adverse events during the intervention period were assessed by 
means of postal questionnaires and home visits paid by the researcher. Group differences 
between the intervention and control group were examined by an analysis of covariance 
with the primary endpoint being after 24 weeks of training/waiting list. 
 Study 2 (see chapter 7) was a non-controlled feasibility study that aimed to include 
ten wheelchair-dependent boys with DMD who had problems with reaching and lifting 
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their arms. After an eight-week period in which baseline information was obtained about 
the stability of the disease course, all boys were provided with a dynamic arm support for 
their non-dominant arm. Thereafter, they began a 24-week training program for their 
non-dominant arm. The program consisted of reaching exercises by using the dynamic 
arm support for playing a virtual reality computer game (5 days per week, 5 games per 
day) and for eating (at least twice a week). Efficacy was assessed after 12 weeks and at the 
primary endpoint after 24 weeks of training. A final follow-up assessment was performed 
12 weeks after the end of the training. Compliance and safety were assessed via a 
questionnaire completed once every two weeks and home visits by the primary 
investigator. The primary efficacy outcome was the functional ability of the upper 
extremities assessed with the Action Research Arm Test (ARAT). Secondary outcome 
measures were the MFM dimension 3 “Distal motor function”, the Nine-Hole Peg Test 
(9HPT), and the Jebsen Taylor Hand Function Test (Jebsen Test). The feasibility, safety and 
effectiveness of the DAS training program were described separately for each participant. 
The untrained dominant arm served as a within-subject reference.
 The results of the NUD study were expected to increase insight into what type of 
physical training should be recommended to boys with DMD. 
Chapter 6 describes the results of the RCT (see chapter 5) on dynamic leg and arm 
training. Thirty boys with DMD with a mean age of 10.5 years participated and were 
randomly allocated to either the intervention (n = 17) or the control group (n = 13). 
Eighteen boys were ambulant and 12 were wheelchair-dependent. Almost all the boys in 
the intervention group, except one wheelchair-dependent boy, completed the 24-week 
training program. After 24 weeks of training, the total MFM score had remained stable in 
the intervention group, whereas it had significantly decreased in the control group (group 
difference in time effect: ∆=4.9, 95%CI=2.2 to 7.6). No such training effects were found on 
the A6MCT for the legs (Δ = 5.6, 95% CI = −56.2 to 67.3), for the arms (Δ = 13.8, 95% CI = 
−60.7 to 88.3) or for the secondary outcome measures. After crossing over, eight of the 13 
boys in the control group completed the same assisted bicycle training. After the training 
period, these eight boys did not show functional decline as assessed with the MFM either. 
No serious adverse events were reported in any of the participants. It was concluded that 
an assisted bicycle training of the legs and arms is feasible and safe for both ambulant and 
wheelchair-dependent boys with DMD and that prolonged physical training delays the 
secondary functional deterioration in these children. 
In chapter 7 the results of the non-controlled feasibility study (see chapter 5) are 
presented. Eight wheelchair-dependent boys, aged 12 to 20 years, received the dynamic 
arm support . Six of these eight boys completed the entire 24-week training program. The 
other two boys discontinued training due to practical reasons. Among the six boys who 
completed the program, four had a larger decrease in ARAT score in the untrained arm 
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(differences in ARAT score ranged from -4 to -21) compared to the trained arm (differences 
in ARAT score ranged from -13 to 6) after 24 weeks of training. This indicates that the 
trained arm retained more motor function than the untrained arm in four boys. 
Comparable results were found for the secondary outcomes. Only the Jebsen Test 
revealed no notable differences between the trained and untrained arms, with the 
exception of the item in which the boys had to pick up and drop small common objects. 
After 24 weeks of training, two participants lost the ability to pick up the objects with their 
untrained arm, although they retained the ability with their trained arm. No serious 
adverse events were reported during the study period. The results indicate that wheel-
chair-dependent boys with DMD with impaired arm function can still train their arms 
using dynamic arm support to preserve motor functions. 
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General discussion
This thesis started with two main research questions: (1) “Are Quantitative Muscle 
Ultrasound (QMUS), the Assisted Six-Minute Cycling Test (A6MCT) and the KIDSCREEN-52 
valid and/or responsive outcome measures to evaluate the effectiveness of a physical 
training intervention in boys with Duchenne muscular dystrophy (DMD)?”, and (2) “Is 
assisted physical training feasible, safe and effective to delay the functional deterioration 
in ambulatory and wheelchair-dependent children with DMD”. Based on the results of the 
No Use is Disuse (NUD) study, it can be concluded that assisted physical training is feasible, 
safe and beneficial to delay the functional deterioration in boys with DMD across different 
stages of their disease. Although the QMUS, A6MCT and KIDSCREEN-52 are all outcome 
measures with good clinimetric properties, their use in the evaluation of the effectiveness 
of physical training in boys with DMD is still ambiguous and needs further investigation. 
This thesis particularly focused on assisted training, as even low-resistance training is often 
too hard to sustain for children with DMD who suffer from severe muscle weakness. To this 
end, two assisted physical training programs were developed: (1) dynamic leg and arm 
training (assisted bicycle training) for ambulant and recently wheelchair-dependent boys 
with DMD, and (2) functional training with arm support for boys with DMD who have 
already been confined to a wheelchair for several years. Together, these two training 
programs constituted the NUD study. It was hypothesized that assisted physical training 
would counteract the secondary functional decline caused by disuse. Delaying the 
functional decline in boys with DMD is important, because these boys gradually lose the 
capacity to perform activities of daily living from a young age onwards. Only very recently, 
a promising drug under investigation in a phase III clinical trial (aimed at exon skipping of 
the genetic defect) failed to demonstrate a significant functional benefit, underscoring 
the persistent need for feasible and effective symptomatic treatments. 
This general discussion first focuses on the potential underlying mechanisms of the 
observed beneficial effects of assisted physical training in the NUD study followed by 
suggestions to optimize the training. Thereafter, the pros and cons of the outcome 
measures selected to evaluate the effectiveness of assisted physical training will be 
discussed. This section is followed by issues concerning the clinical implementation of 
(assisted) physical training and related clinical assessments in the daily care of boys with 
DMD. Finally, some general conclusions will be drawn and recommendations for future 
research in this area will be provided. 
The disuse hypothesis: what do we know? 
The results of the NUD study (chapters 6 and 7) showed that assisted physical training is 
feasible and safe for ambulant and wheelchair-dependent boys with DMD. This is in 
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accordance with previous studies on sub-maximal resistance training in boys with DMD1-3 
and some of the studies on voluntary exercise training in mdx mice4-6, the most commonly 
used mouse model in DMD research. These previous studies concluded that sub-maximal 
resistance training and voluntary exercises did not cause any harm, but the studies in boys 
with DMD did not show a clear functional benefit either. The NUD study reported in 
chapter 6 is, therefore, the first training study to show a significant functional effect of low 
resistance (assisted bicycle) training in boys with DMD: it prevented a 6.3% functional 
deterioration of the total Motor Function Measure (MFM) score during 24 weeks compared 
to a control group receiving no such training.
 Although relatively small, this preventive effect occurred in a period of merely a half 
year, which warrants the speculative question what such exercise training would do when 
maintained over a lifespan compared to an inactive lifestyle. Unfortunately, investigating 
a life-long intervention is virtually impossible using a randomized controlled design. As a 
consequence, ‘formal’ evidence (based on RCTs) for the benefit of life-long, low-to-mod-
erate resistance training in boys with DMD will not readily become available. Recently, our 
group was able to show that an active lifestyle induced by either 16-weeks aerobic 
exercise training or individually tailored cognitive behavior therapy showed long-lasting 
(28 weeks) beneficial effects on fatigue and physical activity compared to no intervention 
in patients with facioscapulohumeral dystrophy (Facts-2-FSHD study).7 This result was 
obtained even though the physical exercise did not reach the level recommended by the 
American College of Sports Medicine8 in many participants of both intervention groups 
(Voet et al., submitted). Remarkably, the observed functional improvements were 
coincided by less fatty degeneration of thigh muscles assessed by magnetic resonance 
imaging (MRI) in both intervention groups compared to the control condition (Janssen et 
al., in preparation). Together, the NUD study and the Facts-2-FSHD study seem to point 
towards two interesting notions: (1) beneficial effects at both a functional and a muscular 
level can be achieved by physical training of low-to-moderate intensity in persons with 
muscular dystrophy of various age groups, and (2) the training effects may be relatively 
small over a period of approximately a half year, but might amount to a much larger size 
when observed over a substantial period of the lifespan. Since the literature is consistent 
about the safety of low-to-moderate physical exercise in patients with muscular 
dystrophy9, we propose to advise these patients a lifestyle as actively as possible, without 
overexertion (see further: recommendations). Future studies should try to compare the 
natural course of muscular dystrophies and their functional consequences between 
‘active’ and ‘inactive’ patients to provide definitive evidence for the legitimacy of this 
advice.            
 The important question remains, however, how the preservation of functional 
abilities through assisted bicycle training as observed in the NUD study can be explained. 
Since it is unlikely that the training positively influenced the lack of dystrophin, it is 
plausible that the training counteracted disuse at several physiological levels. In this thesis, 
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disuse has been defined as “a discrepancy between individual (latent) capacity and actual 
performance in daily life, as a result of a sedentary life style”. Such disuse is commonly 
present in boys with DMD contributing to a loss of functional abilities beyond the degree 
that might be predicted based on the muscle pathology itself.10 The effects of disuse due 
to a lack physical activity may, as a matter of ‘physiological law’, occur in (1) the neuro- 
muscular system, (2) the cardiovascular system, (3) the joint-ligamental-skeletal system, 
and/or (4) the central nervous system. 
Neuromuscular system
At the neuromuscular level, it is possible that the assisted bicycle training prevented part 
of the muscle atrophy secondary to disuse. Muscle atrophy is defined as a decrease in 
muscle mass leading to a loss of muscle strength and increased muscular fatigability.11-13 
Indeed, there are indications that a combination of static and dynamic resistance exercises 
can reduce muscle atrophy during unloading.14 However, the assisted bicycle training did 
not significantly affect muscle strength or quantitative muscle ultrasound (QMUS) in the 
participants of the NUD study. This lack of observed effect at the neuromuscular level 
might be explained by the fact that the training was not primarily aimed at muscle 
strengthening, but rather at reducing physical inactivity. It is still possible that the assisted 
bicycle training increased the number of oxidative muscle fibers and reduced muscle 
fatigability15, since these neuromuscular characteristics were not assessed in our study. 
Although yet to be proven, several neuromuscular mechanisms of DMD pathology may 
have been beneficially influenced by the increased level of physical activity as hypothesized 
by Markert et al. (2011)16, including (1) mechanical weakening of the sarcolemma, (2) 
inappropriate calcium influx, (3) aberrant cell signalling, (4) increased oxidative stress, and 
(5) recurrent muscle ischemia. For example, chronic exercises may temporarily enhance 
muscle regeneration and repair in the early stages of the disease.17 Another example is 
that low-intensity exercises may reduce markers of oxidative stress by increased antioxidant 
activity.18 Nevertheless, cellular influences of exercise in DMD remain speculative and 
sensitive biomarkers are needed to underscore such underlying mechanisms.16  
Cardiovascular system
Another possibility is that the assisted bicycle training prevented or reversed some of the 
disuse effects within the cardiovascular system. This possibility is, however, questionable. 
The cardiovascular response to disuse includes a decreased maximum oxygen uptake, 
which is defined as “the highest volume of oxygen that can be consumed by the body per 
time unit”.19,20 In healthy children, a physical training at ~80% of the maximum heart rate 
can improve the maximum oxygen uptake by increasing the cardiac output.20,21 In boys 
with DMD, however, the main limiting factor of a decreased maximum oxygen uptake is 
the reduced muscle mass rather than the respiratory or cardiac function.22 This notion 
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implies that boys with DMD often reach a very low peak heart rate during conventional 
ergometry22 and potentially also during training. Therefore, the intensity of the assisted 
bicycle training that the participants of the NUD study perceived as “easy” to “somewhat 
easy” may have been too low to impose serious demands on the aerobic capacity, which 
would explain the absence of a significant training effect on the Assisted Six-Minute 
Cycling Test (A6MCT), a submaximal endurance test reported in chapter 3. On the other 
hand, the low-intensity assisted bicycle training may have had peripheral effects on the 
vascular system, for instance a reduction in vascular resistance in the extremities, as occurs 
in healthy human beings.23 Such effects were not assessed in the NUD study and may be 
limited in boys with DMD, since the lack of dystrophin causes a loss of neuronal nitric 
oxide synthase (NOS) which may result in muscle ischemia, and no reactive vasodilatation, 
when the muscles are exercised.24,25
Joint-ligamental-skeletal system  
Although in the NUD study no significant effect of assisted bicycle training was found on 
the well-known flexion contractures of the hip, knee and elbow, and plantarflexion 
contracture of the ankle26, the training could be a positive addition to the current set of 
stretching techniques. A combination of stretching techniques, including active stretching, 
active-assisted stretching, passive stretching, and prolonged elongation using orthoses 
and/or standing devices may delay the development of contractures in the early stages of 
DMD.27,28 Assisted cycling would be a form of active-assisted stretching without the need 
of help from a parent or a physiotherapist. Stretching is usually recommended to be 
performed four to six days per week, which was the case for assisted bicycle training in our 
study.    
Central nervous system
Also at the level of the central nervous system, beneficial changes may have occurred as a 
result of increased physical activity, such as improved coordination of extremity muscles, 
as a result of which performance on the MFM may have been improved. Indeed, it is well 
known that functional exercises not only induce peripheral adaptations of the neuromus-
culoskeletal and cardiovascular systems, but also central (e.g. cortical) adaptations of 
sensorimotor representations and motor programs underlying improved motor 
performance.29-31 Tests to assess such underlying mechanisms were, however, not included 
in the NUD study.     
Combined effects
A last possibility is that, even though the assisted bicycle training did not lead to 
measurable training effects at the muscular, cardiovascular or joint-ligamental-skeletal 
levels, several insignificant trends towards improvement in all systems together may have 
constituted a significant effect at the performance level of the MFM as a result of assisted 
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bicycle training. Whether this calls for the development of more sensitive outcome 
measures directed at each individual system or whether this should be regarded as a plea 
for functional (composite) outcome measures requiring the use of multiple systems can 
be debated. In the case of clinical benefit, researchers will most likely emphasize the 
relevance of the identification of underlying determinants, whereas clinicians may be 
satisfied with improved functional outcome in its own right.   
Optimizing physical training: ‘one size fits all’ or a personalized approach? 
Although the training intensity of both the assisted bicycle training (chapters 6 and 8) and 
the functional arm training with dynamic arm support (chapter 7) were individually 
determined, the frequency and type of training were the same for each participant. This 
standardized approach is thought to be essential to evaluate the effectiveness of an 
intervention in a clinical trial, but it raises the question whether a more personalized 
approach should be used when implementing training programs in daily care, since the 
response to a certain physical training may differ per individual. A personalized approach 
means that the intervention (training frequency, intensity and type) is tailored to the 
individual capacities, which is the opposite of the ‘one-size-fits-all’ principle.32,33
  
Frequency of training
The boys (chapters 6 and 7) who participated in the assisted physical training programs 
were instructed to train five times per week. This high training frequency was chosen to 
achieve as much increase in physical activity as possible to prevent or reverse disuse. 
Indeed, the World Health Organization (WHO) recommends sixty minutes of moder-
ate-to-vigorous daily physical activity to maintain well-loadable musculoskeletal tissues in 
healthy children.34 Taken into account that patients with a neuromuscular disorder are 
often sedentary, suffering from poor physical fitness, it is questionable whether training 
less than five days per week could be meaningful. It is, nevertheless, possible that there are 
boys with DMD who have already adopted a physically active lifestyle, which would 
reduce the need to participate in a training program for five times a week. Training less 
frequently (e.g. three times a week) might be enough for them. Still, the assisted bicycle 
training was beneficial for 24 of the 30 participants for whom the training was additional 
to their habitual sports activities such as swimming (n=15) and wheelchair-hockey (n=8) 
in which they participated once or twice a week.
The working mechanism by which assisted physical training delays the functional 
deterioration in boys with DMD is still unclear. Insight in underlying mechanisms may 
help to develop and improve (new) training interventions.
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Intensity of training
The training intensity of the assisted physical training programs was low-to-moderate as 
determined with the OMNI scale for perceived exertion.35 A low-to-moderate training 
intensity was chosen, because of the positive effects of voluntary low-intensity physical 
training on fatigue resistance in mdx mice. Although a low-to-moderate intensity may be 
sufficient for children who are in different stages of DMD, a higher training load may be 
needed for the young ambulant boys than for the older wheelchair-dependent boys. Yet, 
caution is warranted to prevent exhausting high-resistance exercises that may increase 
the mechanical stress on the muscle fibers and may, therefore, negatively influence the 
progression of DMD.36-38 Although in the NUD study the OMNI scale for perceived exertion 
was used to determine the training intensity, it would be worthwhile to search for more 
objective tools. Hearth rate was not used to establish the training intensity in the assisted 
bicycle training, because it was considered to be impossible to validly determine the 
maximum heart rate in boys with DMD due to reasons explained above (see cardiovascular 
system). The results of chapter 3 showed, however, that boys with DMD can achieve 
comparable maximum heart rates as healthy boys during sub-maximal endurance tests, 
but these results were achieved during the study and the study protocol has not been 
changed during the study. 
Type of training
Although two types of assisted physical training were investigated in the NUD study, 
other types of (assisted) physical training such as cycling outdoors on an electric bicycle 
should be considered. It is important that these activities are joyful, besides effective. This 
point was underscored by all eight boys who played the virtual reality game as part of 
their arm training (chapter 7). They did not like the game anymore after 24 weeks of 
training which resulted in non-adherence. Conversely, a physical training that is meaningful 
and pleasurable will enhance compliance. This is important since boys with DMD are to be 
recommended to implement physical training into their daily lives from a young age 
onwards. The high level of adherence in the assisted bicycle training study confirms that 
good compliance is possible. It is also indicative of the notion that boys with DMD are 
willing to play an active role in their disease management. The assisted-physical-training 
facilities for wheelchair-dependent boys should be extended, especially with a growing 
population of older patients with DMD having upper extremity impairments. One could 
think of three dimensional arm training while using a dynamic arm support. For example, 
boys can play standard virtual-reality computer games or sports activities such as table 
tennis while using a mechanical support that assists the arm through the entire range of 
motion. Also power-assisted manual wheelchairs might be considered as training devices. 
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Clinical outcome measures: poor results or poor responsiveness?
The selection of outcome measures for studies in patients with DMD receives a lot of 
attention in literature39-42, in particular with regard to several ongoing and planned efficacy 
studies on pharmacological treatments. Outcome measures should be responsive to 
measure small but relevant changes in disease progression that are related to clinical 
milestones such as the loss of walking ability. Moreover, outcome measures should be 
appropriate for various stages of DMD. From this point of view, composite scales of motor 
functioning reflecting the capacity and performance of several activities of daily living are 
thought to be useful. This is why the primary outcome measures in both sub-studies of 
the NUD study were composite scales of motor functioning: the MFM43 and the Action 
Research Arm Test (ARAT).44-45 
The MFM was the only outcome measure that showed a significant effect of assisted 
bicycle training in the NUD study. The MFM is a clinical test that assesses (1) standing 
positions and transfers as well as (2) axial and proximal motor functions and (3) distal 
motor functions, of the arms and legs in ambulant and wheelchair-dependent patients 
with a neuromuscular disorder.43 Although the MFM was sensitive enough to measure 
training-induced group differences, a disadvantage of the MFM is that it is a generic test.39 
The MFM has not been specifically designed for patients with DMD, which is reflected in, 
for example, the limited number of items on upper-arm functioning. Only three items 
measure activities needing antigravity strength in the shoulder: touching a bal, moving 
the hands to the head, and reaching for a pencil. This can be considered a limitation with 
regard to a population in which proximal arm functions are more affected than distal arm 
functions.46 It might be that composite scales that are more specifically designed for DMD, 
such as the Performance of the Upper Limb (PUL)47 and the North Start Ambulatory 
Assessment (NSAA)48, would have been (even) more responsive to measure changes in 
motor functioning over time. However, the participants in the NUD study were both 
ambulant and wheelchair-dependent and they trained their legs as well as their arms. 
Thus, neither the PUL nor the NSAA would have been an appropriate primary outcome. 
The current advantage of the MFM is its applicability to assess all main domains of motor 
functioning in both ambulant and wheelchair-dependent boys. 
None of the secondary outcome measures showed a significant difference between the 
intervention and control group after 24 weeks of assisted bicycle training. As described 
above, this could be explained either by an absence of training effects on the secondary 
Further research is needed to develop specific guidelines including frequency, intensity, 
and type of physical training in boys with DMD.
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outcomes or by a limitation of the outcome measures themselves. For instance, echo 
intensity as assessed with QMUS showed a good sensitivity to time effects during a 1-year 
follow-up (chapter 2), but did not show a significant training-related group difference 
(chapter 6). This could reflect that there was indeed no training effect on the quality of the 
muscle tissue, but it is also possible that the follow-up of 24 weeks was too short to 
measure significant change. In addition, assessing more ‘DMD-specific’ muscles, such as 
the deltoid muscle, might have increased sensitivity of QMUS. It is also possible that MRI 
would have been a more sensitive alternative since MRI can measure progression of fat 
replacements already after nine months in boys with DMD.49,50 MRI has, however, the 
disadvantages of being much more expensive and requiring sedation in young children. 
In any case, for future studies, muscle imaging is expected to be a relevant supplement to 
the clinical tests in order to objectify structural muscle changes in boys with DMD, without 
influence of cooperation or fatigue. 
The training-related preservations of motor functions in the NUD study were also not 
paralleled by significant preservations in physical endurance as assessed with the A6MCT. 
This can probably be explained by the relatively low training intensity of the assisted 
bicycle training, limiting the impact on the aerobic capacity. It could also be related to a 
limited reproducibility of the A6MCT in boys with DMD. Although the A6MCT showed 
good reproducibility in healthy boys (chapter 3), it might be that its reproducibility in boys 
with DMD is lower, because they are less used to bicycle than healthy boys. This should be 
further studied. Furthermore, the performance on the A6MCT is influenced by motivation 
and cooperation, which can be tough for young boys. Comparable results have been 
found in clinical trials using the Six-Minute Walk Test (6MWT) as a primary outcome. 
Although the 6MWT has shown good psychometric properties51,52, it has a large standard 
deviation and just very recently a clinical trial on exon-skipping in boys with DMD failed to 
demonstrate that the drug drisapersen could significantly improve the distance walked. 
The need to assess Health Related Quality of Life (HRQoL), an individual’s perception of his 
own health, in clinical trials is widely recognized.53,54 The NUD study included the 
KIDSCREEN-52 that showed that the HRQoL of boys with DMD was similar to age- and 
gender-matched healthy controls (chapter 4). In accordance with previous studies, only 
the dimension “physical well being” was lower in boys with DMD.55-57 The results of chapter 
4 are also in line with the finding that HRQoL remains constant over time and, thus, is not 
related to disease severity.55 Although these findings are positive and indicate that boys 
with DMD keep being satisfied with their lives, they are also counterintuitive in a population 
that gradually loses the ability to participate in several physical and social activities.54 It 
may, therefore, be that the questionnaires used to assess HRQoL in boys with DMD, 
including the KIDSCREEN-52 and the Pediatric Quality of Life Inventory (PedsQL), are not 
sensitive enough to measure changes over time. An explanation for the possibly limited 
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sensitivity of the KIDSCREEN-52 and PedsQL may be that these questionnaires assess to 
what extend a child has had a problem had with a certain activity during the past month 
rather than asking for a more absolute measure of difficulty of the activity.52 A recently 
published study showed that the Pediatric Society of North America (POSNA) Pediatric 
Outcomes Data Collection Instrument (PODCI), a self-report or proxy-measure of 
functional abilities, may be a better questionnaire for use in clinical trials on DMD, since it 
is able to detect one-year changes that are more related to the 6MWT than the PedsQL.52 
Implementation of physical training and clinical assessment in daily 
practice: what can be recommended? 
There has been a long-lasting debate about the recommendation of physical training to 
boys with DMD because of the putative fragility of the muscle fibers. This is the reason 
that many boys with DMD, as well as their families and therapists, may be worried that 
physical training might accelerate disease progression. There is, however, besides the NUD 
study (chapter 6), increasing evidence that low-to-moderate physical training in persons 
with neuromuscular disease is safe and beneficial to preserve motor functions, reduce 
fatigue and improve physical activity (Voet et al., submitted).9 The implementation of 
(assisted) physical training, as part of an active life-style, should therefore be promoted in 
boys with DMD to prevent disuse and other complication of deconditioning.28 Physio-
therapists and rehabilitation physicians should inform the boys and parents about the 
do’s and don’ts of physical training. Although not proven in clinical studies in humans, 
based on the pathophysiology of DMD, the results of training studies in mdx mice, and on 
clinical experience, it can be recommended to refrain from (eccentric) exercises with a 
high mechanical load.28,58-62 Furthermore, physiotherapists should help the boys to find an 
appropriate type and intensity of (assisted) physical training that is also pleasant and 
motivating. It is the responsibility of the boys and parents to actually become and sustain 
being physically active, taking into account the individual physical limitations.  
Specific (inter)national guidelines for physical therapy and physical training in DMD do not 
exist63, which makes it hard to know what physiotherapists already do in their taking care 
of boys with DMD. Do they already recommend them to become physically active? More 
particularly, is (assisted) physical training part of their treatment advice? The implementation 
of (assisted) physical training in the daily routine of boys with DMD may actually reduce 
the need for physiotherapy. In the NUD study, the participants visited a physiotherapist 
The ideal set of outcome measures to evaluate the effectiveness of physical training or 
drug treatment in boys with DMD is still a matter of debate, since the quality of many 
clinical outcomes is uncertain. There is an urgent need for a core set of valid, reliable and 
responsive outcome measures in clinical DMD research.
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once or twice a week. Yet, frequent, life-long, visits to the physiotherapist are burdensome 
and expensive or may result in ‘therapy fatigue’ and non-compliance. The implementation 
of routine (assisted) physical training may, therefore, enhance the responsibility of the 
boys and their parents for disease management and (partly) shift the role of the physio-
therapist from ‘traditional therapist’ towards ‘coach’ and ‘assessor’.
The role of the physiotherapist as a coach and assessor is important to monitor disease 
progression and allow for well-timed interventions and application of facilities and 
medical devices by appropriate referral to an occupational therapist and/or rehabilitation 
physician. Furthermore, the physiotherapist can evaluate the effects of interventions over 
a prolonged period. Table 1 gives an overview of the outcome measures that can be used 
in a regular community-based physiotherapy practice to monitor boys with DMD at 
different disease stages. For additional assessments, such as muscle imaging and 
spirometry, patients should be referred to specialized DMD centres. If possible, routine 
clinical evaluations should take place every 6 months. Because these evaluations will take 
on average two hours (including breaks), they could be spread out over two appointments. 
An alternative is to conduct a complete assessment once a year and a selection of the 
assessments every six months. Such a selection might consist of a motor function scale 
and timed functional tests, which will reduce the administration time to approximately 
30-40 minutes. Because not all the recommended tests and questionnaires are freely 
available on the internet, their implementation in daily practice may be hampered. 
Regular (assisted) physical training with a low-to-moderate intensity should be recommended 
to boys with DMD in order to counteract the negative effects of disuse. It seems advisable 
to avoid (eccentric) exercises with a high mechanical load.
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Table 1   Recommended outcome measures for the different stages in the course  
of DMD 
Domain Outcome measures for ambulant 
boys
Outcome measures for 
wheelchair-dependent boys
Muscle strength Quantitative muscle testing of the 
lower (quadriceps and hamstring 
muscles and ankle dorsiflexors) and 
upper extremity (biceps, triceps 
and deltoid muscle), or use manual 
muscle testing if the muscle is not 
able to move against gravity  
(MRC <3)
Quantitative muscle testing of the 
upper extremity (biceps, triceps and 
deltoid muscle, and grip strength), 
or use manual muscle testing if the 
muscle is not able to move against 
gravity (MRC <3)
Range of motion Goniometry of the lower (hip 
extension, knee extension and ankle 
dorsiflexion) and upper extremity 
(elbow extension)
Goniometry of the upper extremity 
(elbow extension, supination and 
pronation, wrist extension and 
finger extension) 
Endurance 6MWT A6MCT 
Motor function Vignos lower extremity scale and 
Brooke upper extremity scale 
Composite motor function scales 
for the lower, and preferably also 
the upper, extremity (MFM, or NSAA 
and PUL)
Timed functional tests including the 
time to rise from the floor, the time 
to walk 10 meter, and the time to 
climb 4 standard stairs
Brooke upper extremity scale, and 
Vignos lower extremity scale if the 
boy is still able to stand for a transfer 
Composite motor function scales 
for the upper extremity (PUL), and 
also the trunk motor functions in 
recently wheelchair-dependent 
boys (MFM)
Activities of daily 
living
Mobility, self-care and social 
functioning (PEDI, or potentially the 
recently developed PROM)
Self-care and social functioning 
(PEDI, ABILHAND, and/or potentially 
the recently developed PROM)
Participation CAPE from 6 years onwards CAPE
Health Related 
Quality of Life 
PedsQL Neuromuscular module, or 
PODCI
PedsQL Neuromuscular module, or 
PODCI
MRC, Medical Research Council; 6MWT, Six-Minute Walk test; A6MCT, Assisted Six-Minute Cycling Test; MFM, 
Motor Function Measure; NSAA, North Star Ambulatory Assessment; PUL, Performance of the Upper Limb; 
PEDI, Pediatric Evaluation of Disability Inventory; PROM, Patient Reported Outcome Measure; CAPE, Children’s 
Assessment of Participation and Enjoyment; PODCI, Pediatric Outcomes Data Collection Instrument
(Table based on Bushby et al. (2010), and adjusted.)
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Conclusions and future research 
The NUD study comprises the first randomized controlled trial (RCT) on assisted physical 
training in boys with DMD. The results have filled part of the current gap of knowledge 
about the safety and effectiveness of physical training in DMD. In addition, it has increased 
insight into the applicability of several clinical measures to evaluate the effectiveness of 
treatments.
Further research is required to gain insight in the working mechanisms underlying the 
training-induced preservation of functional abilities. Further research is also recommended 
to increase insight in which type of training should be recommended to boys with DMD: 
what exactly should they do at which stage of the disease? For this purpose, an upper 
limb training program with dynamic arm support is currently being developed for boys 
with DMD who experience difficulties in lifting their arms. In this new RCT, the clinical 
evaluator will be blinded to treatment allocation. Furthermore, strict inclusion criteria will 
be applied and stratified group randomization (able to lift the arms above the head vs. 
unable to lift the arms above head but able to bring the hands to the mouth) will be used 
to reduce the phenotypic variability in each group. 
Future clinical trials on physical training should use responsive outcome measures that are 
meaningful to the boys and their parents. With an increasing population of older wheel-
chair-dependent boys with DMD, there is a need to develop and validate a tool that can 
be used across the different disease stages and assess the specific abilities affected in boys 
with DMD. Recently, the Performance of the Upper Limb (PUL) module for DMD has been 
developed47, which covers the whole spectrum of upper limb disabilities in these boys. 
Further research is needed on the responsiveness of the PUL. In addition, it deserves 
further investigation whether the echo intensity of ‘DMD-specific’ muscles, including the 
deltoid muscle, is more responsive to disease progression and effects of interventions. The 
A6MCT, a test of physical endurance, should be further standardized and its validity in 
older boys with DMD should be established. Next to the A6MCT, accelerometers can be 
used to gain insight into the level of daily physical activity in DMD.64 Above all, outcome 
measures should be selected carefully and be restricted to relevant clinical characteristics, 
since they are often time consuming and confronting for the boys as well as their parents. 
Future clinical trials should ideally use stratified randomization to allocate participants to 
either the intervention or control group according to DMD phenotype: the ‘common’, 
‘mild’ or ‘severe’ form.65 This is, however, difficult with a relatively low number of 
approximately 500 patients in the Netherlands. Other study designs than RCTs, such as a 
comparison of an experimental group to a large and representative natural cohort, should 
therefore be considered. Also large prospective cohort studies on different treatment 
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regiments could be valuable, especially in a time that multiple clinical trials are being 
conducted and patients and their families may be overwhelmed with research. 
Lastly, knowledge about the relationship between the level of dystrophin and functional 
abilities is needed by conducting studies that aim to (partially) restore the level of 
dystrophin in the muscles. A recent study among adults with Becker muscular dystrophy 
showed that the level of dystrophin is an important determinant of disease severity, 
however only if the level of dystrophin is below 10%.66 There is still a lack of knowledge of 
the relationship between the level of dystrophin and the ability to exercise. A case-study 
of a girl with DMD (see Appendix) gives some insight into this matter by showing that 
assisted physical training is feasible and probably beneficial also for a girl who expresses a 
low level of dystrophin. It seems also relevant to combine drug treatment with physical 
training in order to investigate whether (partial) restoration of dystrophin levels can 
optimize training effects.
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Abstract
In this case study a 9-year old ambulatory girl with Duchenne muscular dystrophy  (DMD) 
due to a mosaic translocation mutation participated in dynamic training. Since the role of 
exercise is unclear in both boys and girls with DMD, a recently developed assisted bicycle 
training regimen was evaluated for its feasibility and effectiveness in this girl. The girl 
trained at home, first 15 minutes with her legs and then 15 minutes with her arms, 5 times 
a week, for 24 weeks. This case study showed that the training was feasible and safe. 
Additionally, we found that no physical deterioration occurred during the training period: 
the Motor Function Measure and the Assisted Six-Minute Cycling Test results remained 
stable. Slight improvements in quantitative muscle ultrasound intensity were found, 
indicating less fatty infiltration in the muscles. These results suggest that physical training 
could beneficial in females with DMD who express low levels of dystrophin. 
Key words: Duchenne muscular dystrophy, female, Becker muscular dystrophy, exercise, 
assisted bicycle training
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Introduction
A deficit of the protein dystrophin causes dystrophinopathies like Duchenne muscular 
dystrophy (DMD) and Becker muscular dystrophy (BMD). Absence or near-absence (<3%) 
of dystrophin results in progressive muscle wasting and eventually loss of function. 
Dystrophin is encoded by the DMD gene located on the short arm of the X-chromosome. 
The pattern of inheritance of dystrophinopathies is X-linked recessive and, therefore, 
primarily boys are affected. Female carriers who inherit mutations in the DMD gene are 
generally asymptomatic1, because they usually express sufficient amounts of dystrophin 
(~50%) from one X-chromosome to prevent symptoms.2 However, some girls develop 
clinical signs similar to DMD, because of several genetic mechanisms that reduce residual 
dystrophin expression (e.g. skewed X-inactivation3, chromosomal rearrangements4 or 
additional syndromes like Turner’s syndrome5). 
There is no curative treatment for DMD, but improved health care has increased life 
expectancy in the Western world.6 Muscle training regimens associated with high levels of 
mechanical stress may be harmful in the setting of dystophin deficiency, whereas 
low-stress exercise may produce beneficial effects on myofiber contractility and energetic 
defiency.7 It is hypothesized that non-strenuous exercise can potentially be used to avoid 
disuse atrophy and other secondary complications of physical inactivity.8 Health care 
guidelines, therefore, recommend participation in regular sub-maximum functional 
activities and avoidance of exhausting high-resistance strength and eccentric training,8 
but this is based on limited evidence. Only five randomized controlled trials (RCT’s) have 
been performed in adults with muscle diseases, from which no general training advices 
can be given.9 Only one case report on an adult symptomatic DMD carrier exists showing 
that resistance exercise results in increased muscle strength and a decreased number of 
falls.10  
In this case report, we describe a girl with DMD who received assisted bicycle training for 
her legs and arms. A recently finished RCT concluded that this training maintained the 
functional abilities in ambulant and wheelchair-dependent boys with DMD during 24 
weeks of training (manuscript accepted for publication in Neurorehabilitation and Neural 
Repair). We assessed whether this training was also safe and beneficial in this girl with 
DMD. The results of this case report provide some insight into the influence of a certain 
level of dystrophin on the effects of exercise. 
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Case Summary
A 9-year old ambulatory girl with DMD participated in assisted bicycle training. The girl 
had muscle weakness, and used a buggy for long distances. She participated in yoga and 
swimming and had hydrotherapy, all for one hour per week.
 The first signs of delayed motor skill development were noticed by her parents at the 
age of 11 months as she did not shift position at night and could not move her head from 
left to right. A muscle disease was suspected due to her enlarged calves and Gower’s sign. 
At the age of 2.5 years, her creatine kinase level was above 28.000 U/L (normal < 200 U/L). 
At the age of 4 years the diagnosis DMD was established by a de novo translocation 
between the short arm of the X-chromosome (in frame the DMD gene) and the long arm 
of chromosome 13 [t(X; 13)(p21;q22)] and a selective inactivation of the normal 
X-chromosome A muscle biopsy of the quadriceps muscle exhibited 26.3% (76 out of 267 
fibers) dystrophin-positive fibers distributed in a mosaic pattern. She received the same 
rehabilitative care as DMD boys and was put on an oral intermittent (ten days on, ten days 
off) prednisolone regimen (dose 0.75 mg/kg) from the age of 7 years onwards, which was 
continued during the training period.  
Assisted bicycle training
The  girl performed training as a part of the No Use is Disuse (NUD) study, which was 
approved by our regional Medical Ethics Committee. Parents provided informed consent. 
An extensive description of the 24 weeks assisted bicycle training protocol is freely 
available online.11 The girl trained at home, 15 minutes with her legs followed by her arms, 
5 times a week at an assistance level passive mode 1 (i.e. no-load, speed 7 revolutions per 
minute). The training intensity was low-to-moderate as established with the OMNI scale of 
perceived exertion (max OMNI score=6). 
Outcome parameters 
Figure 1 shows the clinical assessments (T0-T6) throughout the training period. Assessments 
were performed at the Department of Rehabilitation (T0,T2,T4,T6) and at home (other 
assessments). The primary endpoint was after 24 weeks of training (T4). The primary 
outcomes were the Motor Function Measure (MFM) and the Assisted Six-Minute Cycling 
Test (A6MCT). Secondary outcomes were the Vignos and Brooke scale for lower and upper 
extremity functioning, timed tests (time to rise from a floor, to rise from a chair, to climb 3 
stairs and to walk 10 meters), the Medical Research Scale (MRC) for muscle strength, and 
quantitative muscle ultrasound (QMUS) to determine the echo intensity (EI) of the biceps 
brachii, the forearm flexors, the rectus femoris and the tibialis anterior. EIs are presented as 
z-scores, i.e. the number of SD from the mean of the reference group. In boys with DMD, 
EIs increase with age and as the disease severity worsens due to muscle fibrosis. 
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Performance and disease progression
The girl completed the entire training program while no adverse effects were recorded. 
During each training session she achieved on average 1068 (SD±43.3) revolutions with the 
legs and 992 revolutions (SD±82.8) with the arms. Her median OMNI score was 1 (range 
0-3) for the legs, 3.5 (range 2-9) for the arms, and 0.5 (range 0-6) globally. 
Table 1 shows the study outcomes. With respect to the primary study outcomes, the MFM 
remained stable over time (mean=84.1, SD±1.3, range 82-86), although a small drop was 
observed at T3 due to a decrease in the score of dimension 1 (standing and transfers). The 
A6MCT showed no major changes in the number of revolutions achieved with the legs 
(mean=576, SD±28) or arms (mean=501, SD±49) (revolution reference values for aged 
matched DMD boys: legs mean=405, SD±152 and arms mean=370, SD±120; revolution 
reference values for healthy aged matched boys: legs mean=843, SD±82 and arms 
mean=778, SD±111).12  
None of the secondary outcomes showed a regression either during training or follow-up, 
except the time it took to rise from the floor. During the latter task, the girl showed a wide 
variability in both quality (range 3-5, i.e. without hand-support to bilateral hand-support) 
and time (range 3.5-4.9 seconds), particularly at T3. At start of the training (T2), the 
ultrasound muscle EI was high in all four muscles (EI > 47, z-scores ranged from 2.3 to 5.9) 
indicating muscle fibrosis and fatty infiltration. After 24 weeks of training (T4) all EIs 
decreased with 0.1 to 1.1 z-scores (z-scores ranged from 1.2 to 3.7), with the exception of 
the rectus femoris (z-score at T2=5.9, and at T4=6.1). Only the rectus femoris and tibialis 
anterior showed abnormal EIs after 24 weeks of training (EI > 62, z-scores >2). 
Figure 1  Clinical assessments throughout the study.  
Dark grey area: training period; T2: one day before the start of the training period; T4: one day after 
the end of the training period.
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Table 1   Training results on the primary and secondary outcomes 
TN: measurement
T0 T1 T2 T3 T4 T5 T6
General data
Measurement moment 
(in weeks)
0 4 8 20 32 36 56
Corticosteroids
 Number of days on/off
On
10
Off
5
Off
2
Off
4
On
8
On 
10
Off
6
Primary  outcomes
MFM score (total 96) (%) 84 
(87.5)
84 
(87.5)
85 
(88.5)
82 
(85.4)
85 
(88.5)
86 
(89.6)
83 
(86.4)
MFM_D1 (total 39) (%) 30 
(76.9)
29 
(74.4)
29 
(74.4)
25 
(64.1)
28 
(71.8)
30 
(76.9)
26 
(66.7)
MFM_D2 (total 36) (%) 35 
(97.2)
35 
(97.2)
36 
(100)
36 
(100)
36 
(100)
36 
(100)
36 
(100)
MFM_D3 (total 21) (%) 19 
(90.4)
20 
(95.2)
20 
(95.2)
21 
(100)
21 
(100)
20 
(100)
21 
(100)
A6MCT for the arms 
(Revolutions)
529 - 442 - 552 - 482
A6MCT for the legs 
(Revolutions)
606 - 594 - 547 - 557
Secondary outcomes
Vignos (range 1-10) 2 2 2 2 2 2 2
Brooke (range 1-6) 1 1 1 1 1 1 1
Timed tests
Gait
Quality (range 1-7)
Time (seconds)
3
4.9
-
-
3
5.3
-
-
3
5.3
-
-
3
5.8
Stairs
Quality (range 1-7)
Time (seconds)
1
2.0
-
-
1
3.6
-
-
1
2.6
-
-
1
2.7
Gowers
Quality (range 1-7)
Time (seconds)
4
4.6
5
4.8
3
3.5
5
4.9
3
4.1
5
3.6
5
4.3
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Discussion
The girl with DMD described in this case study showed an overall stable performance in 
outcome parameters, indicating a stability of the functional abilities and endurance 
during 24 weeks of assisted bicycle training. Only the MFM and the time to rise from the 
floor showed a temporary regression after 12 weeks of training which can be explained by 
either the concurrent corticosteroid free period in contrast to baseline, or natural 
Table 1   Continued 
TN: measurement
T0 T1 T2 T3 T4 T5 T6
Secondary outcomes
Chair 
Quality (range 1-6)
Time (seconds)
1
0.6
-
-
2
1.0
2
1.5
2
1.6
-
-
2
1.6
Nine-hole Peg Test 
(seconds)
19.1 20.0 19.4 17.2 17.5 17.8 16.4
MRC scale (range 0-5)
Gluteus left 2 2 3 3 3 3 3
Gluteus right 2 3 3 3 3 3 3
Quadriceps left 5 4 5 5 5 5 5
Quadriceps right 5 4 5 5 5 5 4
Tibialis anterior left 4 4 4 4 5 5 5
Tibialis anterior right 4 4 4 4 5 5 4
Deltoid left 4 4 4 4 4 4 4
Deltoid right 4 4 4 4 4 4 4
Triceps left 4 4 4 4 4 4 4
Triceps right 4 4 4 4 4 4 4
QMUS (mean EI/ z-score)
Biceps brachii, left 47.8/ 2.3 39.2/ 1.2
Forearmflexors, right 48.1/ 2.5 45.4/ 2.0
Rectus femoris, right 
Tibialis anterior, left
64.7/ 5.9
64.1/ 3.8
66.9/ 6.1
62.9/ 3.7
T0 to T2 represent the multiple baseline measurements. The girl started training at T2 and continued training 
until T4. T4 and T5 represent follow-up assessments.
 Abbreviations: MFM: Motor Function Measure; D: domain; A6MCT: Assisted Six-Minute Cycling Test;  Gait: walk 
10 meters; Stairs: climb three stairs; Gowers: rise from the floor; Chair: rise from a chair; MRC scale: Medical 
Research Council scale; QMUS: Quantitative muscle ultrasound; EI: echo intensity
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fluctuations. Notably, the current case study indicates that dynamic training is feasible and 
safe in girls with DMD. This is in accordance with the results of 30 boys with DMD who 
participated in the same assisted bicycle training: the training was feasible and safe for 
both ambulatory and wheelchair-dependent boys, and the training delayed the functional 
deterioration.13
The stable functional abilities in the girl described in this case study could also be 
explained by a BMD-like instead of a DMD-like disease progression. We found 26% 
dystrophin positive fibers in the quadriceps muscle, because not all her cells contained 
the translocation -. Of course with a mosaic pattern it is possible that dystrophin levels in 
other muscles are different, which may explain why this girl presents like a DMD instead of 
a BMD. A longer baseline, and follow-up period with multiple assessments would have 
provide information about the natural progression of her disease.
It remains to be elucidated whether improvements in functional abilities and endurance 
could be achieved with a higher training intensity, a low resistance training or a longer 
training period (i.e. more than 24 weeks). Nevertheless, the number of revolutions and the 
achieved scores on the OMNI scale indicated that this training intensity was preferred. 
Only for the legs the OMNI score was less than 3, so the training intensity could probably 
be higher.  
Next to the stable functional abilities, the girl showed a slight improvement in muscle 
composition at the end of the training period, i.e. she had less fatty infiltration compared 
to baseline. This is in accordance with findings from mdx mice which also showed train-
ing-induced improvements in pathology.14 In addition, a study in a mouse model 
expressing varying low dystrophin levels showed that mice expressing >20% dystrophin 
are protected against exercise-induced damage.15 In our case, the girl had a dystrophin 
level of >20%, and might be protected from exercise-induced damage. 
This case report suggests that assisted bicycle training is a suitable training for patients 
with DMD because it is feasible and safe. Moreover, assisted bicycle training might 
potentially improve muscle function, because the girl in this case report showed a stable 
motor function as well as an improvement in muscle composition during the intervention 
period. In addition, the relation between dystrophin expression and exercise may be well 
studied in girls with DMD expressing low levels of dystrophin. 
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Duchenne spierdystrofie (DMD) is een is een erfelijke spierziekte die voorkomt bij 
gemiddeld 1/5000 jongens. De afwezigheid van dystrofine zorgt voor spierafbraak en 
verlies van spierkracht en functionele mogelijkheden. Jongens met DMD raken rond de 
leeftijd van 10 jaar rolstoelafhankelijk en kunnen daarna al snel de armen  niet meer 
optillen om bijvoorbeeld te eten. Aangezien er op dit moment nog geen genezing 
mogelijk is, is een belangrijk behandeldoel het vertragen van de functionele achteruitgang. 
De functionele achteruitgang komt primair door de spierziekte zelf, maar kan worden 
versneld door ‘disuse’. Onder disuse wordt hier verstaan de discrepantie tussen dat wat 
jongens kunnen (hun capaciteit) en dat wat ze doen (hun activiteit). Met andere woorden, 
de moeite die het kost om te bewegen leidt tot minder bewegen c.q. lichamelijke 
inactiviteit die weer leidt tot secundaire lichamelijke achteruitgang.
De huidige internationale richtlijnen raden jongens met DMD lichamelijke activiteiten 
met een milde intensiteit aan om de secundaire lichamelijke achteruitgang tegen te gaan. 
Deze richtlijnen zijn echter weinig specifiek en zijn gebaseerd op een beperkt aantal 
onderzoeken. De gangbare trainingsprincipes maken doorgaans gebruik van weerstand 
en kunnen te zwaar zijn voor jongens met DMD. Uitputting van de spieren tijdens training 
wordt afgeraden, omdat dit de spierafbraak kan versnellen bij DMD. Een training waarbij 
ondersteuning wordt geboden, bijvoorbeeld in de vorm van een fiets met traponder-
steuning, kan hiervoor uitkomst bieden. Het doel van de onderzoeken die worden 
beschreven in dit proefschrift was het ontwikkelen van een haalbare training met 
mechanische ondersteuning en het evalueren van de effectiviteit hiervan bij jongens in 
diverse stadia van DMD. 
Introductie
Hoofdstuk 1 is de algemene introductie en beschrijft kort de pathofysiologie van DMD, 
het beloop van de ziekte, en de behandeling (inclusief de fysiotherapie). Het beschrijft het 
’disuse’ fenomeen, de rol van training, en de noodzaak voor nieuwe gevalideerde 
uitkomstmaten die het beloop van de spierziekte kunnen meten. Vervolgens worden het 
doel van het proefschrift en de twee belangrijkste vraagstellingen geformuleerd: 
1)  Zijn kwantitatieve spierechografie, de zes-minuten fietstest met mechanische 
ondersteuning en de KIDSCREEN-52 vragenlijst valide en sensitieve meetinstrumenten 
om de effectiviteit van fysieke training bij jongens met DMD te evalueren? 
2)  Is een training met mechanische ondersteuning haalbaar, veilig en effectief om de 
functionele achteruitgang te vertragen bij ambulante (lopende) en rolstoelafhankelijke 
jongens met DMD? 
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De introductie eindigt met een beschrijving van de opbouw van dit proefschrift. De kern 
van dit proefschrift bestaat uit twee delen. Deel 1 beschrijft de ontwikkeling en validatie 
van drie meetinstrumenten die zijn gebruikt om de effectiviteit van fysieke training met 
mechanische ondersteuning te evalueren, namelijk: kwantitatieve echografie van spieren 
(spierechografie) om spierveranderingen te meten (hoofdstuk 2), de zes-minuten 
fietstest met mechanische ondersteuning om het uithoudingsvermogen te meten 
(hoofdstuk 3), en de KIDSCREEN-52 vragenlijst om de gezondheidsgerelateerde kwaliteit 
van leven te meten (hoofdstuk 4). In deel 2 worden het protocol (hoofdstuk 5) en de 
resultaten (hoofdstuk 6 en 7) van twee trainingsprogramma’s beschreven die samen de 
“No Use is Disuse (NUD) study” vormen. De bevindingen worden samengevat en 
bediscussieerd in hoofdstuk 8. 
Deel 1 Meetinstrumenten voor Duchenne spierdystrofie
Het doel van hoofdstuk 2 was het onderzoeken of kwantitatieve spierechografie een 
geschikt meetinstrument is voor interventiestudies bij DMD. Met kwantitatieve spierecho-
grafie kunnen de echo-intensiteit, ofwel de grijswaarde, en spierdikte worden gemeten. 
De verlittekening en vervetting van de spieren is bij jongens met DMD te zien als een 
verhoogde echo-intensiteit. Dit betekent dat de spieren van jongens met DMD met spie-
rechografie witter zijn dan van gezonde jongens. In dit onderzoek werd gekeken of het 
met kwantitatieve spierechografie mogelijk is veranderingen te meten naarmate jongens 
ouder worden. Er is ook gekeken of deze veranderingen gerelateerd zijn aan veranderingen 
in ziekte-ernst zoals gemeten met verschillende fysiotherapeutische tests (de Vignos en 
Brook schaal, spierkracht, de Childhood Myositis Assessment Scale, en de Hammersmith 
Motor Ability Scale). Achttien jongens in de leeftijd van 3.7 tot 15.1 jaar (15 lopers, 3 rolstoe-
lafhankelijk) kregen elk twee tot vijf keer een spierecho gedurende een mediane periode 
van 27.5 maanden. De jongens kregen een spierecho van twee beenspieren (de m. rectus 
femoris en m. tibialis anterior) en twee armspieren (de m. biceps brachii en de flexoren van 
de onderarm). Elf van de achttien jongens werden ook getest door de fysiotherapeut. 
Zoals verwacht lieten de resultaten zien dat de echo-intensiteit toenam naarmate jongens 
ouder werden en lichamelijk achteruit gingen. De echo-intensiteit van de beenspieren 
was het meest gevoelig om veranderingen na een jaar aan te tonen. De spierdikte liet 
geen afname zien naarmate jongens ouder werden. De resultaten van dit onderzoek laten 
zien dat kwantitatieve spierechografie een praktisch, kindvriendelijk en betrouwbaar 
meetinstrument is voor de follow-up van jongens met DMD.       
Hoofdstuk 3 beschrijft de ontwikkeling en validatie van een nieuwe submaximale 
conditietest: de zes-minuten fietstest met mechanische ondersteuning. Submaximale 
conditietesten zijn de primaire uitkomstmaat in lopende klinische studies bij kinderen 
met een neuromusculaire aandoening (NMA), omdat zij gerelateerd zijn aan het 
functioneren in het dagelijks leven. Op dit moment is de meest gebruikte submaximale 
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conditietest voor kinderen met een NMA de zes-minuten looptest. Deze test is echter niet 
geschikt voor jongens met DMD die aan het einde van hun loopfase zijn of rolstoelafhan-
kelijk. Aangezien er momenteel interventiestudies worden opgezet voor oudere jongens 
met DMD is een geschikte submaximale conditietest nodig voor deze groep jongens. Het 
doel van dit onderzoek was een dergelijke test te ontwikkelen. Dit is de zes-minuten 
fietstest met mechanische ondersteuning geworden. Tijdens deze test proberen jongens 
in zes minuten tijd zoveel mogelijk omwentelingen te behalen met de benen en/of de 
armen op een fietsje met mechanische ondersteuning. De ondersteuning betekent dat 
als de jongens niet fietsen de trappers toch zeven keer per minuut rondgaan. Zo is het ook 
voor jongens met weinig spierkracht mogelijk te fietsen. In het tweede deel van het 
onderzoek is de uitvoerbaarheid van de zes-minuten fietstest beoordeeld bij gezonde 
jongens (n= 99) en jongens met DMD (n=30). Bij de gezonde jongens zijn ook de 
test-hertest betrouwbaarheid en de relatie met de zes-minuten looptest onderzocht. Bij 
de jongens met DMD is de relatie tussen de zes-minuten fietstest en de ziekte-ernst zoals 
gemeten met de Motor Function Measure (MFM) onderzocht. De resultaten lieten zien dat 
de fietstest voor de benen uitvoerbaar was voor 99% van de gezonde jongens en 97% van 
de jongens met DMD. De fietstest voor de armen was uitvoerbaar voor alle gezonde 
jongens en jongens met DMD. Zoals verwacht behaalden jongens met DMD minder 
omwentelingen met de benen en armen dan gezonde jongens. Bij de gezonde jongens 
was de fietstest reproduceerbaar. Zowel de test voor de benen (r = 0.58, p < 0.01) als de 
armen (r = 0.65, p < 0.01) correleerden positief met de zes-minuten looptest. In de totale 
groep van jongens met DMD correleerde de fietstest voor de benen positief met de 
totaalscore van de MFM (ρ = 0.65, p < 0.01). Bij rolstoelafhankelijke jongens met DMD 
correleerde ook de fietstest voor de armen positief met de MFM (ρ = 0.84, p < 0.01). De 
zes-minuten fietstest is derhalve een geschikt meetinstrument voor longitudinale studies 
bij kinderen met een NMA die de mogelijkheid om te lopen verliezen. 
Hoofdstuk 4 beschrijft de gezondheidsgerelateerde kwaliteit van leven bij jongens met 
DMD. De gezondheidsgerelateerde kwaliteit van leven wordt gezien als een belangrijke 
uitkomstmaat in klinisch onderzoek, omdat het inzicht geeft in de ervaren gezondheid 
van de deelnemers. Dit onderzoek had drie doelen. Als eerste zijn verschillende domeinen 
van kwaliteit van leven (zoals lichamelijk welzijn en zelfbeeld) onderzocht bij veertig 
jongens met DMD. Negentien van deze veertig jongens waren lopers, 14 jongens waren 
rolstoelafhankelijk en hadden een goede armfunctie en 7 jongens waren rolstoelafhanke-
lijk en hadden een beperkte armfunctie. Als tweede is de gezondheidsgerelateerde 
kwaliteit van leven van deze jongens vergeleken met de perceptie van de ouders. Als 
laatste is de relatie tussen de gezondheidsgerelateerde kwaliteit van leven en de functies 
en activiteiten van de jongens onderzocht. De verwachting was dat DMD een negatieve 
invloed zou hebben op de gezondheidsgerelateerde kwaliteit van leven, wat gunstig 
beïnvloed zou kunnen worden door een interventie. De gezondheidsgerelateerde 
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kwaliteit van leven is gemeten met de KIDSCREEN-52 vragenlijst. De scores van de jongens 
met DMD zijn vergeleken met normwaarden van gezonde Nederlandse leeftijdsgenoten. 
De resultaten lieten zien dat jongens met DMD alleen hun “Lichamelijk welzijn” minder 
goed ervaren dan gezonde leeftijdsgenoten. De gezondheidsgerelateerde kwaliteit van 
leven was niet gerelateerd aan de functies en activiteiten van de jongens. Dit betekent dat 
DMD en de progressie van de ziekte de gezondheidsgerelateerde kwaliteit van leven niet 
nadelig beïnvloeden. De perceptie van de ouders is echter dat hun zoons lager scoren op 
de domeinen “Zelfbeeld”, “Stemming en emoties”, en “Pesten”. Het is belangrijk ouders te 
wijzen op deze onderwaardering. 
Deel 2 Training bij jongens met Duchenne spierdystrofie
Hoofdstuk 5 beschrijft de onderzoeksvragen, hypothesen en onderzoeksmethoden van 
de NUD studie. De NUD studie is het eerste gerandomiseerd gecontroleerde onderzoek 
(RCT) naar de effecten van fysieke training bij jongens met DMD. Het is ook het eerste 
onderzoek dat de effecten van een fysieke training met mechanische ondersteuning 
heeft onderzocht. De hypothese was dat regelmatige training met ondersteuning, en dus 
met een lage trainingsintensiteit, de secundaire functionele achteruitgang als gevolg van 
disuse zou tegengaan. De NUD studie bestond uit twee sub-studies die de uitvoerbaarheid, 
veiligheid en effectiviteit van (1) een fietstraining voor de benen en armen met traponder-
steuning en (2) een functionele training met dynamische armondersteuning hebben 
onderzocht. 
 Substudie 1 (zie hoofdstuk 6) was een RCT met multipele baselinemetingen. Het doel 
was 30 jongens met DMD mee te laten doen die aan het eind van hun loopfase waren 
of recent rolstoelafhankelijk waren geworden. Jongens werden op basis van loting 
toegewezen aan een trainings- of een controlegroep. Na een periode van acht weken 
waarin uitgangsmetingen werden gedaan startte de trainingsgroep met de 24-weken 
durende fietstraining, terwijl de controlegroep geen specifieke interventie kreeg 
(standaard zorg). De trainingsgroep fietste vijf keer per week, 15 minuten met de benen en 
15 minuten met de armen. Het fietsen deden zij op een fiets (bewegingstrainer) met 
ondersteuning, die zorgde voor ten minste zeven omwentelingen per minuut als er niet 
actief gefietst werd. Jongens werden geïnstrueerd met een constant tempo van ongeveer 
65 omwentelingen per minuut te fietsen met een ervaren vermoeidheid van “een beetje 
moe” tot “iets meer moe”. De ervaren vermoeidheid werd gemeten met de OMNI schaal 
voor ervaren vermoeidheid. Jongens trainden thuis of op school. De controlegroep kreeg 
dezelfde fietstraining na een controleperiode (wachtlijstperiode). De trainings- en 
controlegroep zijn gemeten tot respectievelijk 56 en 60 weken na de start van de studie. 
De primaire uitkomstmaten waren de MFM en de zes-minuten fietstest met ondersteuning 
voor de benen en armen. De MFM meet de motorische functies (in deze studie 
omschreven als de functionele mogelijkheden), terwijl de zes-minuten fietstest met 
ondersteuning het submaximale uithoudingsvermogen meet. Secundaire uitkomstmaten 
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waren de Pediatric Evaluation of Disability Inventory (PEDI), tijdsgebonden functionele 
testen, spierkracht, gewrichtsmobiliteit en spierechografie. Bijwerkingen tijdens de trainings-
periode zijn gemeten met vragenlijsten en huisbezoeken door de onderzoeker. Groeps-
verschillen tussen de trainings- en controlegroep zijn gemeten met een covariantie- 
analyse (ANCOVA). Het primaire eindpunt was na 24 weken trainen/controle periode. 
 Substudie 2 (zie hoofdstuk 7) was haalbaarheidsstudie zonder controle personen. Het 
doel was tien rolstoelafhankelijke jongens met DMD mee te laten doen die problemen 
hadden met het reiken en optillen van de armen. Na een baselineperiode van acht weken 
kregen alle jongens een dynamische armondersteuner voor hun niet-dominante arm. 
Met de armondersteuner trainden zij gedurende 24 weken het voorwaarts en zijwaarts 
reiken door het spelen van een virtual reality computerspel (vijf dagen per week, vijf 
spellen per dag). Hierbij werd de jongens gevraagd ten minste twee keer per week met de 
armondersteuner te eten. De jongens werden na 12 en 24 (primaire eindpunt) weken 
trainen beoordeeld. Een laatste follow-up meting werd 12 weken na het eind van de 
training gedaan. Therapietrouw en veiligheid werden gemeten met een tweewekelijkse 
vragenlijst en huisbezoeken door de onderzoeker. De primaire uitkomstmaat voor het 
evalueren van de effectiviteit van de training was de Action Research Arm Test (ARAT). De 
ARAT meet de motorische functies (in deze studie omschreven als de functionele 
mogelijkheden) van de bovenste extremiteit. Secundaire uitkomstmaten waren de derde 
dimensie van de MFM (“Distale motorische functies”), de Nine-hole Peg Test, en de Jebsen 
Taylor Hand Function Test. De haalbaarheid, veiligheid en effectiviteit van de training zijn 
beschreven per deelnemer. De ongetrainde arm diende hierbij als referentie voor de 
getrainde arm. 
Hoofdstuk 6 beschrijft de resultaten van de fietstraining voor de benen en armen met 
mechanische ondersteuning (zie hoofdstuk 5). Dertig jongens met DMD met een 
gemiddelde leeftijd van 10.5 jaar werden ingeloot in een trainings- (n = 17) of controlegroep 
(n = 13). Achttien jongens waren ambulant en 12 jongens rolstoelafhankelijk. Op één 
jongen na hebben alle jongens uit de trainingsgroep de fietstraining afgerond. Na 24 
weken trainen was de totale MFM score stabiel gebleven in de trainingsgroep terwijl deze 
was afgenomen in de controlegroep (verschil tussen de trainings- en controlegroep bij 24 
weken gecorrigeerd voor baseline = 4.9, 95% betrouwbaarheidsinterval = 2.2 - 7.6). Er zijn 
geen effecten gevonden voor de zes-minuten fietstest voor de benen (Δ = 5.6, 95% 
 betrouwbaarheidsinterval = −56.2 - 67.3), de armen (Δ = 13.8, 95% betrouwbaarheidsinterval = 
−60.7 - 88.3) of de secundaire uitkomstmaten. Na de controleperiode hebben acht van de 
13 jongens uit de controlegroep alsnog dezelfde fietstraining afgerond. Na 24 weken 
trainen lieten zij dezelfde stabilisatie op de MFM zien als de trainingsgroep. Er werden 
geen nadelige bijwerkingen van de training gevonden. De resultaten van dit onderzoek 
lieten zien dat een fietstraining met mechanische ondersteuning voor de benen en 
armen haalbaar en veilig is voor ambulante en rolstoelafhankelijke jongens met DMD. De 
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training vertraagde de secundaire functionele achteruitgang als gevolgd van ‘disuse’ bij 
de deelnemers gedurende de trainingsperiode en lijkt hiermee een zinvolle aanvulling op 
het behandelprogramma van jongens met DMD. 
In hoofdstuk 7 worden de resultaten van de haalbaarheid, veiligheid en effectiviteit van 
de functionele training met dynamische armondersteuning beschreven. Acht rolstoel-
afhankelijk jongens in de leeftijd van 12 tot 20 jaar kregen een armondersteuning voor 
hun niet-dominante arm. Zes van deze jongens hebben het trainingsprogramma afgerond. 
De andere twee jongens zijn halverwege de training gestopt met deelname aan het 
onderzoek om praktische redenen. Er zijn geen bijwerkingen van de training gevonden. 
Vier van de zes jongens die de training hebben afgerond hadden een grotere afname 
op de ARAT met hun ongetrainde (verschillen in ARAT scores tussen baseline en 
24 weken trainen varieerden tussen de -4 en -21 punten) dan getrainde (verschillen in 
ARAT scores tussen baseline en 24 weken trainen varieerden tussen de -13 en 6 punten) 
arm. Vergelijkbare resultaten werden gevonden voor de secundaire uitkomstmaten. 
De resultaten zijn een eerste aanwijzing dat rolstoelafhankelijke jongens met DMD die een 
beperkte armfunctie hebben hun armen kunnen trainen met dynamische armonder-
steuning. 
In de algemene discussie (hoofdstuk 8) worden mechanismen beschreven die de 
gevonden vertraging in functionele achteruitgang door training met mechanische 
ondersteuning kunnen verklaren. Er wordt gesteld dat deze vertraging mogelijk te 
verklaren is door een optelsom van kleine effecten op het niveau van de spieren en 
gewrichten, het hart- en vaatstelsel, en het centraal zenuwstelsel. Verder onderzoek naar 
de effecten van fysieke training (al dan niet met mechanische ondersteuning) bij jongens 
met DMD is nodig om de onderliggende werkingsmechanismen beter te kunnen 
begrijpen en specifieke trainingsrichtlijnen voor deze jongens te kunnen opstellen. Dit 
toekomstige onderzoek zal gebruik moeten maken van betrouwbare meetinstrumenten 
die aansluiten bij het ziektestadium van de deelnemers en (kleine) veranderingen in de 
loop van de tijd kunnen meten. Op dit moment kan aan  jongens met DMD, hun ouders 
en behandelend (para)medici worden geadviseerd dat een training met mechanische 
ondersteuning een zinvolle aanvulling kan zijn op het behandelprogramma om de 
lichamelijke achteruitgang als gevolg van disuse te vertragen.   
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